N (2010-2018)

STUDIES ON CONDITIONS and RELATED ARTICLES 2010-2018


+Studies in 2000-2009 List
*Studies in Pre-2000 List
>Information in Another Section

>NAIL-PATELLA SYNDROME + (See News Articles 2010-2018)
NARCOLEPSY
NAUSEA*+ (See Also MORNING SICKNESS, MOTION SICKNESS, RADIATION-INDUCED NAUSEA)
NEOINTIMA (Thickening of Arterial Walls)
NEUROGENESIS (Formation of New Neurons)
NEUROMA (Growth or Tumor on Nerve Tissue – Tend to be Benign (Non-Cancerous)
NEUROMYELITIS OPTICA/DEVICA’S DISEASE (Disorder Causing Swelling of Eye Nerves)
NEURONS/BRAIN CELLS*+
NEUROPATHIC PAIN*+
NEUROPROTECTION*+
>NIEMANN-PICK DISEASE (See Pre-2000 List)
NUTRITION-GENERAL*+ (See Also OMEGA-3/CB1 CONNECTION, METHODS OF USE-EDIBLES)
NUTRITION-HEMP SEED*+
NUTRITION-HEMP SEED OIL*+ (See Also OMEGA-3/CB1 CONNECTION)
NUTRITION-HEMP SEED PROTEIN ISOLATES/POWDERS
NUTRITION-HIGH FAT DIET and the ENDOCANNABINOID SYSTEM


NARCOLEPSY
Marijuana helps narcolepsy (case report–undated) http://cannabisclinicians.org/view-all-case-reports/entry/598/?pagenum=2
Urine Toxicology Screen in Multiple Sleep Latency Test: The Correlation of Positive  Tetrahydrocannabinol, Drug Negative Patients, and Narcolepsy (full–2014)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4298782/
Marijuana helps narcolepsy (case report–undated) http://cannabisclinicians.org/view-all-case-reports/entry/598/?pagenum=2
Emerging Drugs for Common Conditions of Sleepiness: Obstructive Sleep Apnea and
Narcolepsy (full–2015)  http://www.tandfonline.com/doi/full/10.1517/14728214.2015.1115480


NAUSEA*+
Preliminary efficacy and safety of an oromucosal standardized cannabis extract in chemotherapy-induced nausea and vomiting (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2997305/pdf/bcp0070-0656.pdf
Motion Sickness, Stress and the Endocannabinoid System (full-2010)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2873996/?tool=pmcentrez
Cannabinoid-Induced Hyperemesis: A Conundrum—From Clinical Recognition to Basic Science Mechanisms (full-2010) http://www.mdpi.com/1424-8247/3/7/2163/htm
Mechanisms of Broad-Spectrum Antiemetic Efficacy of Cannabinoids against Chemotherapy-Induced Acute and Delayed Vomiting (full–2010)  http://www.mdpi.com/1424-8247/3/9/2930/htm
Information for Health Care Professionals- Marihuana (marijuana, cannabis) dried plant
for administration by ingestion or other means (Health Canada) (full – 2010)
http://www.hc-sc.gc.ca/dhp-mps/marihuana/med/infoprof-eng.php
Pharmacology and toxicology of Cannabis derivatives and endocannabinoid agonists (link to download–2010) http://www.eurekaselect.com/85221/article
The abuse potential of the synthetic cannabinoid nabilone (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20402993
Cannabidiol, a Non-Psychotropic Component of Cannabis, Attenuates Vomiting and Nausea-like Behaviour via Indirect Agonism of 5-HT(1A) Somatodendritic: Auto-receptors in the Dorsal Raphe Nucleus (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3423241/
Regulation of nausea and vomiting by cannabinoids (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165951/
The intersection between cannabis and cancer in the United States (full–2011) http://www.croh-online.com/article/S1040-8428(11)00231-9/fulltext
Medical Marijuana: Can Pot Help Pregnant Women With Vomiting and Nausea? (article–2011) http://patients4medicalmarijuana.wordpress.com/2011/01/13/pregnancy-and-medical-marijuana-can-pothelp-pregnant-women-with-vomiting-and-nausea/
Interaction between non-psychotropic cannabinoids in marihuana: effect of cannabigerol (CBG) on the anti-nausea or anti-emetic effects of cannabidiol (CBD) in rats and shrews (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21243485
Medical cannabis: the opportunity versus the temptation (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/22352284
Cannabinoid hyperemesis syndrome: an underreported entity causing nausea and  vomiting of pregnancy (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21170540
Medical Marijuana: Clearing Away the Smoke (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3358713/
top
Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid? (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3579248/
The anti-nausea effects of CB(1) agonists are mediated by an action at the visceral insular cortex (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3492992/
The Therapeutic Potential of Cannabis and Cannabinoids (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3442177/
Tumor necrosis factor activation of vagal afferent terminal calcium is blocked by cannabinoids (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3342927/
Inhibition of monoacylglycerol lipase attenuates vomiting in Suncus murinus and 2-arachidonoyl glycerol attenuates nausea in rats (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3423233/
Effects of parabolic flight and spaceflight on the endocannabinoid system in humans  (download–2012) https://pdfs.semanticscholar.org/700c/01d83f2bc080f6ba242cc9c927394f5bf111.pdf
Cannabinoids in the treatment of chemotherapy-induced nausea and vomiting (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22491047
Effects of dronabinol on morphine-induced dopamine-related behavioral effects in animals (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22807156
Cannabidiolic acid prevents vomiting in Suncus murinus and nausea-induced behaviour in rats by enhancing 5-HT(1A) receptor activation (full-2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3596650/
Effect of low doses of cannabidiolic acid and ondansetron on LiCl-induced conditioned gaping (a model of nausea-induced behaviour) in rats (full-2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3682714/
Evaluation of the potential of the phytocannabinoids, cannabidivarin (CBDV) and Δ9 -tetrahydrocannabivarin (THCV), to produce CB1 receptor inverse agonism symptoms of nausea in rats (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3792004/
Anandamide transport inhibition by ARN272 attenuates nausea-induced behaviour in rats, and vomiting in shrews (Suncus murinus) (full–2013)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3949659/
Regulation of nausea and vomiting by cannabinoids and the endocannabinoid system  (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3883513/
Tetrahydrocannabinolic acid reduces nausea-induced conditioned gaping in rats and vomiting in Suncus murinus (full–2013)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3792001/
The Medical Necessity for Medicinal Cannabis: Prospective, Observational Study  Evaluating the Treatment in Cancer Patients on Supportive or Palliative Care (full–2013) http://cannabisclinicians.org/wp-content/uploads/2013/09/Med-Nec-for-Cannabis-in-Cancer-Israel.pdf
Dronabinol Treatment of Refractory Nausea and Vomiting Related to Peritoneal Carcinomatosis (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24052427
Therapeutic potential of cannabinoid medicines (full–2013) http://onlinelibrary.wiley.com/doi/10.1002/dta.1529/full
Additive antiemetic efficacy of low-doses of the cannabinoid CB1/2 receptor agonist Δ9-THC with ultralow-doses of the vanilloid TRPV1 receptor agonist resiniferatoxin in the least shrew (Cryptotis parva) (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24157976
top
2-arachidonoylglycerol interferes with lithium-induced vomiting in the house musk shrew, Suncus murinus (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23958470
Suppression of lithium chloride-induced conditioned gaping (a model of nausea-induced behaviour) in rats (using the taste reactivity test) with metoclopramide is enhanced by cannabidiolic acid (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24012649
Cannabinoids may be therapeutic in breast cancer (abst–2013)  http://resources.metapress.com/pdf-preview.axd?code=b831165531850165&size=largest
Additive antiemetic efficacy of 9-THC with vanilloid TRPV1 receptor agonists in the least shrew (Cryptotis parva) (abst-2013)  http://www.fasebj.org/content/27/1_Supplement/1093.20
Plasma Anandamide and Related N-acylethanolamide Levels are not Elevated in  Pregnancies Complicated by Hyperemesis Gravidarum (abst–2013)  http://www.ncbi.nlm.nih.gov/pubmed/24117326
Using cannabinoids in pain and palliative care (abst–2013)
https://www.magonlinelibrary.com/doi/10.12968/ijpn.2010.16.10.79211
Nabilone for Non-chemotherapy Associated Nausea and Weight Loss due to Medical  Conditions: A Review of the Clinical Effectiveness and Guidelines [Internet] (full–2014) http://www.ncbi.nlm.nih.gov/books/NBK253668/toc/?report=reader

Medical marijuana for cancer (full–2014) http://onlinelibrary.wiley.com/doi/10.3322/caac.21260/full
Medical marijuana: more questions than answers (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4243838/
K2-Not the Spice of Life; Synthetic Cannabinoids and ST Elevation Myocardial Infarction: A Case Report (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4371021/
Dexamethasone alleviates motion sickness in rats in part by enhancing the endo-cannabinoid system (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24508383
A comparison of cannabidiolic acid with other treatments for anticipatory nausea using a rat model of contextually elicited conditioned gaping (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24595502
Meta-analysis of adjunctive non-NK1 receptor antagonist medications for the control of acute and delayed chemotherapy-induced nausea and vomiting (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25145507
Effect of selective inhibition of monoacylglycerol lipase (MAGL) on acute nausea, anticipatory nausea, and vomiting in rats and Suncus murinus (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25085768
Therapeutic Potential of Cannabinoids in Counteracting Chemotherapy-induced Adverse Effects: An Exploratory Review (full–2014) http://onlinelibrary.wiley.com/doi/10.1002/ptr.5265/full
Potential applications of marijuana and cannabinoids in medicine (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25518584
Toward modulation of the endocannabinoid system for treatment of gastrointestinal  disease: FAAHster but not “higher” (abst–2014)  http://onlinelibrary.wiley.com/doi/10.1111/nmo.12329/full
The successful use of dronabinol for failure to thrive secondary to intestinal dysmotility (full–2015) http://www.casereports.com/article/S2210-2612%2815%2900219-9/pdf
Cannabis in cancer care (full–2015) http://onlinelibrary.wiley.com/doi/10.1002/cpt.108/full
top

Cannabinoid hyperemesis syndrome: Marijuana is both antiemetic and proemetic (full–2015) http://www.ccjm.org/index.php?id=107953&tx_ttnews%5Btt_news%5D=412809&cHash=0c1f8670f2fa499ee88aeff79ee2a47e
Cannabinoids for Medical Use A Systematic Review and Meta-analysis (full–2015) http://jama.jamanetwork.com/article.aspx?articleid=2338251&resultClick=24
Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders (full–2015)
http://ascpjournal.biomedcentral.com/articles/10.1186/s13722-015-0032-7
Novel associations between FAAH genetic variants and postoperative central opioid related adverse effects (full–2015)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4492912/
Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy  (full–2015) http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD009464.pub2/full
Medical marijuana: Hints of headway? Despite a conflicted regulatory landscape, support for medical marijuana is growing amid increasing evidence of potential benefits (Part 2 of 2) (article–2015) http://onlinelibrary.wiley.com/doi/10.1002/cncy.21524/full
Medical Marijuana: Is the Cart Before the Horse? (1st page–2015) http://jama.jamanetwork.com/article.aspx?articleid=2338230
Intra-visceral insular cortex 2-arachidonoylglycerol, but not N-arachidonoylethanolamide, suppresses acute nausea-induced conditioned gaping in rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25499318
The role of cannabinoids in regulation of nausea and vomiting, and visceral pain (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25715910
Cannabinoids suppress acute and anticipatory nausea in pre-clinical rat models of conditioned gaping (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25691302
Synergy between cannabidiol, cannabidiolic acid, and Δ⁹-tetrahydrocannabinol in the regulation of emesis in the Suncus murinus (house musk shrew) (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26030435
Interference with acute nausea and anticipatory nausea in rats by fatty acid amide hydrolase (FAAH) inhibition through a PPARα and CB1 receptor mechanism, respectively: a double dissociation (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26297326
Cannabis – therapy for the future? (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26375695
Effect of combined doses of Δ9-tetrahydrocannabinol (THC) and cannabidiolic acid (CBDA) on acute and anticipatory nausea using rat (Sprague- Dawley) models of conditioned gaping (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26381155
top
Neuromotor tolerability and behavioural characterisation of cannabidiolic acid, a phytocannabinoid with therapeutic potential for anticipatory nausea (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26439367
Endocannabinoid regulation of nausea is mediated by 2-arachidonoylglycerol (2-AG) in the rat visceral insular cortex (abst–2015) http://www.sciencedirect.com/science/article/pii/S0028390815301623
Controlled release tablet formulation containing natural δ9 tetrahydrocannabinol (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5098422/
Endocannabinoid Mechanisms Influencing Nausea (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26638766
Intravenous Delta-9-Tetrahydrocannabinol to Prevent Postoperative Nausea and Vomiting: A Randomized Controlled Trial (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26426861
Cannabis and cancer: toward a new understanding (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791146/
Integrating cannabis into clinical cancer care (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791148/
Dronabinol for chemotherapy-induced nausea and vomiting unresponsive to antiemetics (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4869612/
The Gut-Itch Connection (full–2016) http://onlinelibrary.wiley.com/doi/10.1111/exd.12994/full
The involvement of TRPV1 in emesis and anti-emesis (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4843889/
A user’s guide to cannabinoid therapies in oncology (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5176373/
The role of the endocannabinoid system in the brain-gut axis (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4961581/
Hypophosphatemia in Users of Cannabis (full–2016) http://www.ajkd.org/article/S0272-6386(16)30414-0/fulltext
Elevation of 2-AG by monoacylglycerol lipase inhibition in the visceral insular cortex  interferes with anticipatory nausea in a rat model (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4793281/
Variants in the CNR1 gene predispose to headache with nausea in the presence of life  stress (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5347942/
A comparison of novel, selective fatty acid amide hydrolase (FAAH), monoacyglycerol  lipase (MAGL) or dual FAAH/MAGL inhibitors to suppress acute and anticipatory
nausea in rat models (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5531749/
Using Medical Cannabis in an Oncology Practice (article–2016)  http://www.cancernetwork.com/oncology-journal/using-medical-cannabis-oncology-practice#sthash.CjT8fR9n.uWvEhfSG.dpuf
Cannabis and Cannabinoids (1st page–2016)  http://jamanetwork.com/journals/jama/article-abstract/2592497
Medical use of cannabis products : Lessons to be learned from Israel and Canada (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26767992
Adverse effects after the use of JWH-210 – a case series from the EU Spice II plus project  (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26768345
Efficacy, tolerability, and safety of cannabinoids in gastroenterology : A systematic review (abst in German & English-2016)  https://link.springer.com/article/10.1007%2Fs00482-015-0087-0
Cannabinoid 2 (CB2) receptor agonism reduces lithium chloride-induced vomiting in Suncus murinus and nausea-induced conditioned gaping in rats (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27263826
Cannabinoids for Symptom Management and Cancer Therapy: The Evidence (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27407130
Effect of combined oral doses of Δ9-tetrahydrocannabinol (THC) and cannabidiolic acid (CBDA) on acute and anticipatory nausea in rat models (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27438607
Novel Treatments for Cyclic Vomiting Syndrome: Beyond Ondansetron and Amitriptyline (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27757817
Cannabis and Cannabinoids (PDQ®): Patient Version (full–2017)  https://www.ncbi.nlm.nih.gov/books/NBK65875/
Cannabis and Cannabinoids (PDQ®): Health Professional Version (full–2017)  https://www.ncbi.nlm.nih.gov/books/NBK65755/
Cannabis use among patients at a comprehensive cancer center in a state with legalized
medicinal and recreational use (full–2017)  http://onlinelibrary.wiley.com/doi/10.1002/cncr.30879/full
Overview of Chemotherapy-Induced Nausea and Vomiting and Evidence-Based  Therapies (full–2017) http://www.ajmc.com/journals/supplement/2017/managed-care-considerations-in-chemotherapy-induced-nausea-andvomiting/overview-of-chemotherapy-induced-nausea-and-vomiting-and-evidence-based-therapies-article/
Cannabis Use in Palliative Oncology: A Review of the Evidence for Popular Indications  (link to PDF–2017) https://www.ima.org.il/IMAJ/ViewArticle.aspx?aId=4043
Systematic review of safeness and therapeutic efficacy of cannabis in patients with  multiple sclerosis, neuropathic pain, and in oncological patients treated with  chemotherapy (abst in English–2017) https://www.ncbi.nlm.nih.gov/pubmed/29119763  (full in Italian) http://www.epiprev.it/articolo_scientifico/revisione-sistematica-sull%E2%80%99efficacia-terapeutica-e-la-sicurezza-della-cannabis
Role of cannabis in digestive disorders (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/27792038
A randomized-controlled trial of nabilone for the prevention of acute postoperative  nausea and vomiting in elective surgery. (abst in English & French–2017)  https://link.springer.com/article/10.1007%2Fs12630-017-0814-3
Concise review of the management of iatrogenic emesis using cannabinoids: emphasis on nabilone for chemotherapy-induced nausea and vomiting (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28235999
Cannabinoid signaling in health and disease (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28263083
Cannabinoid Receptor Type 1 and mu-Opioid Receptor Polymorphisms Are Associated  With Cyclic Vomiting Syndrome (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28349993
Resolution of cannabis hyperemesis syndrome with topical capsaicin in the emergency  department: a case series (abst–2017)  http://www.tandfonline.com/doi/abs/10.1080/15563650.2017.1324166?journalCode=ictx20
Experts’ Perspectives on the Role of Medical Marijuana in Oncology: a semi-structured  interview study (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28040884
Medical Cannabinoids in Children and Adolescents: A Systematic Review (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29061872
Cannabinoids for nausea and vomiting related to chemotherapy: Overview of systematic  reviews (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29168289
Are cannabinoids effective for the management of chemotherapy induced nausea and  vomiting? (abst in English, link to abst in Spanish–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29286355
The therapeutic effects of Cannabis and cannabinoids: An update from the National  Academies of Sciences, Engineering and Medicine report (abst–2018)  https://www.ncbi.nlm.nih.gov/pubmed/29325791
Practical considerations in medical cannabis administration and dosing (full–2018)
http://www.ejinme.com/article/S0953-6205(18)30004-9/fulltext
Rates of cannabis use in patients with cancer (full–2018)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6023560/
Therapeutic potential of medicinal marijuana: an educational primer for health care
professionals (full–2018) 
https://www.dovepress.com/therapeutic-potential-of-medicinal-marijuana-an-educational-primer-for-peer-reviewed-fulltext-articleDHPS
Suppression of Cisplatin-Induced Vomiting by Cannabis sativa in Pigeons: Neurochemical Evidences (full–2018) https://www.frontiersin.org/articles/10.3389/fphar.2018.00231/full
Dronabinol oral solution in the management of anorexia and weight loss in AIDS and
cancer (full–2018) 
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5896684/
Prospective analysis of safety and efficacy of medical cannabis in large unselected
population of patients with cancer (abst–2018) 
https://www.ncbi.nlm.nih.gov/pubmed/29482741
Recommendations From Cannabis Dispensaries About First-Trimester Cannabis Use  (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29742676
Epidemiology, Clinical Characteristics, and Associations for Rome IV Functional Nausea
and Vomiting Disorders in Adults (abst–2018) 
https://www.ncbi.nlm.nih.gov/pubmed/29857155
Cannabinoids in Patients with Nausea and Vomiting Associated with Malignancy and Its Treatments (1st page-2018) https://www.amjmed.com/article/S0002-9343(18)30033-0/fulltext
Safety and efficacy of nabilone for acute chemotherapy-induced vomiting prophylaxis in
pediatric patients: A multicenter, retrospective review (abst–2018)
https://www.ncbi.nlm.nih.gov/pubmed/30051617


NEOINTIMA
Targeting cannabinoid receptor CB2 in cardiovascular disorders: promises and controversies (full–2012) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2012.02042.x/pdf
Cannabinoid receptor CB2 protects against balloon-induced neointima formation (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3774259/
Endogenous cannabinoid receptor CB1 activation promotes vascular smooth muscle cell proliferation and neointima formation (full–2013) http://www.jlr.org/content/early/2013/03/11/jlr.M035147.long
Magnolol inhibits migration of vascular smooth muscle cells via cytoskeletal remodeling pathway to attenuate neointima formation (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23906924
Abstract 577: Medical Marijuana Use: Effect on Lipid Metabolism and Atherosclerosis  (abst–2015) http://atvb.ahajournals.org/content/35/Suppl_1/A577
top


NEUROGENESIS +
Cannabinoid receptor CB1 mediates baseline and activity-induced survival of new neurons in adult hippocampal neurogenesis (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2898685/?tool=pmcentrez
Loss of retrograde endocannabinoid signaling and reduced adult neurogenesis in diacylglycerol lipase knock-out mice (full-2010) http://www.jneurosci.org/content/30/6/2017.long
Converging action of alcohol consumption and cannabinoid receptor activation on adult hippocampal neurogenesis (full–2010) http://ijnp.oxfordjournals.org/content/13/2/191.long
The cannabinoid WIN55212-2 promotes neural repair after neonatal hypoxia-ischemia  (full-2010) http://stroke.ahajournals.org/content/41/12/2956.long
CB2: a cannabinoid receptor with an identity crisis (full–2010)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931549/?tool=pubmed
The development of cannabinoid CBII receptor agonists for the treatment of central  neuropathies (link to download–2010) http://www.eurekaselect.com/85808/article
CB1 receptor deficiency decreases wheel-running activity: consequences on emotional behaviours and hippocampal neurogenesis (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20138171
Cannabidiol Reduces Aβ-Induced Neuroinflammation and Promotes Hippocampal Neurogenesis through PPARγ Involvement (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3230631/?tool=pubmed
CB2 Cannabinoid Receptors Promote Neural Progenitor Cell Proliferation via mTORC1 Signaling (full–2011) http://www.jbc.org/content/287/2/1198.full
N-Docosahhexanoyllethanolamide promotes development of hippocampal neurons (full–2011) http://www.biochemj.org/content/435/2/327
EFFECT OF CANNABIS SATIVA ALCOHOLIC EXTRACT ON HIPPOCAMPUS NEURONAL DENSITY IN RATS (abst–2011) http://en.journals.sid.ir/ViewPaper.aspx?ID=258946
EFFECT OF AQUATIC EXTRACT OFCANNABIS SATIVA LEAVES ON DEGENERATION OF ALPHA MOTONEURONS IN SPINAL CORD AFTER SCIATIC NERVE COMPRESSION IN RATS (abst–2011) http://en.journals.sid.ir/ViewPaper.aspx?ID=258699
Can the benefits of cannabinoid receptor stimulation on neuroinflammation, neurogenesis and memory during normal aging be useful in AD prevention? (full–2012) http://www.jneuroinflammation.com/content/9/1/10
Endocannabinoids via CB₁ receptors act as neurogenic niche cues during cortical development (full–2012) http://rstb.royalsocietypublishing.org/content/367/1607/3229.long
The endocannabinoid, anandamide, augments Notch-1 signaling in cultured cortical  neurons exposed to amyloid-β and in the cortex of aged rats (full–2012)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3464574/
Relationships between dietary macronutrients and adult neurogenesis in the regulation of energy metabolism (full–2013) http://journals.cambridge.org/action/displayFulltext?type=6&fid=8904779&jid=BJN&volumeId=109&issueId=09&aid=8904778&bodyId=&membershipNumber=&societyETOCSession=&fulltextType=RV&fileId=S000711451200579X
Cannabinoids, Neurogenesis and Antidepressant Drugs: Is there a Link? (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3648779/
Activation of Type 1 Cannabinoid Receptor (CB1R) Promotes Neurogenesis in Murine Subventricular Zone Cell Cultures (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0063529
The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system (full–2013) http://ijnp.oxfordjournals.org/content/16/6/1407.long
Neuroimmmune interactions of cannabinoids in neurogenesis: focus on interleukin-1β (IL-1β) signalling (full–2013) http://www.biochemsoctrans.org/content/41/6/1577
top
CB2 cannabinoid agonist enhanced neurogenesis in GFAP/Gp120 transgenic mice displaying deficits in neurogenesis (full–2013)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3904265/
High hopes for CB(2) receptors in neurogenesis (full–2014) http://onlinelibrary.wiley.com/doi/10.1111/bph.12548/full
The cannabinoid CB2 receptor agonist AM1241 enhances neurogenesis in GFAP/Gp120 transgenic mice displaying deficits in neurogenesis (full–2014) http://onlinelibrary.wiley.com/doi/10.1111/bph.12478/full
Impaired Neurogenesis by HIV-1-Gp120 is Rescued by genetic deletion of Fatty Acid Amide Hydrolase Enzyme (full–2014)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4594266/
Nutritional omega-3 modulates neuronal morphology in the prefrontal cortex along with depression-related behaviour through corticosterone secretion (full–2014) http://www.nature.com/tp/journal/v4/n9/full/tp201477a.html
Programming and reprogramming neural cells by (endo-) cannabinoids: from  physiological rules to emerging therapies (full–2014)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4765324/
Identification of Small Molecules That Selectively Inhibit Diacylglycerol Lipase–α Activity (full–2014) http://journals.sagepub.com/doi/full/10.1177/1087057113511111
Blockade of 2-arachidonoylglycerol hydrolysis produces antidepressant-like effects and enhances adult hippocampal neurogenesis and synaptic plasticity (full–2015) http://onlinelibrary.wiley.com/doi/10.1002/hipo.22344/full
Potential Therapeutical Contributions of the Endocannabinoid System towards Aging and Alzheimer’s Disease (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4567222/
Pharmacological activation of CB2 receptors counteracts the deleterious effect of ethanol on cell proliferation in the main neurogenic zones of the adult rat brain (full–2015) http://journal.frontiersin.org/article/10.3389/fncel.2015.00379/full
The role of cannabinoids in adult neurogenesis (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4543605/
CB1 cannabinoid receptor enrichment in the ependymal region of the adult human spinal cord (full–2015) http://www.nature.com/articles/srep17745
Ultra-low doses of tetrahydrocannabinol contribute to the survival of newly-born cells in the dentate gyrus of adult rats (2 pages–2015)  http://link.springer.com/article/10.1134/S1819712415030046
Influence of single and repeated cannabidiol administration on emotional behavior and markers of cell proliferation and neurogenesis in non-stressed mice (abst–2015) http://www.sciencedirect.com/science/article/pii/S027858461530004X
ACEA (a highly selective cannabinoid CB1 receptor agonist) stimulates hippocampal neurogenesis in mice treated with antiepileptic drugs (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26225920
Dual effects of the non-esterified fatty acid receptor ‘GPR40’ for human health (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25615413
Cannabinoid receptor signaling induces proliferation but not neurogenesis in the mouse  olfactory epithelium (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4973592/
Cannabinoid Type-2 Receptor Drives Neurogenesis and Improves Functional Outcome After Stroke (full–2016) http://stroke.ahajournals.org/content/48/1/204.long
Cannabidiol, neuroprotection and neuropsychiatric disorders (abst–2016) http://www.sciencedirect.com/science/article/pii/S1043661816000396 Immunohistochemical distribution of the cannabinoid receptor 1 and fatty acid amide hydrolase in the dog claustrum (abst–2016) http://www.sciencedirect.com/science/article/pii/S0891061815300405
Functional effects of cannabinoids during dopaminergic specification of human neural precursors derived from induced pluripotent stem cells (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27027565
Distinctive effects of eicosapentaenoic and docosahexaenoic acids in regulating neural stem cell fate are mediated via endocannabinoid signalling pathways (abst–2016) http://www.sciencedirect.com/science/article/pii/S0028390816301277
Cannabidiol reduces neuroinflammation and promotes neuroplasticity and functional recovery after brain ischemia (abst–2016) http://www.sciencedirect.com/science/article/pii/S0278584616302524
Cannabidiol Activates Neuronal Precursor Genes in Human Gingival Mesenchymal Stromal Cells (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27918106
In vivo Evidence for Therapeutic Properties of Cannabidiol (CBD) for Alzheimer’s Disease  (full–2017)  http://journal.frontiersin.org/article/10.3389/fphar.2017.00020/full
A Long-Term Treatment with Arachidonyl-2′-Chloroethylamide Combined with Valproate Increases Neurogenesis in a Mouse Pilocarpine Model of Epilepsy (full–2017) http://www.mdpi.com/1422-0067/18/5/900
Plastic and Neuroprotective Mechanisms Involved in the Therapeutic Effects of  Cannabidiol in Psychiatric Disorders (full–2017)  http://journal.frontiersin.org/article/10.3389/fphar.2017.00269/full
Modulation of Astrocyte Activity by Cannabidiol, a Nonpsychoactive Cannabinoid (full–2017) http://www.mdpi.com/1422-0067/18/8/1669/htm
Interaction between Cannabinoid Type 1 and Type 2 Receptors in the Modulation of  Subventricular Zone and Dentate Gyrus Neurogenesis (full–2017)  http://journal.frontiersin.org/article/10.3389/fphar.2017.00516/full
An Update on Safety and Side Effects of Cannabidiol: A Review of Clinical Data and  Relevant Animal Studies (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5569602/
Interplay Between n-3 and n-6 Long-Chain Polyunsaturated Fatty Acids and the  Endocannabinoid System in Brain Protection and Repair (full–2017)  https://link.springer.com/article/10.1007%2Fs11745-017-4292-8
AM1241 alleviates MPTP-induced Parkinson’s disease and promotes the regeneration of  DA neurons in PD mice (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5620217/
Cannabinoid Modulation of the Stressed Hippocampus (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5742214/
HDAC1 and HDAC3 Underlie Dynamic H3K9 Acetylation During Embryonic Neurogenesis and in Schizophrenia-like Animals (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28300292
AM1241 alleviates MPTP-induced Parkinson’s disease and promotes the regeneration of  DA neurons in PD mice (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28733540
Maternal Cannabinoid Use Alters Cannabinoid (CB1) and Endothelin (ETB) Receptor  Expression in the Brains of Dams but Not Their Offspring (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29131068


NEUROMA
Mechanisms and treatment of painful neuromas (full–2018)  https://www.degruyter.com/view/j/revneuro.ahead-of-print/revneuro-2017-0077/revneuro-2017-0077.xml


NEUROMYELITIS OPTICA/DEVICA’S DISEASE
The major brain endocannabinoid 2-AG controls neuropathic pain and mechanical hyperalgesia in patients with neuromyelitis optica (full–2012) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0071500
top


NEURONS/BRAIN CELLS*+
Cyclooxygenase-2 Mediates Anandamide Metabolism in the Mouse Brain (full–2010) http://jpet.aspetjournals.org/content/335/2/380.full?sid=af53ea87-ab4b-426e-9c7e-8f750e9c4a17
Cannabinoids Excite Circadian Clock Neurons (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2927117/?tool=pmcentrez
Cannabinoid receptor CB1 mediates baseline and activity-induced survival of new neurons in adult hippocampal neurogenesis (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2898685/?tool=pmcentrez
Delta9-tetrahydrocannabinol is a full agonist at CB1 receptors on GABA neuron axon terminals in the hippocampus (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2882293/pdf/nihms200194.pdf
AAV vector-mediated overexpression of CB1 cannabinoid receptor in pyramidal neurons of the hippocampus protects against seizure-induced excitoxicity (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3006205/?tool=pubmed
CB1 cannabinoid receptors increase neuronal precursor proliferation through AKT / glycogen synthase kinase-3beta/beta-catenin signaling (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2843172/?tool=pubmed
Converging action of alcohol consumption and cannabinoid receptor activation on adult hippocampal neurogenesis (full–2010) http://ijnp.oxfordjournals.org/content/13/2/191.long
Endocannabinoids Prevent β-Amyloid-mediated Lysosomal Destabilization in Cultured Neurons (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2992287/
The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2970523/
Regulatory Role of Cannabinoid Receptor 1 in Stress-Induced Excitotoxicity and Neuroinflammation (full-2010) http://www.nature.com/npp/journal/vaop/ncurrent/full/npp2010214a.html
Dynamic changes of CB1-receptor expression in hippocampi of epileptic mice and  humans (full–2010)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2909018/
The cannabinoid WIN55212-2 promotes neural repair after neonatal hypoxia-ischemia  (full-2010) http://stroke.ahajournals.org/content/41/12/2956.long
CB2: a cannabinoid receptor with an identity crisis (full–2010)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931549/?tool=pubmed
A model of endocannabinoid 2-AG-mediated depolarization-induced suppression of
inhibition (article–2010)  http://www.biomedcentral.com/content/pdf/1471-2202-11-S1-P189.pdf
Endocannabinoids: Going retro with DAGLα (article–2010)  http://www.lipidmaps.org/update/2010/100401/full/nrn2824.html?s=cannabinoid
Adjuvant topical therapy with a cannabinoid receptor agonist in facial postherpetic
neuralgia (abst-2010) http://www.ncbi.nlm.nih.gov/pubmed/19744255
Effects of caffeine on striatal neurotransmission: focus on cannabinoid CB1 receptors  (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20087854
Palmitoylethanolamide and other anandamide congeners. Proposed role in the diseased
brain (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20353771
Protective effects of the synthetic cannabinoids CP55,940 and JWH-015 on rat brain  mitochondria upon paraquat exposure (abst–2010)  http://www.ncbi.nlm.nih.gov/pubmed/20514518
Dopamine modulation of excitatory currents in the striatum is dictated by the expression of D1 or D2 receptors and modified by endocannabinoids (abst–2010)  http://www.ncbi.nlm.nih.gov/pubmed/20092552
top
Cannabidiol Reduces Aβ-Induced Neuroinflammation and Promotes Hippocampal Neurogenesis through PPARγ Involvement (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3230631/?tool=pubmed
A synaptogenic amide N-docosahexaenoylethanolamide promotes hippocampal development (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3215906/
A catalytically silent FAAH-1 variant drives anandamide transport in neurons (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3245783/
Sex difference in cell proliferation in developing rat amygdala mediated by
endocannabinoids has implications for social behavior (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2996668/?tool=pubmed
Dual inhibition of alpha/beta hydrolase domain 6 and fatty acid amide hydrolase
increases endocannabinoid levels in neurons (full–2011) http://www.jbc.org/content/early/2011/06/10/jbc.M110.202853.long
Endocannabinoid hydrolysis generates brain prostaglandins that promote neuroinflammation (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3249428/
CNS effects of CB2 cannabinoid receptors: beyond neuro-immuno-cannabinoid activity (full–2011) http://jop.sagepub.com/content/26/1/92.full
Activation of cannabinoid type 2 receptors inhibits HIV-1 envelope glycoprotein gp120-induced synapse loss (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3164336/
Cannabinoid receptor expression in HIV encephalitis and HIV-associated neuro-pathologic comorbidities (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3135748/
Cannabinoid receptor-mediated regulation of neuronal activity in the main olfactory bulb (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3397690/
Cannabinoid receptor agonist protects cultured dopaminergic neurons from the death by the proteasomal dysfunction (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3145842/?tool=pubmed
CB2 Cannabinoid Receptors Promote Neural Progenitor Cell Proliferation via mTORC1 Signaling (full–2011) http://www.jbc.org/content/287/2/1198.full
HIV-1 infection and alcohol abuse: neurocognitive impairment, mechanisms of neurodegeneration and therapeutic interventions (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3098312/
Cannabinoid Receptor Type 1 Protects Nigrostriatal Dopaminergic Neurons against MPTP Neurotoxicity by Inhibiting Microglial Activation (full–2011) http://www.jimmunol.org/content/187/12/6508.full?sid=c3422dd2-7ad0-42e4-a862-845dc670f7cf
Endocannabinoid 2-arachidonoylglycerol protects neurons against β-amyloid insults (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3052737/pdf/nihms266962.pdf
top
The Dopamine and Cannabinoid Interaction in the Modulation of Emotions and Cognition: Assessing the Role of Cannabinoid CB1 Receptor in Neurons Expressing Dopamine D1 Receptors (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3156975/
Pharmacological activation/inhibition of the cannabinoid system affects alcohol withdrawal-induced neuronal hypersensitivity to excitotoxic insults (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3158793/
Endocannabinoid signaling in the amygdala: anatomy, synaptic signaling, behavior, and adaptations to stress (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3236282/
The major central endocannabinoid directly acts at GABA(A) receptors (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3207709/
N-Docosahhexanoyllethanolamide promotes development of hippocampal neurons (full–2011) http://www.biochemj.org/content/435/2/327
Alterations in Corticolimbic Dendritic Morphology and Emotional Behavior in Cannabinoid CB1 Receptor–Deficient Mice Parallel the Effects of Chronic Stress (full–2011) http://cercor.oxfordjournals.org/content/21/9/2056.full
Sex difference in cell proliferation in developing rat amygdala mediated by  endocannabinoids has implications for social behavior (full–2011)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2996668/?tool=pubmed
Commentary: Functional Neuronal CB2 Cannabinoid Receptors in the CNS (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3137183/?tool=pubmed
Role of CB1 cannabinoid receptors on GABAergic neurons in brain aging (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3131310/?tool=pubmed
Nutritional omega-3 deficiency abolishes endocannabinoid-mediated neuronal functions (download–2011) https://hal.archives-ouvertes.fr/hal-00612705/document
Nutritional omega-3 deficiency abolishes endocannabinoid-mediated neuronal functions. Figure 1: n-3/n-6 PUFA dietary imbalance alters PUFAs level in mouse brain  (charts–2011) http://www.nature.com/neuro/journal/v14/n3/fig_tab/nn.2736_F1.html
Synaptic plasticity: A new partnership (article–2011) http://www.lipidmaps.org/update/2011/110201/full/nrn2972.html?s=cannabinoid
History of cannabis use is not associated with alterations in striatal dopamine D2/D3 receptor availability (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21890594
The Effect of Hypoxia on G Protein Coupled (CB1) Receptor Gene Expression in Cortical B50 Neurons in Culture (abst–2011) http://www.maxwellsci.com/jp/abstract.php?jid=BJPT&no=92&abs=05
The G protein-coupled cannabinoid-1 (CB(1)) receptor of mammalian brain: Inhibition by phthalate esters in vitro (abst-2011) http://www.ncbi.nlm.nih.gov/pubmed/21763743
α-Tocopherol and α-tocopheryl phosphate interact with the cannabinoid system in the rodent hippocampus (abst-2011) http://www.ncbi.nlm.nih.gov/pubmed/21843633
Plasticity in vagal afferent neurones during feeding and fasting: mechanisms and significance (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21062423
Effects of synthetic cannabinoids on electroencephalogram power spectra in rats (abst–2011) http://www.unboundmedicine.com/medline/ebm/record/21640532/abstract/Effects_of_synthetic_cannabinoids_on_electroencephalogram_power_spectra_in_rats_
Δ(9)-THC and WIN55,212-2 affect brain tissue levels of excitatory amino acids in a phenotype-, compound-, dose-, and region-specific manner (abst–2011) http://www.unboundmedicine.com/medline/ebm/record/21645556/abstract/%CE%94_9__THC_and_WIN55212_2_affect_brain_tissue_levels_of_excitatory_amino_acids_in_a_phenotype__compound__dose__and_region_specific_manner_
Palmitoylethanolamide restores myelinated-fibre function in patients with chemotherapy induced painful neuropathy (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/22229320
Effects of palmitoylethanolamide on release of mast cell peptidases and neurotrophic factors after spinal cord injury (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21354467
top
EFFECT OF CANNABIS SATIVA ALCOHOLIC EXTRACT ON HIPPOCAMPUS NEURONAL DENSITY IN RATS (abst–2011) http://en.journals.sid.ir/ViewPaper.aspx?ID=258946
EFFECT OF AQUATIC EXTRACT OFCANNABIS SATIVA LEAVES ON DEGENERATION OF ALPHA MOTONEURONS IN SPINAL CORD AFTER SCIATIC NERVE COMPRESSION IN RATS (abst–2011) http://en.journals.sid.ir/ViewPaper.aspx?ID=258699
Increased vulnerability to 6-hydroxydopamine lesion and reduced development of dyskinesias in mice lacking CB1 cannabinoid receptors (abst–2011) http://www.neurobiologyofaging.org/article/S0197-4580%2809%2900116-X/abstract
Neuropathology of sporadic Parkinson disease before the appearance of parkinsonism:  preclinical Parkinson disease (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/20862500
Endocannabinoids in nervous system health and disease: the big picture in a nutshell (full–2012) http://rstb.royalsocietypublishing.org/content/367/1607/3193.long
Type-1 Cannabinoid Receptor Signaling in Neuronal Development (full–2012) http://content.karger.com/produktedb/produkte.asp?DOI=000339075&typ=pdf
Endocannabinoids and the processing of value-related signals (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3270484/?tool=pubmed
Neuron to Astrocyte Communication via Cannabinoid Receptors Is Necessary for Sustained Epileptiform Activity in Rat Hippocampus (full–2012) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0037320
Pathological plasticity in fragile X syndrome (full–2012) http://www.hindawi.com/journals/np/2012/275630/
Palmitoylethanolamide exerts neuroprotective effects in mixed neuroglial cultures and organotypic hippocampal slices via peroxisome proliferator-activated receptor-α (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3315437/?tool=pubmed
Review article: The endocannabinoid system in normal and pathological brain ageing (full–2012) http://rstb.royalsocietypublishing.org/content/367/1607/3326.full?sid=161e7b36-5055-448b-962e-697c782e901d
Excitability of prefrontal cortical pyramidal neurons is modulated by activation of 98 intracellular type-2 cannabinoid receptors (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3295302/
Intrinsic Up-Regulation of 2-AG Favors an Area Specific Neuronal Survival in Different In Vitro Models of Neuronal Damage (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3527460/
Functional diversity on synaptic plasticity mediated by endocannabinoids (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3481528/
Endocannabinoids via CB₁ receptors act as neurogenic niche cues during cortical development (full–2012) http://rstb.royalsocietypublishing.org/content/367/1607/3229.long
The CB(2)-preferring agonist JWH015 also potently and efficaciously activates CB(1) in autaptic hippocampal neurons (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3601544/
Long-lasting potentiation of hippocampal synaptic transmission by direct cortical input is mediated via endocannabinoids (full–2012) http://jp.physoc.org/content/590/10/2305.full
The CB1 Cannabinoid Receptor Drives Corticospinal Motor Neuron Differentiation through the Ctip2/Satb2 Transcriptional Regulation Axis (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3545190/
Multiple functions of endocannabinoid signaling in the brain (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4273654/
Endocannabinoid-Goα signalling inhibits axon regeneration in Caenorhabditis elegans by antagonizing Gqα-PKC-JNK signalling (full–2012) http://www.nature.com/ncomms/journal/v3/n10/full/ncomms2136.html

Pharmacological manipulation of cannabinoid neurotransmission reduces neuro-inflammation associated with normal aging (full–2012) http://file.scirp.org/Html/1-8201656_23229.htm
Cortical basket cell dysfunction in schizophrenia (full–2012)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3381305/
Cannabinoid receptor-mediated regulation of neuronal activity and signaling in glomeruli of the main olfactory bulb (full-2012)  http://www.jneurosci.org/content/32/25/8475.long
siRNA knockdown of GPR18 receptors in BV-2 microglia attenuates N-arachidonoyl  glycine-induced cell migration (full–2012)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3493281/
Alelle specific differences in the activity of a novel cannabinoid receptor 1(CNR1) gene  intronic enhancer in hypothalamus, dorsal root ganglia and hippocampus (full–2012)
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3339935/
Cortisol-mediated adhesion of synovial fibroblasts is dependent on the degradation of  anandamide and activation of the endocannabinoid system (download-2012)  http://onlinelibrary.wiley.com/doi/10.1002/art.37684/pdf
Synaptic Targets of Δ9-Tetrahydrocannabinol in the Central Nervous System (full–2012)  http://perspectivesinmedicine.cshlp.org/content/early/2012/12/03/cshperspect.a012237.long
top
Psychopharmacology of the endocannabinoids: far beyond anandamide (full–2012) http://www.researchgate.net/publication/51201177_Psychopharmacology_of_the_endocannabinoids_far_beyond_anandamide
A cell population that strongly expresses the CB1 cannabinoid receptor in the ependyma of the rat spinal cord (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22791629
Mitochondrial CB(1) receptors regulate neuronal energy metabolism (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22388959
Effects of cannabinoids Δ(9)-tetrahydrocannabinol, Δ(9)-tetrahydrocannabinolic acid and cannabidiol in MPP(+) affected murine mesencephalic cultures (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22571976
Cannabinoid modulation of midbrain urocortin 1 neurones during acute and chronic stress (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22734681
Manipulating brain connectivity with δ(9)-tetrahydrocannabinol: A pharmacological resting state FMRI study (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22885247
Cannabinoid CB(1) receptor in the modulation of stress coping behaviour in mice: the role of serotonin and different forebrain neuronal subpopulations (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23000076
Olvanil acts on transient receptor potential vanilloid channel 1 and cannabinoid receptors to modulate neuronal transmission in the trigeminovascular system (abst–2012) http://journals.lww.com/pain/Abstract/2012/11000/Olvanil_acts_on_transient_receptor_potential.13.aspx
Unbalance of CB1 receptors expressed in GABAergic and glutamatergic neurons in a  transgenic mouse model of Huntington’s disease (abst–2012)  http://www.ncbi.nlm.nih.gov/pubmed/22207189
The endocannabinoid N-arachidonoyldopamine (NADA) exerts neuroprotective effects  after excitotoxic neuronal damage via cannabinoid receptor 1 (CB(1)) (abst–2012)
http://www.sciencedirect.com/science/article/pii/S0028390811005053

Type-1 (CB(1)) Cannabinoid Receptor Promotes Neuronal Differentiation and Maturation of Neural Stem Cells (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0054271
Orexin neurons use endocannabinoids to break obesity-induced inhibition (full–2013) http://www.pnas.org/content/110/24/9625.full
Signaling Pathways Involved in Striatal Synaptic Plasticity are Sensitive to Temporal Pattern and Exhibit Spatial Specificity (full–2013) http://www.ploscompbiol.org/article/info%3Adoi%2F10.1371%2Fjournal.pcbi.1002953
A biophysical model of endocannabinoid-mediated short term depression in hippocampal inhibition (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0058926
top
The endocannabinoid system, cannabinoids, and pain (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3820295/
Activation of Type 1 Cannabinoid Receptor (CB1R) Promotes Neurogenesis in Murine
Subventricular Zone Cell Cultures (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0063529
N-arachidonoyl-L-serine (AraS) possesses proneurogenic properties in vitro and in vivo after traumatic brain injury (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3734775/
Using the endocannabinoid system as a neuroprotective strategy in perinatal hypoxic-ischemic brain injury (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4146074/
HINT1 protein cooperates with cannabinoid 1 receptor to negatively regulate glutamate NMDA receptor activity (full–2013) http://www.molecularbrain.com/content/6/1/42
Obesity-driven synaptic remodeling affects endocannabinoid control of orexinergic neurons (full–2013) http://www.pnas.org/content/110/24/E2229.full
Cannabinoid- and lysophosphatidylinositol-sensitive receptor GPR55 boosts neuro-transmitter release at central synapses (full–2013) http://www.pnas.org/content/early/2013/03/06/1211204110.full.pdf+html
Stimulatory and Inhibitory Roles of Brain 2-Arachidonoylglycerol in Bombesin-Induced Central Activation of Adrenomedullary Outflow in Rats (full–2013) https://www.jstage.jst.go.jp/article/jphs/121/2/121_12208FP/_pdf
Association between a genetic variant of type-1 cannabinoid receptor and inflammatory neurodegeneration in multiple sclerosis (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3877004/
Relationships between dietary macronutrients and adult neurogenesis in the regulation of energy metabolism (full-2013) http://journals.cambridge.org/action/displayFulltext?type=6&fid=8904779&jid=BJN&volumeId=109&issueId=09&aid=8904778&bodyId=&membershipNumber=&societyETOCSession=&fulltextT ype=RV&fileId=S000711451200579X
Food for thought: hormonal, experiential, and neural influences on feeding and obesity  (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3818543/
Temporal changes of CB1 cannabinoid receptor in the basal ganglia as a possible structure-specific plasticity process in 6-OHDA lesioned rats (full–2013) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0076874
Neuroprotective effects of Cannabis sativa leaves extracts on α-Motoneurons density after sciatic nerve injury in rats (full–2013) http://www.lifesciencesite.com/lsj/life1005s/113_15973life1005s_644_648.pdf
Neuron-type specific cannabinoid-mediated G protein signalling in mouse hippocampus (full–2013) http://onlinelibrary.wiley.com/doi/10.1111/jnc.12137/full
Diacylglycerol Lipaseα (DAGLα) and DAGLβ Cooperatively Regulate the Production of 2-Arachidonoyl Glycerol in Autaptic Hippocampal Neurons (full–2013) http://molpharm.aspetjournals.org/content/84/2/296.full.pdf+html
CB2 Receptor Agonists Protect Human Dopaminergic Neurons against Damage from HIV-1 gp120 (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0077577
top
Astroglial CB1 cannabinoid receptors regulate leptin signaling in mouse brain astrocytes (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3854987/
Sex-specific tonic 2-arachidonoylglycerol signaling at inhibitory inputs onto dopamine neurons of Lister Hooded rats (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3867690/
Insulin induces long-term depression of VTA dopamine neurons via endocannabinoids (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072656/
Rapid Glucocorticoid-Induced Activation of TRP and CB1 Receptors Causes Biphasic Modulation of Glutamate Release in Gastric-Related Hypothalamic Preautonomic Neurons (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3560102/
Activation-dependent plasticity of polarized GPCR distribution on the neuronal surface (full–2013) http://jmcb.oxfordjournals.org/content/5/4/250.long
Therapeutic Opportunities through the Modulation of Endocannabinoid Transport (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4255948/
CB2 cannabinoid agonist enhanced neurogenesis in GFAP/Gp120 transgenic mice  displaying deficits in neurogenesis (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3904265/
CB1 Cannabinoid Receptors Promote Maximal FAK Catalytic Activity By Stimulating Cooperative Signaling Between Receptor Tyrosine Kinases and Integrins in Neuronal Cells (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4165595/
Acute inhibition of diacylglycerol lipase blocks endocannabinoid-mediated retrograde synaptic suppression: evidence for on-demand biosynthesis of 2-arachidonoylglycerol (full-2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3800453/
Optogenetic identification of an intrinsic cholinergically driven inhibitory oscillator sensitive to cannabinoids and opioids in hippocampal CA1 (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3903354/
Induction of Endocannabinoid Levels in Juvenile Rat Brain Following Developmental Chlorpyrifos Exposure (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3954109/
High fat diet and body weight have different effects on cannabinoid CB1 receptor expression in rat nodose ganglia (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3866822/
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies (full–2013) http://www.karger.com/Article/FullText/350094
The role of androgen receptor in transcriptional modulation of cannabinoid receptor type 1 gene in rat trigeminal ganglia (full–2013)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3870904/
Endocannabinoids in the Brainstem Modulate Dural Trigeminovascular Nociceptive  Traffic via CB1 and “Triptan” Receptors: Implications in Migraine (full–2013)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3771033/
Effect of high fat-diet and obesity on gastrointestinal motility (full–2013)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3890396/
Resuscitation from experimental traumatic brain injury by magnolol therapy (full–2013) http://www.journalofsurgicalresearch.com/article/S0022-4804(13)00432-0/fulltext
Depolarisation-induced suppression of a glycinergic synapse in the superior olivary  complex by endocannabinoids (full–2013)  http://onlinelibrary.wiley.com/doi/10.1111/jnc.12369/full
CB1 Cannabinoid Receptor Agonist Prevents NGF-Induced Sensitization of TRPV1 in  Sensory Neurons (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3752375/
DGLα and DGLβ Cooperatively Regulate the Production of 2-arachidonoyl Glycerol in  Autaptic Hippocampal Neurons (full–2013)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3716324/
The role of endocannabinoids in pain modulation (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23278562
The neuroprotective role of endocannabinoids against chemical-induced injury and other adverse effects (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23296873
2-AG into the lateral hypothalamus increases REM sleep and cFos expression in melanin concentrating hormone neurons in rats (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23603032
The satiety signal oleoylethanolamide stimulates oxytocin neurosecretion from rat hypothalamic neurons (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23959001
top
Anandamide produced by Ca2+-insensitive enzymes induces excitation in primary sensory neurons (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24114173
Cytotoxicity of synthetic cannabinoids on primary neuronal cells of the forebrain: the involvement of cannabinoid CB1 receptors and apoptotic cell death (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24211273
Glutamate spillover drives endocannabinoid production and inhibits GABAergic transmission in the Substantia Nigra pars compacta (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24334069
Motor effects of the non-psychotropic phytocannabinoid cannabidiol that are mediated by 5-HT1A receptors (abst–2013) http://www.sciencedirect.com/science/article/pii/S0028390813003419
Neural responses to subliminally presented cannabis and other emotionally evocative  cues in cannabis-dependent individuals (abst–2013)  https://link.springer.com/article/10.1007%2Fs00213-013-3342-z
The CB1 cannabinoid receptor mediates glucocorticoid-induced effects on behavioural  and neuronal responses during lactation (abst–2013)  http://www.ncbi.nlm.nih.gov/pubmed/23417606
Vestibulodynia: synergy between palmitoylethanolamide + transpolydatin and  transcutaneous electrical nerve stimulation (abst–2013)  http://www.ncbi.nlm.nih.gov/pubmed/23343704
Cannabinoids increase type 1 cannabinoid receptor expression in a cell culture model of  striatal neurons: implications for Huntington’s disease (abst–2013)  http://www.sciencedirect.com/science/article/pii/S0028390813001433
Δ(9)-THC and N-arachidonoyl glycine regulate BV-2 microglial morphology and cytokine release plasticity: implications for signaling at GPR18 (full-2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3877838/
Presynaptic mechanisms of neuronal plasticity and their role in epilepsy (full–2014) http://journal.frontiersin.org/Journal/10.3389/fncel.2014.00164/full
Endogenous Signaling by Omega-3 Docosahexaenoic Acid-derived Mediators Sustains Homeostatic Synaptic and Circuitry Integrity (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3180614/
Cannabinoid, melanocortin and opioid receptor expression on DRD1 and DRD2 sub-populations in rat striatum (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3972466/
Anandamide Protects HT22 Cells Exposed to Hydrogen Peroxide by Inhibiting CB1 Receptor-Mediated Type 2 NADPH Oxidase (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4127243/
Regulatory effects of anandamide on intracellular Ca(2+) concentration increase in trigeminal ganglion neurons (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4146256/
Endocannabinoid-dependent modulation of phasic dopamine signaling encodes external and internal reward-predictive cues (full–2014) http://journal.frontiersin.org/Journal/10.3389/fpsyt.2014.00118/full
Cannabinoid receptors contribute to astroglial Ca2+-signalling and control of synaptic plasticity in the neocortex (full–2014) http://rstb.royalsocietypublishing.org/content/369/1654/20140077.long
Cannabinoid CB2 receptors modulate midbrain dopamine neuronal activity and dopamine-related behavior in mice (full–2014) http://www.pnas.org/content/early/2014/10/30/1413210111.long
High hopes for CB(2) receptors in neurogenesis (full–2014) http://onlinelibrary.wiley.com/doi/10.1111/bph.12548/full
Input- and Cell-Type-Specific Endocannabinoid-Dependent LTD in the Striatum (full–2014) http://www.cell.com/cell-reports/fulltext/S2211-1247%2814%2901016-X
Individual differences in response to positive and negative stimuli: endocannabinoidbased insight on approach and avoidance behaviors (full–2014) http://journal.frontiersin.org/Journal/10.3389/fnsys.2014.00238/full
CB1 cannabinoid receptor in SF1-expressing neurons of the ventromedial hypothalamus determines metabolic responses to diet and leptin (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4209357/
top
CB1 augments mGluR5 function in medial prefrontal cortical neurons to inhibit amygdala hyperactivity in an arthritis pain model (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288820/
β-Amyloid Inhibits E-S Potentiation through Suppression of Cannabinoid Receptor 1-Dependent Synaptic Disinhibition (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4114400/
Control of Inhibition by the Direct Action of Cannabinoids on GABAA Receptors (full–2014) http://cercor.oxfordjournals.org/content/early/2014/03/18/cercor.bhu045.long
The cannabinoid CB2 receptor agonist AM1241 enhances neurogenesis in GFAP / Gp120 transgenic mice displaying deficits in neurogenesis (full–2014) http://onlinelibrary.wiley.com/doi/10.1111/bph.12478/full
Fatty Acid-binding Protein 5 (FABP5) Regulates Cognitive Function Both by Decreasing Anandamide Levels and by Activating the Nuclear Receptor Peroxisome Proliferatoractivated Receptor β/δ (PPARβ/δ) in the Brain (full–2014) http://www.jbc.org/content/289/18/12748.full.pdf+html
Multiple Mechanistically Distinct Modes of Endocannabinoid Mobilization at Central Amygdala Glutamatergic Synapses (full–2014) http://www.sciencedirect.com/science/article/pii/S0896627314000178
Advances in the management of multiple sclerosis spasticity: multiple sclerosis spasticity nervous pathways (full–2014) http://www.karger.com/Article/Pdf/367615
Control of synaptic function by endocannabinoid-mediated retrograde signaling (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4237895/
Effects of pubertal cannabinoid administration on attentional set-shifting and dopaminergic hyper-responsivity in a developmental disruption model of schizophrenia (full–2014) http://ijnp.oxfordjournals.org/content/ijnp/18/2/pyu018.full.pdf
Hypoximimetic activity of N-acyl-dopamines. N-arachidonoyl-dopamine stabilizes HIF-1α protein through a SIAH2-dependent pathway (full–2014) http://www.sciencedirect.com/science/article/pii/S0167488914002821
Astrocytes in endocannabinoid signalling (full–2014) http://rstb.royalsocietypublishing.org/content/369/1654/20130599
Systemic Administration of Oleoylethanolamide Protects from Neuroinflammation and Anhedonia Induced by LPS in Rats (full–2014) http://ijnp.oxfordjournals.org/content/18/6/pyu111
Cannabinoid Receptor Type 2 Agonist Attenuates Apoptosis by Activation of Phosphorylated CREB-Bcl-2 Pathway After Subarachnoid Hemorrhage in Rats (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4194247/
Molecular Basis for the Improvement in Muscle Metaboreflex and Mechanoreflex Control in Exercise-Trained Humans with Chronic Heart Failure (full–2014) http://ajpheart.physiology.org/content/307/11/H1655
Role of corticosterone in the murine enteric nervous system during fasting (full–2014) http://ajpgi.physiology.org/content/307/9/G905
top
Impaired Neurogenesis by HIV-1-Gp120 is Rescued by genetic deletion of Fatty Acid Amide Hydrolase Enzyme (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4594266/
Genetic rescue of CB1 receptors on medium spiny neurons prevents loss of excitatory striatal synapses but not motor impairment in HD mice (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4180675/
Morphological and Behavioural Evidence for Impaired Prefrontal Cortical Function in Female CB1 Receptor Deficient Mice (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4128323/
Endocannabinoid modulation by FAAH and MAGL within the analgesic circuitry of the periaqueductal grey (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4294036/
Activation of CB1 inhibits NGF-induced sensitization of TRPV1 in adult mouse afferent neurons (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4626020/
Developmental Increase in Hippocampal Endocannabinoid Mobilization: Role of Metabotropic Glutamate Receptor Subtype 5 and Phospholipase C (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4233278/
Type 1 Cannabinoid Receptor Ligands Display Functional Selectivity in a Cell Culture Model of Striatal Medium Spiny Projection Neurons (full–2014) http://www.jbc.org/content/289/36/24845.long
Hippocampal Cannabinoid Transmission Modulates Dopamine Neuron Activity: Impact on Rewarding Memory Formation and Social Interaction (full–2014) http://www.nature.com/npp/journal/v40/n6/full/npp2014329a.html
Programming of neural cells by (endo)cannabinoids: from physiological rules to emerging therapies (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4765324/
Cannabinoid Type 1 (CB1) Receptors on Sim1-Expressing Neurons Regulate Energy Expenditure in Male Mice (full–2014) http://press.endocrine.org/doi/10.1210/en.2014-1437
Prior stimulation of the endocannabinoid system prevents methamphetamine-induced dopaminergic neurotoxicity in the striatum through activation of CB2 receptors (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4939842/
Multifractal analysis of information processing in hippocampal neural ensembles during working memory under Δ9-tetrahydrocannabinol administration (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4312266/
Endocannabinoids in Synaptic Plasticity and Neuroprotection (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4143501/
Chronic activation of CB2 cannabinoid receptors in the hippocampus increases excitatory synaptic transmission (full-2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4398527/
Cannabinoid modulation of drug reward and the implications of marijuana legalization (full–2014) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4442758/
The Neurobiology of Cancer Pain (full–2014) http://journals.sagepub.com/doi/full/10.1177/1073858414525828
Programming and reprogramming neural cells by (endo-) cannabinoids: from physiological rules to emerging therapies (full–2014) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4765324/
Nutritional omega-3 modulates neuronal morphology in the prefrontal cortex along with depression-related behaviour through corticosterone secretion (full–2014) http://www.nature.com/tp/journal/v4/n9/full/tp201477a.html

The fatty acid amide hydrolase inhibitor PF-3845 promotes neuronal survival, attenuates inflammation and improves functional recovery in mice with traumatic brain injury (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4437642/
A restricted population of CB1 cannabinoid receptors with neuroprotective activity (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4050577/
The CB1 cannabinoid receptor agonist reduces L-DOPA-induced motor fluctuation and  ERK1/2 phosphorylation in 6-OHDA-lesioned rats (full–2014)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4226453/
Endocannabinoids and neuropathic pain: focus on neuron-glia and endocannabinoid neurotrophin interactions (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24494680
Normal aging in rats and pathological aging in human Alzheimer disease decrease FAAH  activity: Modulation by cannabinoid agonists (abst–2014)  http://www.sciencedirect.com/science/article/pii/S0531556514002903
Anandamide in primary sensory neurons: too much of a good thing? (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24494681
Trans-Caryophyllene Suppresses Hypoxia-Induced Neuroinflammatory Responses by Inhibiting NF-κB Activation in Microglia (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24488604
Endocannabinoid 2-Arachidonylglycerol Protects Primary Cultured Neurons Against LPS-Induced Impairments in Rat Caudate Nucleus (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24510751
Cellular approaches to the interaction between cannabinoid receptor ligands and nicotinic acetylcholine receptors (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24642359
Mechanisms of synaptic dysfunction and excitotoxicity in Huntington’s disease (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24603212
Endocannabinoid-mediated retrograde modulation of synaptic transmission (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24747340
Inhibition of Peripheral Fatty Acid Amide Hydrolase Depresses Activities of Bladder Mechanosensitive Nerve Fibers of the Rat (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24746881
Effect of N-Arachidonoyl Dopamine on Activity of Neuronal Network in Primary Hippo-campus Culture upon Hypoxia Modelling (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24771427
Roles of fatty acid ethanolamides (FAE) in traumatic and ischemic brain injury (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24874648
Endocannabinoid signaling modulates neurons of the pedunculopontine nucleus (PPN) via astrocytes (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25009314
Cannabinoid Receptor-2 and HIV-Associated Neurocognitive Disorders (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25015040
Cannabinoid receptor intracellular signalling: The long journey from binding sites to biological effects (abst–2014) http://onlinelibrary.wiley.com/doi/10.1002/9781118451281.ch2/summary
The interaction between serotonergic and cannabinoidergic modulations involved in the fear extinction (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25069241
Descending modulation of pain: the GABA disinhibition hypothesis of analgesia (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25064178
Chronic cannabinoid receptor stimulation selectively prevents motor impairments in a mouse model of Huntington’s disease (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25123645
Analysis in conditional cannabinoid 1 receptor-knockout mice reveals neuronal sub-population-specific effects on epileptogenesis in the kindling paradigm (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25123336
Cannabinoid-mediated short-term plasticity in hippocampus (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25123173
Differential regulation of NMDAR and NMDAR-mediated metaplasticity by anandamide and 2-AG in the hippocampus (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25087967
Cannabinoid-induced changes in respiration of brain mitochondria (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25195527
Inhibition of endocannabinoid neuronal uptake and hydrolysis as strategies for developing anxiolytic drugs (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25083569
Differences in receptor binding affinity of several phytocannabinoids does not explain their effects on neural cell cultures (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25311884
Post-status epilepticus treatment with the cannabinoid agonist WIN 55,212-2 prevents chronic epileptic hippocampal damage in rats (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25447228
Cannabinoid receptor agonists reduce the short-term mitochondrial dysfunction and oxidative stress linked to excitotoxicity in the rat brain (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25446347
Identification of CB2 receptors in human nigral neurons that degenerate in Parkinson’s disease (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25481767
Cerebellar Endocannabinoids: Retrograde Signaling from Purkinje Cells (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25520276
Protective effects of cannabidiol against hippocampal cell death and cognitive impairment induced by bilateral common carotid artery occlusion in mice (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24532152
Magnolol protects neurons against ischemia injury via the downregulation of p38/MAPK, CHOP and nitrotyrosine (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25038313
Endocannabinoid Modulation of Synaptic Inputs to Magnocellular Neurons (abst-2014) http://onlinelibrary.wiley.com/doi/10.1002/9781118606803.ch10/summary
Nonpsychotropic Plant Cannabinoids, Cannabidivarin (CBDV) and Cannabidiol (CBD), Activate and Desensitize Transient Receptor Potential Vanilloid 1 (TRPV1) Channels in Vitro: Potential for the Treatment of Neuronal Hyperexcitability (abst–2014) http://pubs.acs.org/doi/abs/10.1021/cn5000524
Effects of cannabidiol in the treatment of patients with Parkinson’s disease: An  exploratory double-blind trial (abst–2014) 
https://www.ncbi.nlm.nih.gov/pubmed/25237116
Augmented Inhibition from Cannabinoid-Sensitive Interneurons Diminishes CA1 Output after Traumatic Brain Injury (full–2015) http://journal.frontiersin.org/Journal/10.3389/fncel.2014.00435/full
top
Blockade of monoacylglycerol lipase inhibits oligodendrocyte excitotoxicity and prevents demyelination in vivo (full–2015) http://onlinelibrary.wiley.com/doi/10.1002/glia.22742/full
Cocaine-induced endocannabinoid release modulates behavioral and neurochemical sensitization in mice (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/adb.12080/full
Cannabinoid receptor 1 signaling in cardiovascular regulating nuclei in the brainstem: A review (full–2015) http://www.ncbi.nlm.nih.gov/pubmed/25685481
Genetic Dissection of Behavioural and Autonomic Effects of Δ9-Tetrahydrocannabinol in Mice (full–2015) http://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.0050269
The Combined Inhibitory Effect of the Adenosine A1 and Cannabinoid CB1 Receptors on cAMP Accumulation in the Hippocampus Is Additive and Independent of A1 Receptor Desensitization (full–2015) http://www.hindawi.com/journals/bmri/2015/872684/
Drugs of Abuse in HIV infection and neurotoxicity (full–2015) http://journal.frontiersin.org/article/10.3389/fmicb.2015.00217/full
WIN 55,212-2, Agonist of Cannabinoid Receptors, Prevents Amyloid β1-42 Effects on Astrocytes in Primary Culture (full–2015) http://www.plosone.org/article/fetchObject.action?uri=info:doi/10.1371/journal.pone.0122843&representation=PDF
Exposure to Allergen Causes Changes in NTS Neural Activities after Intratracheal Capsaicin Application, in Endocannabinoid Levels and in the Glia Morphology of NTS (full–2015) http://www.hindawi.com/journals/bmri/2015/980983/
Promising cannabinoid-based therapies for Parkinson’s disease: motor symptoms to neuroprotection (full–2015) http://www.molecularneurodegeneration.com/content/pdf/s13024-015-0012-0.pdf
Role for Endogenous BDNF in Endocannabinoid-Mediated Long-Term Depression at Neocortical Inhibitory Synapses (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4415885/
Sex-dependent vulnerability to Cannabis abuse in adolescence (full–2015) http://journal.frontiersin.org/article/10.3389/fpsyt.2015.00056/full
Involvement of GluR2 up-regulation in neuroprotection by electroacupuncture pretreatment via cannabinoid CB1 receptor in mice (full–2015) http://www.nature.com/srep/2015/150330/srep09490/full/srep09490.html
Effects of high-fructose diets on central appetite signaling and cognitive function (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4429636/
Rapid Non-Genomic Glucocorticoid Actions in Male Mouse Hypothalamic Neuroendocrine Cells Are Dependent on the Nuclear Glucocorticoid Receptor (full–2015) http://press.endocrine.org/doi/pdf/10.1210/en.2015-1273
The CB1 cannabinoid receptor signals striatal neuroprotection via a PI3K / Akt / mTORC1 / BDNF pathway (full–2015) http://www.nature.com/cdd/journal/vaop/ncurrent/full/cdd201511a.html
Cannabinoid CB2 Receptors in a Mouse Model of Aβ Amyloidosis: Immunohistochemical Analysis and Suitability as a PET Biomarker of Neuroinflammation (full–2015) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0129618
Palmitoylethanolamide Inhibits Glutamate Release in Rat Cerebrocortical Nerve Terminals (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4394492/
Tonic endocannabinoid-mediated modulation of GABA release is independent of the CB1 content of axon terminals (full–2015) http://www.nature.com/ncomms/2015/150420/ncomms7557/full/ncomms7557.html
Anandamide, Acting via CB2 Receptors, Alleviates LPS-Induced Neuroinflammation in Rat Primary Microglial Cultures (full–2015) http://www.hindawi.com/journals/np/2015/130639/
Lack of hypophagia in CB1 null mice is associated to decreased hypothalamic POMC and CART expression (full–2015)  http://ijnp.oxfordjournals.org/content/early/2015/03/09/ijnp.pyv011.long
Hypothalamic POMC neurons promote cannabinoid-induced feeding (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4496586/
Homeostatic regulation of brain functions by endocannabinoid signaling (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4468750/
Metabolic Interplay between Astrocytes and Neurons Regulates Endocannabinoid Action (full–2015) http://www.cell.com/cell-reports/fulltext/S2211-1247%2815%2900725-1
Impaired 2-AG signaling in hippocampal glutamatergic neurons: aggravation of anxietylike behavior and unaltered seizure susceptibility (full–2015) http://ijnp.oxfordjournals.org/content/ijnp/early/2015/07/29/ijnp.pyv091.full.pdf
Multiple Forms of Endocannabinoid and Endovanilloid Signaling Regulate the Tonic Control of GABA Release (full–2015) http://www.jneurosci.org/content/35/27/10039.full?sid=7e769d1b-9b77-42fe-92d0-8b337b34b9b6
Endogenous vs Exogenous Allosteric Modulators in GPCRs: A dispute for shuttling CB1 among different membrane microenvironments (full–2015) http://www.nature.com/articles/srep15453
Pharmacological activation of CB2 receptors counteracts the deleterious effect of ethanol on cell proliferation in the main neurogenic zones of the adult rat brain (full–2015) http://journal.frontiersin.org/article/10.3389/fncel.2015.00379/full
The Cannabinoid Receptor CB1 Interacts with the WAVE1 Complex and Plays a Role in Actin Dynamics and Structural Plasticity in Neurons (full–2015) http://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.1002286
Increased Cortical Inhibition in Autism-Linked Neuroligin-3R451C Mice Is Due in Part to Loss of Endocannabinoid Signaling (full–2015) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0140638
Coordinated Regulation of Synaptic Plasticity at Striatopallidal and Striatonigral Neurons Orchestrates Motor Control (full–2015) http://www.cell.com/cell-reports/fulltext/S2211-1247%2815%2901163-8
Fine-tuning of synaptic upscaling at excitatory synapses by endocannabinoid signaling is mediated via the CB1 receptor (full–2015) http://www.nature.com/articles/srep16257
Fetal Alcohol Spectrum Disorder: Potential Role of Endocannabinoids Signaling (full–2015) http://www.mdpi.com/2076-3425/5/4/456/htm
Endocannabinoid signaling mediates oxytocin-driven social reward (full–2015) http://www.pnas.org/content/112/45/14084.full
Ventral tegmental area dopamine and GABA neurons: Physiological properties and expression of mRNA for endocannabinoid biosynthetic elements (full–2015) http://www.nature.com/articles/srep16176
Loss of Either Rac1 or Rac3 GTPase Differentially Affects the Behavior of Mutant Mice and the Development of Functional GABAergic Networks (full–2015) http://cercor.oxfordjournals.org/content/early/2015/11/17/cercor.bhv274.long
Hypothalamic control of brown adipose tissue thermogenesis (full–2015) http://journal.frontiersin.org/article/10.3389/fnsys.2015.00150/full
CB1 cannabinoid receptor enrichment in the ependymal region of the adult human spinal cord (full–2015) http://www.nature.com/articles/srep17745
Endocannabinoids Mediate Muscarinic Acetylcholine Receptor-Dependent Long-Term Depression in the Adult Medial Prefrontal Cortex (full–2015) http://journal.frontiersin.org/article/10.3389/fncel.2015.00457/full
Cannabinoid receptor activation in the juvenile rat brain results in rapid biomechanical alterations: Neurovascular mechanism as a putative confounding factor (full–2015) http://jcb.sagepub.com/content/early/2015/09/23/0271678X15606923.long
top
cnrip1 is a regulator of eye and neural development in Xenopus laevis (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/gtc.12225/full
To Act or Not to Act: Endocannabinoid/Dopamine Interactions in Decision-Making (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4681836/
Neural correlates of cannabidiol and Δ9-tetrahydrocannabinol interactions in mice: implications for medical cannabis (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/bph.13333/full
Increasing levels of the endocannabinoid 2-AG is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson’s disease (full–2015) http://www.sciencedirect.com/science/article/pii/S0014488615300583
Deletion of Monoglyceride Lipase in Astrocytes Attenuates Lipopolysaccharide-Induced Neuroinflammation (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4705409/
Cocaine-Induced Endocannabinoid Mobilization in the Ventral Tegmental Area (full–2015) http://www.cell.com/cell-reports/fulltext/S2211-1247%2815%2900926-2
Cellular Mechanisms of Action of Drug Abuse on Olfactory Neurons (full–2015) http://www.mdpi.com/1660-4601/13/1/5/htm
Interactions between ethanol and the endocannabinoid system at GABAergic synapses on basolateral amygdala principal neurons (full–2015) http://www.alcoholjournal.org/article/S0741-8329%2815%2930019-7/fulltext
Corticotropin-Releasing Hormone Drives Anandamide Hydrolysis in the Amygdala to Promote Anxiety (full-2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4348185/
Mitochondrial CB1 receptor is involved in ACEA-induced protective effects on neurons and mitochondrial functions (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4516969/
VGluT3-Expressing CCK-Positive Basket Cells Construct Invaginating Synapses Enriched with Endocannabinoid Signaling Proteins in Particular Cortical and Cortex-Like Amygdaloid Regions of Mouse Brains (full–2015) http://www.jneurosci.org/content/35/10/4215.long
Cannabinoid CB1 Receptor Calibrates Excitatory Synaptic Balance in the Mouse Hippocampus (full–2015) http://www.jneurosci.org/content/35/9/3842.long
Role of dopamine type 1 receptors and DARPP-32 in Δ9-THC-mediated induction of ΔFosB in the mouse forebrain (full–2015) http://jpet.aspetjournals.org/content/early/2015/06/22/jpet.115.224428.long
Neurotoxicity of Synthetic Cannabinoids JWH-081 and JWH-210 (full–2015) http://www.biomolther.org/journal/view.html?volume=23&number=6&spage=597&year=2015
Postnatal ethanol exposure alters levels of 2-arachidonylglycerol-metabolizing enzymes and pharmacological inhibition of monoacylglycerol (MAGL) does not cause neurodegeneration in neonatal mice (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4490952/
Enhancement of endocannabinoid signalling protects against cocaine-induced neurotoxicity (full–2015) http://www.sciencedirect.com/science/article/pii/S0041008X15001556
Cannabinoid-dopamine interactions in the physiology and physiopathology of the basal ganglia (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/bph.13215/full
Opposite control of frontocortical 2-arachidonoylglycerol turnover rate by cannabinoid type-1 (CB1 ) receptors located on glutamatergic neurons and on astrocytes (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/jnc.13044/full
Simultaneous inhibition of fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL) shares discriminative stimulus effects with ∆9-THC in mice (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4407717/
Peroxide-Dependent MGL Sulfenylation Regulates 2-AG-Mediated Endocannabinoid Signaling in Brain Neurons (full–2015) http://www.sciencedirect.com/science/article/pii/S107455211500157X
A highly selective, reversible inhibitor identified by comparative chemoproteomics modulates diacylglycerol lipase activity in neurons (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4773911/
Anandamide Depresses Glycinergic and GABAergic Inhibitory Transmissions in Adult Rat Substantia Gelatinosa Neurons (full–2015) http://file.scirp.org/Html/1-2500613_54452.htm
Cannabinoid receptor interacting protein (CRIP1a) attenuates CB1R signaling in neuronal cells (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4332989/
Cannabinoid Receptor–Interacting Protein 1a Modulates CB1 Receptor Signaling and Regulation (full–2015) http://molpharm.aspetjournals.org/content/87/4/747.long
Cannabinoids in Neurodegenerative Disorders and Stroke/Brain Trauma: From Preclinical Models to Clinical Applications (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604192/
Neuronal expression of CB2 cannabinoid receptor mRNAs in the mouse hippocampus (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4917208/
The role of cannabinoids in adult neurogenesis (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4543605/
Differential Pharmacological Regulation of Sensorimotor-Gating Deficit in CB1 Knockout Mice and Associated Neurochemical and Histological Alterations (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4569956/
An endocannabinoid system is present in the mouse olfactory epithelium but does not modulate olfaction (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4485596/
Ultrastructural evidence for synaptic contacts between cortical noradrenergic afferents and endocannabinoid-synthesizing post-synaptic neurons (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4542008/
Cannabinoid receptor type 1 agonist ACEA improves motor recovery and protects neurons in ischemic stroke in mice (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/jnc.13288/full
Habenular CB1 Receptors Control the Expression of Aversive Memories (full – 2015) http://www.cell.com/neuron/fulltext/S0896-6273(15)00729-1
β-Neurexins Control Neural Circuits by Regulating Synaptic Endocannabinoid Signaling (full–2015) http://www.cell.com/cell/fulltext/S0092-8674(15)00826-0
Detection of cannabinoid receptors CB1 and CB2 within basal ganglia output neurons in macaques: changes following experimental parkinsonism (link to PDF–2015) http://link.springer.com/article/10.1007/s00429-014-0823-8
top
Involvement of cannabinoid receptors in infrasonic noise-induced neuronal impairment  (full–2015) https://academic.oup.com/abbs/article-lookup/doi/10.1093/abbs/gmv049
A selective cannabinoid CB2 agonist attenuates damage and improves memory retention  following stroke in mice (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4552583/
Active endocannabinoids are secreted on extracellular membrane vesicles (full–2015)  http://embor.embopress.org/content/early/2015/01/07/embr.201439668
Phenotype-dependent inhibition of glutamatergic transmission on nucleus accumbens  medium spiny neurons by the abused inhalant toluene (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4561223/
Maternal separation and early stress cause long-lasting effects on dopaminergic and  endocannabinergic systems and alters dendritic morphology in the nucleus accumbens  and frontal cortex in rats (full–2015)  http://onlinelibrary.wiley.com/doi/10.1002/dneu.22361/full
Negative Regulation of Leptin-induced ROS Formation by CB1 Receptor Activation in  Hypothalamic Neurons (link to PDF–2015)  http://www.jbc.org/content/early/2015/04/13/jbc.M115.646885.full.pdf+html
Cannabinoid Receptors May Control Aversive Memories (news & abstract-2015)  http://neurosciencenews.com/habenula-cb1-receptors-memory-2742/
Oxytocin Enhances Pleasure of Social Interactions by Stimulating Production of “Bliss  Molecule” (news & abstract–2015) http://neurosciencenews.com/oxytocin-anandamide-2926/
The basolateral amygdala γ-aminobutyric acidergic system in health and disease (abst–2015) http://onlinelibrary.wiley.com/doi/10.1002/jnr.23690/full
Dissecting the cannabinergic control of behavior: The where matters (abst–2015) http://onlinelibrary.wiley.com/doi/10.1002/bies.201500046/abstract;jsessionid=222EC084D6C5E7ECF95BFF9D2752CFE4.f01t01
Endocannabinoid Signaling in Motivation, Reward, and Addiction: Influences on  Mesocorticolimbic Dopamine Function (abst–2015)  https://www.ncbi.nlm.nih.gov/pubmed/26638769
On the Role of Astroglial Syncytia in Self-Repairing Spiking Neural Networks (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25576582
Cannabinoid agonists rearrange synaptic vesicles at excitatory synapses and depress motoneuron activity in vivo (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25595101
Changes in the endocannabinoid signaling system in CNS structures of TDP-43 transgenic mice: relevance for a neuroprotective therapy in TDP-43-related disorders (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25819934
N-stearoyltyrosine protects primary cortical neurons against Aβ(1-40)-induced injury through inhibiting endocannabinoid degradation (abst–2015) http://www.sciencedirect.com/science/article/pii/S0024320515000521
A Synthetic Cannabinoid MAM-2201 Potently Suppresses Synaptic Transmission via
Activation of Presynaptic CB1 Receptors and Reduces Synaptically-Evoked Intracellular Ca2+ Transients in Cerebellar Purkinje Cells (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25747605
Spinal neuronal cannabinoid receptors mediate urodynamic effects of systemic fatty acid amide hydrolase (FAAH) inhibition in rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25788026
Further Evidence for the Neuroplastic Role of Cannabinoids: A Study in Organotypic Hippocampal Slice Cultures (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25645684
Cannabinoid receptor agonist WIN55,212-2 and fatty acid amide hydrolase inhibitor URB597 suppress chronic cerebral hypoperfusion-induced neuronal apoptosis by inhibiting c-Jun N-terminal kinase signaling (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25795598
Individual differences and vulnerability to drug addiction: a focus on the endocannabinoid system (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25714966
Analysis of calretinin early expression in the rat hippocampus after beta amyloid (1-42) peptide injection (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25813826
2-AG promotes the expression of conditioned fear via cannabinoid receptor type 1 on GABAergic neurons (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25814137
Localization and production of peptide endocannabinoids in the rodent CNS and adrenal medulla (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25839900
The interactive role of cannabinoid and vanilloid systems in hippocampal synaptic plasticity in rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25843413
top
Dissociation between the panicolytic effect of cannabidiol microinjected into the substantia nigra, pars reticulata, and fear-induced antinociception elicited by bicuculline administration in deep layers of the superior colliculus: The role of CB1-endoccannabinoid receptor in the ventral mesencephalon (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25841876
Emerging concepts of pain therapy based on neuronal mechanisms (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25846611
Potential of the cannabinoid CB2 receptor as a pharmacological target against inflammation in Parkinson’s disease (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25863279
Inhibition of FAAH reduces nitroglycerin-induced migraine-like pain and trigeminal neuronal hyperactivity in mice (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25910421
Enhanced function of inhibitory presynaptic cannabinoid CB1 receptors on sympathetic nerves of DOCA-salt hypertensive rats (abst–2015) http://www.sciencedirect.com/science/article/pii/S0024320515002155
The effect of endocannabinoid system in ischemia-reperfusion injury: a friend or a foe? (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25936364
Chronic ethanol exposure decreases CB1 receptor function at GABAergic synapses in the rat central amygdala (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25940135
Astroglial type-1 cannabinoid receptors (CB1): A new player in the tripartite synapse (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25967266
Layer-specific endocannabinoid-mediated LTD of GABAergic neurotransmission onto principal neurons in mouse visual cortex (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25997857
Signaling Mechanism of Cannabinoid Receptor-2 Activation-Induced β-Endorphin Release (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26108183
Colocalization of cannabinoid receptor 1 with somatostatin and neuronal nitric oxide synthase in rat brain hippocampus (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26115586
Endocannabinoid signaling mechanisms in the substantia nigra pars reticulata modulate GABAergic nigrotectal pathways in mice threatened by urutu-cruzeiro venomous pit viper snake (abst–2015) http://www.sciencedirect.com/science/article/pii/S0306452215005898
Effect of Homocysteine on Voltage-Gated Sodium Channel Currents in Primary Cultured Rat Caudate Nucleus Neurons and Its Modulation by 2-Arachidonylglycerol (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26179279
Comparative effects of parathion and chlorpyrifos on endocannabinoid and endocannabinoid-like lipid metabolites in rat striatum (abst–2015)
http://www.ncbi.nlm.nih.gov/pubmed/26215119
ACEA (a highly selective cannabinoid CB1 receptor agonist) stimulates hippocampal neurogenesis in mice treated with antiepileptic drugs (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26225920
Physiological roles for the subfornical organ – A dynamic transcriptome shaped by autonomic state (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26227400
Neuroprotective mechanisms of cannabinoids in brain ischemia and neurodegenerative disorders (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26299059
Pro-inflammatory obesity in aged cannabinoid-2 receptor deficient mice (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26303348
Genetic Manipulation of the Endocannabinoid System (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26408160
Neuroprotective Effect Is Driven Through the Upregulation of CB1 Receptor in Experimental Autoimmune Encephalomyelitis (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26411568
Chronic stress and peripheral pain: Evidence for distinct, region-specific changes in visceral and somatosensory pain regulatory pathways (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26408049
Intracellular postsynaptic cannabinoid receptors link thyrotropin-releasing hormone receptors to TRPC-like channels in thalamic paraventricular nucleus neurons (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26470810
Excitatory drive from the subthalamic nucleus attenuates GABAergic transmission in the Substantia Nigra pars compacta via endocannabinoids (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26472124
Dopamine-dependent CB1 receptor dysfunction at corticostriatal synapses in homozygous PINK1 knockout mice (abst–2015) http://www.sciencedirect.com/science/article/pii/S0028390815301441
The brain in bone and fuel metabolism (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26545334
top
The neuroprotection of cannabidiol against MPP+-induced toxicity in PC12 cells involves trkA receptors, upregulation of axonal and synaptic proteins, neuritogenesis, and might be relevant to Parkinson’s disease (abst–2015) http://www.sciencedirect.com/science/article/pii/S0887233315300047
The interactive role of CB1 and GABAB receptors in hippocampal synaptic plasticity in rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26611204
The Endocannabinoid System and Its Role in Regulating the Intrinsic Neural Circuitry of the Gastrointestinal Tract (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/26638765
Cannabinoid Transmission in the Hippocampus Activates Nucleus Accumbens Neurons and Modulates Reward and Aversion-Related Emotional Salience (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26681496
Synthetic and endogenous cannabinoids protect retinal neurons from AMPA  excitotoxicity in vivo, via activation of CB1 receptors: Involvement of PI3K/Akt and  MEK/ERK signaling pathways (abst–2015)  http://www.sciencedirect.com/science/article/pii/S0014483515001554

Dual effects of the non-esterified fatty acid receptor ‘GPR40’ for human health (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25615413
Expression and Function of the Endocannabinoid System in the Retina and the Visual Brain (full–2016) http://www.hindawi.com/journals/np/2016/9247057/
Characterization of a novel adult murine immortalized microglial cell line and its activation by amyloid-beta (full–2016) http://jneuroinflammation.biomedcentral.com/articles/10.1186/s12974-016-0484-z
GABABR-Dependent Long-Term Depression at Hippocampal Synapses between CB1- Positive Interneurons and CA1 Pyramidal Cells (full–2016) http://journal.frontiersin.org/article/10.3389/fncel.2016.00004/full
GABA and Endocannabinoids Mediate Depotentiation of Schaffer Collateral Synapses Induced by Stimulation of Temperoammonic Inputs (full–2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0149034
top
Endogenous and Synthetic Cannabinoids as Therapeutics in Retinal Disease (full–2016) http://www.hindawi.com/journals/np/2016/8373020/
Systematic Review of Pharmacological Properties of the Oligodendrocyte Lineage (full–2016) http://journal.frontiersin.org/article/10.3389/fncel.2016.00027/full
Monoacylglycerol lipase inhibitors produce pro- or antidepressant responses via hippocampal CA1 GABAergic synapses (full–2016) http://www.nature.com/mp/journal/vaop/ncurrent/full/mp201622a.html
Estrogen Receptor Beta and 2-arachidonoylglycerol Mediate the Suppressive Effects of Estradiol on Frequency of Postsynaptic Currents in Gonadotropin-Releasing Hormone Neurons of Metestrous Mice: An Acute Slice Electrophysiological Study (full–2016) http://journal.frontiersin.org/article/10.3389/fncel.2016.00077/full
Cannabis for posttraumatic stress disorder: A neurobiological approach to treatment (full–2016) http://journals.lww.com/tnpj/Fulltext/2016/01000/Cannabis_for_posttraumatic_stress_disorder__A.6.aspx
Synthetic Ligands of Cannabinoid Receptors Affect Dauer Formation in the Nematode Caenorhabditis elegans (full–2016) http://www.g3journal.org/content/early/2016/04/11/g3.116.026997.long
Impaired Ethanol-Induced Sensitization and Decreased Cannabinoid Receptor-1 in a Model of Posttraumatic Stress Disorder (full–2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0155759#pone.0155759.ref024
Neuronal and Astrocytic Monoacylglycerol Lipase Limit the Spread of Endocannabinoid Signaling in the Cerebellum (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4865651/
Cannabinoid receptor type-1: breaking the dogmas (full–2016) http://f1000research.com/articles/5-990/v1
CB2 Cannabinoid Receptor As Potential Target against Alzheimer’s Disease (full–2016) http://journal.frontiersin.org/article/10.3389/fnins.2016.00243/full#B36
p21-activated kinase 1 restricts tonic endocannabinoid signaling in the hippocampus (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4907698/
Endocannabinoid Modulation of Orbitostriatal Circuits Gates Habit Formation (full–2016) http://www.cell.com/neuron/fulltext/S0896-6273%2816%2930157-X
Stimulation of brain glucose uptake by cannabinoid CB2 receptors and its therapeutic potential in Alzheimer’s disease (full–2016) http://www.sciencedirect.com/science/article/pii/S0028390816300879
Amyloid proteotoxicity initiates an inflammatory response blocked by cannabinoids (full–2016) http://www.nature.com/articles/npjamd201612
Enkephalin levels and the number of neuropeptide Y-containing interneurons in the hippocampus are decreased in female cannabinoid-receptor 1 knock-out mice (full–2016) http://www.sciencedirect.com/science/article/pii/S0304394016301689
Impaired Excitatory Neurotransmission in the Urinary Bladder from the Obese Zucker Rat: Role of Cannabinoid Receptors (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4902197/
Endocannabinoid control of glutamate NMDA receptors: the therapeutic potential and consequences of dysfunction (full–2016) http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path %5B%5D=10095&path%5B%5D=31745
L-type calcium channels and MAP kinase contribute to thyrotropin-releasing hormone induced depolarization in thalamic paraventricular nucleus neurons (full–2016) http://ajpregu.physiology.org/content/310/11/R1120.long
Medullary Endocannabinoids Contribute to the Differential Resting Baroreflex Sensitivity in Rats with Altered Brain Renin-Angiotensin System Expression (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4899471/
Effect of interaction between acute administration of morphine and cannabinoid compounds on spontaneous excitatory and inhibitory postsynaptic currents of magnocellular neurons of supraoptic nucleus (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951608/
Orexins contribute to restraint stress-induced cocaine relapse by endocannabinoid mediated disinhibition of dopaminergic neurons (full–2016) http://www.nature.com/ncomms/2016/160722/ncomms12199/full/ncomms12199.html
Endocannabinoids and Heterogeneity of Glial Cells in Brain Function (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4932105/
Orchestrated activation of mGluR5 and CB1 promotes neuroprotection (full–2016) http://molecularbrain.biomedcentral.com/articles/10.1186/s13041-016-0259-6
A role of CB1R in inducing θ-rhythm coordination between the gustatory and gastrointestinal insula (full–2016) http://www.nature.com/articles/srep32529
Targeting Cannabinoid CB2 Receptors in the Central Nervous System. Medicinal Chemistry Approaches with Focus on Neurodegenerative Disorders (full–2016) http://journal.frontiersin.org/article/10.3389/fnins.2016.00406/full
Biased Agonism of Three Different Cannabinoid Receptor Agonists in Mouse Brain Cortex (full–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00415/full
fMRI study of neural sensitization to hedonic stimuli in long-term, daily cannabis users (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5012952/
Individual differences in frontolimbic circuitry and anxiety emerge with adolescent changes in endocannabinoid signaling across species (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4843434/
Cannabinoids reverse the effects of early stress on neurocognitive performance in adulthood (full–2016) http://learnmem.cshlp.org/content/23/7/349.long
Ontogeny of sensorimotor gating and short-term memory processing throughout the adolescent period in rats (full–2016) http://www.sciencedirect.com/science/article/pii/S1878929316300639
Acetylcholine receptors from human muscle as pharmacological targets for ALS therapy. (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4801305/
Mild Traumatic Brain Injury Produces Neuron Loss That Can Be Rescued by Modulating Microglial Activation Using a CB2 Receptor Inverse Agonist (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5052277/
Orexin-A represses satiety-inducing POMC neurons and contributes to obesity via stimulation of endocannabinoid signaling (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4855580/
CB2 receptor activation prevents glial-derived neurotoxic mediator production, BBB leakage and peripheral immune cell infiltration and rescues dopamine neurons in the MPTP model of Parkinson’s disease (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4892852/
Target-specific modulation of the descending prefrontal cortex inputs to the dorsal raphe nucleus by cannabinoids (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4868450/
Neurophysiology of space travel: energetic solar particles cause cell type-specific plasticity of neurotransmission (full–2016) http://link.springer.com/article/10.1007%2Fs00429-016-1345-3
Target regulation of PI3K/Akt/mTOR pathway by cannabidiol in treatment of experimental multiple sclerosis (full–2016) http://www.sciencedirect.com/science/article/pii/S0367326X16304476
Diacylglycerol lipase disinhibits VTA dopamine neurons during chronic nicotine exposure (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4743781/
Cannabidiol Counteracts Amphetamine-Induced Neuronal and Behavioral Sensitization  of the Mesolimbic Dopamine Pathway through a Novel mTOR/p70S6 Kinase Signaling  Pathway (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4854973/
Spatial Distribution of the Cannabinoid Type 1 and Capsaicin Receptors May Contribute to the Complexity of Their Crosstalk (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5032030/
Coordinated regulation of endocannabinoid-mediated retrograde synaptic suppression in the cerebellum by neuronal and astrocytic monoacylglycerol lipase (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5075776/
Endocannabinoid signaling regulates regenerative axon navigation in Caenorhabditis elegans via the GPCRs NPR-19 and NPR-32 (full–2016) http://onlinelibrary.wiley.com/doi/10.1111/gtc.12377/full
Alteration of SLP2‐like immunolabeling in mitochondria signifies early cellular damage in developing and adult mouse brain (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4784115/
Cannabidiol attenuates OGD/R-induced damage by enhancing mitochondrial bioenergetics and modulating glucose metabolism via pentose-phosphate pathway in hippocampal neurons (full–2016) http://www.sciencedirect.com/science/article/pii/S221323171630338X
Lipids in psychiatric disorders and preventive medicine (full–2016)  http://www.sciencedirect.com/science/article/pii/S0149763415303353
Inhibitors of diacylglycerol lipases in neurodegenerative and metabolic disorders (full–2016) http://www.sciencedirect.com/science/article/pii/S0960894X16306874
Acute Stress Suppresses Synaptic Inhibition and Increases Anxiety via Endocannabinoid  Release in the Basolateral Amygdala (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4978804/
Aberrant epilepsy-associated mutant Nav1.6 sodium channel activity can be targeted with cannabidiol (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4958898/
Acute Neurologic Disorder from an Inhibitor of Fatty Acid Amide Hydrolase (full–2016) https://www.ncbi.nlm.nih.gov/pubmed/27806235
Dentate cannabinoid-sensitive interneurons undergo unique and selective strengthening of mutual synaptic inhibition in experimental epilepsy (full–2016)  http://www.ncbi.nlm.nih.gov/pubmed/26804027
Nutritional n-3 PUFA Deficiency Abolishes Endocannabinoid Gating of Hippocampal  Long-Term Potentiation (full–2016) https://academic.oup.com/cercor/article-lookup/doi/10.1093/cercor/bhw052
Peripheral and central CB1 cannabinoid receptors control stress-induced impairment of  memory consolidation (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5024630/
Cannabinoid Type-2 Receptor Drives Neurogenesis and Improves Functional Outcome  After Stroke (full–2016) http://stroke.ahajournals.org/content/48/1/204.long
Antagonism of dopamine receptor 2 long (D2L) affects cannabinoid receptor 1 (CB1)  signaling in a cell culture model of striatal medium spiny projection neurons (full–2016) http://molpharm.aspetjournals.org/content/89/6/652.long
Differences in Chloride Gradients Allow for Three Distinct Types of Synaptic Modulation by Endocannabinoids (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4982905/
Projection-Specific Dynamic Regulation of Inhibition in Amygdala Micro-Circuits (full–2016) http://www.cell.com/neuron/fulltext/S0896-6273(16)30346-4?_returnURL=http%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0896627316303464%3Fshowall%3Dtrue
Neuroprotective effect of endogenous cannabinoids on ischemic brain injury induced by
the excess microglia-mediated inflammation (full–2016)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4931157/
The effects of Δ9-tetrahydrocannabinol on the dopamine system (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5123717/
Harvesting Benefits from Cannabinoids (article–2016)  http://www.cell.com/cell/fulltext/S0092-8674(16)31675-0
Suppressing Schizophrenia Symptoms Without Side Effects: Mouse Study (news & abst–2016) http://neurosciencenews.com/schizophrenia-compound-striatum-5089/
Physiological impact of CB1 receptor expression by hippocampal GABAergic interneurons (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26739712
Major dorsoventral differences in the modulation of the local CA1 hippocampal network by NMDA, mGlu5, adenosine A2A and cannabinoid CB1 receptors (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26762803
The endocannabinoid system and neuropathic pain (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26785153
Expression of functional cannabinoid CB2 receptor in VTA dopamine neurons in rats (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26833913
Stimulation of cannabinoid CB1 receptors prevents nerve-mediated airway hyperreactivity in NGF-induced inflammation in mouse airways (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26896777
The Hyperpolarization-Activated Cation Current Ih: The Missing Link Connecting Cannabinoids to Cognition (abst–2016) http://www.cell.com/neuron/abstract/S0896-6273(16)00144-6?_returnURL=http%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0896627316001446%3Fshowall%3Dtrue
Functional effects of cannabinoids during dopaminergic specification of human neural precursors derived from induced pluripotent stem cells (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27027565

Targeting the cannabinoid CB2 receptor to attenuate the progression of motor deficits in LRRK2-transgenic mice (abst–2016) http://www.sciencedirect.com/science/article/pii/S1043661816302663
Distinct neuronal activation patterns are associated with PCP-induced social withdrawal and its reversal by the endocannabinoid-enhancing drug URB597 (abst–2016) http://www.sciencedirect.com/science/article/pii/S0168010216300220
Broad impact of deleting endogenous cannabinoid hydrolyzing enzymes and the CB1 cannabinoid receptor on the endogenous cannabinoid-related lipidome in eight regions of the mouse brain (abst–2016) http://www.sciencedirect.com/science/article/pii/S1043661816303449
WHERE’s MY ENTOURAGE? THE CURIOUS CASE OF 2-oleoylglycerol, 2- linolenoylglycerol, and 2-palmitoylglycerol (abst–2016) http://www.sciencedirect.com/science/article/pii/S1043661816303346
Endocannabinoid 2-Arachidonoylglycerol Suppresses LPS-Induced Inhibition of A-Type Potassium Channel Currents in Caudate Nucleus Neurons Through CB1 Receptor (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27129498
Cannabinoid Type 2 Receptors Mediate a Cell Type-Specific Plasticity in the Hippocampus (abst–2016) http://www.cell.com/neuron/abstract/S0896-6273%2816%2930025-3
Stimulated CB1 Cannabinoid Receptor Inducing Ischemic Tolerance and Protecting Neuron from Cerebral Ischemia (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27142423
Direct presynaptic and indirect astrocyte-mediated mechanisms both contribute to endocannabinoid signaling in the pedunculopontine nucleus of mice (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27169390
Phytocannabinoids and cannabimimetic drugs: recent patents in central nervous system disorders (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27184693
Inhibition of Endocannabinoid Degradation Improves Outcomes from Mild Traumatic Brain Injury: A Mechanistic Role for Synaptic Hyperexcitability (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/27189876
Pharmacological characterization of emerging synthetic cannabinoids in HEK293T cells and hippocampal neurons (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27260125
Effect of synthetic cannabinoids on spontaneous neuronal activity: Evaluation using Ca2+ spiking and multi-electrode arrays (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27262380
Reduced Noradrenergic Signaling in the Spleen Capsule in the Absence of CB1 and CB2 Cannabinoid Receptors (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27287619
Upregulation of the cannabinoid CB2 receptor in environmental and viral inflammation driven rat models of Parkinson’s disease (abst–2016) http://www.sciencedirect.com/science/article/pii/S0014488616301790
Ischemic Stroke, Excitatory Amino Acids Toxicity and the Adjustment of Acupuncture Intervention (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27323449
FABP1 in wonderland (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27329821
Cannabinoids and Neuro-Inflammation: Regulation of Brain Immune Response (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27334610
Microglia activation states and cannabinoid system: Therapeutic implications (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27373505
Expression of the Endocannabinoid Receptor 1 in Human Stroke: An Autoptic Study (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27425766
Cannabinoid receptor agonist WIN55,212-2 and fatty acid amide hydrolase inhibitor URB597 may protect against cognitive impairment in rats of chronic cerebral hypoperfusion via PI3K/AKT signaling (abst–2016) http://www.sciencedirect.com/science/article/pii/S0166432816304375
PAK1 regulates inhibitory synaptic function via a novel mechanism mediated by endocannabinoids (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27645771
Cannabinoids: Glutamatergic Transmission and Kynurenines (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27651254
Restricted vs. unrestricted wheel running in mice: Effects on brain, behavior and endocannabinoids (abst-2016) http://www.sciencedirect.com/science/article/pii/S0018506X16301799
Functions of synapse adhesion molecules neurexin/neurexins and neurodevelopmental disorders (abst–2016) http://www.sciencedirect.com/science/article/pii/S0168010216301419
Interaction between hippocampal serotonin and cannabinoid systems in reactivity to spatial and object novelty detection (abst–2016) http://www.sciencedirect.com/science/article/pii/S016643281630715X CB1CB1 Cannabinoid Receptors Mediate Cognitive Deficits and Structural Plasticity Changes During Nicotine Withdrawal (abst–2016)  https://www.ncbi.nlm.nih.gov/pubmed/27737762
Chronic stress leads to epigenetic dysregulation of neuropeptide-Y and cannabinoid CB1 receptor in the mouse cingulate cortex (abst–2016)  http://www.sciencedirect.com/science/article/pii/S0028390816304580

Cannabinoids prevent the amyloid β-induced activation of astroglial hemichannels: A neuroprotective mechanism (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27757991
Descending serotonergic and noradrenergic systems do not regulate the antipruritic effects of cannabinoids (abst–2016) https://www.cambridge.org/core/journals/acta-neuropsychiatrica/article/descending-serotonergic-andnoradrenergic-systems-do-not-regulate-the-antipruritic-effects-ofcannabinoids/5BE6C9C7BA28268807D522354F70199A
The central cannabinoid receptor type-2 (CB2) and chronic pain (abst–2016)  https://www.ncbi.nlm.nih.gov/pubmed/27842450
Regulation of fear extinction by long-term depression: the roles of endocannabinoids and  brain derived neurotrophic factor (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27867101
The cannabinoid beta-caryophyllene (BCP) induces neuritogenesis in PC12 cells by a  cannabinoid-receptor-independent mechanism (abst–2016) http://www.sciencedirect.com/science/article/pii/S0009279716305920
Cannabidiol reduces neuroinflammation and promotes neuroplasticity and functional recovery after brain ischemia (abst–2016) http://www.sciencedirect.com/science/article/pii/S0278584616302524
Cannabidiol Activates Neuronal Precursor Genes in Human Gingival Mesenchymal Stromal Cells (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27918106
Role of Cannabinoid Receptor Type 1 in Tibial and Pudendal Neuromodulation of Bladder Overactivity in Cats (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27927655
Inflammation of peripheral tissues and injury to peripheral nerves induce diferring effects in the expression of the calcium-sensitive anandamide-synthesising enzyme and related molecules in rat primary sensory neurons (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27997038
Inhibitors of oxidative and hydrolytic endocannabinoid degradation do not enhance depolarization-induced suppression of excitation on dorsal cochlear nucleus glycinergic neurons (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27997730
Muscarinic acetylcholine receptors control baseline activity and Hebbian stimulus-timing dependent plasticity in fusiform cells of the dorsal cochlear nucleus (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/28003407
Synaptic Reorganization of the Perisomatic Inhibitory Network in Hippocampi of Temporal Lobe Epileptic Patients (full–2017) https://www.hindawi.com/journals/bmri/2017/7154295/
A Pulsed Electromagnetic Field Protects against Glutamate-Induced Excitotoxicity by  Modulating the Endocannabinoid System in HT22 Cells (full–2017)  http://journal.frontiersin.org/article/10.3389/fnins.2017.00042/full
Inflammatory Regulation by Driving Microglial M2 Polarization: Neuroprotective Effects of Cannabinoid Receptor-2 Activation in Intracerebral Hemorrhage (full–2017) http://journal.frontiersin.org/article/10.3389/fimmu.2017.00112/full
Neuroprotective effect of WIN55,212-2 against 3-nitropropionic acid-induced toxicity in  the rat brain: involvement of CB1 and NMDA receptors (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5340665/
Protective Effects of Cannabidiol against Seizures and Neuronal Death in a Rat Model of  Mesial Temporal Lobe Epilepsy (full–2017)  http://journal.frontiersin.org/article/10.3389/fphar.2017.00131/full
Altered striatal endocannabinoid signaling in a transgenic mouse model of  spinocerebellar ataxia type-3 (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5407801/
Endocannabinoid signaling in hypothalamic circuits regulates arousal from general  anesthesia in mice (full–2017) https://www.jci.org/articles/view/91038
Neuroprotective Effects of β-Caryophyllene against Dopaminergic Neuron Injury in a  Murine Model of Parkinson’s Disease Induced by MPTP (full–2017)  http://www.mdpi.com/1424-8247/10/3/60/htm
Spatial distribution of cannabinoid receptor type 1 (CB1) in normal canine central and  peripheral nervous system (full–2017) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0181064
Endocannabinoids exert CB1 receptor-mediated neuroprotective effects in models of  neuronal damage induced by HIV-1 Tat protein (full–2017)  http://www.sciencedirect.com/science/article/pii/S1044743117300830?via%3Dihub
A novel crosstalk within the endocannabinoid system controls GABA transmission in the  striatum (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5544685/
Addictive neurons (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5479441/
Interaction between Cannabinoid Type 1 and Type 2 Receptors in the Modulation of  Subventricular Zone and Dentate Gyrus Neurogenesis (full–2017)  http://journal.frontiersin.org/article/10.3389/fphar.2017.00516/full
Cannabinoids in Parkinson’s Disease (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5436333 /
Addressing sufficiency of the CB1 receptor for endocannabinoid-mediated functions  through conditional genetic rescue in forebrain GABAergic neurons (full–2017)  https://link.springer.com/article/10.1007%2Fs00429-017-1411-5
Cannabinoid type 1 receptor-containing axons innervate NPY/AgRP neurons in the  mouse arcuate nucleus (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5369208/
Cannabinoid Receptor Signaling in Central Regulation of Feeding Behavior: A Mini Review (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5442223/
Singular Location and Signaling Profile of Adenosine A2A-Cannabinoid CB1 Receptor Heteromers in the Dorsal Striatum. (link to download–2017) http://www.nature.com/npp/journal/vaop/naam/abs/npp201712a.html
CB1 Receptor Activation on VgluT2-Expressing Glutamatergic Neurons Underlies Δ9-
Tetrahydrocannabinol (Δ9-THC)-Induced Aversive Effects in Mice (full–2017)  https://www.nature.com/articles/s41598-017-12399-z
Cannabinoids disrupt memory encoding by functionally isolating hippocampal CA1 from CA3 (full–2017) http://journals.plos.org/ploscompbiol/article?id=10.1371/journal.pcbi.1005624
Cell-Autonomous Excitation of Midbrain Dopamine Neurons by Endocannabinoid Dependent Lipid Signaling (full–2017) http://www.cell.com/neuron/fulltext/S0896-6273(17)30109-5
Fatty-acid-binding protein inhibition produces analgesic effects through peripheral and
central mechanisms (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5407663/
The Epac-phospholipase Cε pathway regulates endocannabinoid signaling and cocaine induced disinhibition of VTA dopamine neurons (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5354337/
N-Arachidonoyl Dopamine: A Novel Endocannabinoid and Endovanilloid with  Widespread Physiological and Pharmacological Activities (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5627668/
Regulation of human glioblastoma cell death by combined treatment of cannabidiol,
γ-radiation and small molecule inhibitors of cell signaling pathways (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5650324/
The Endocannabinoid System Differentially Regulates Escape Behavior in Mice (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655002/
Regulation of noradrenergic and serotonergic systems by cannabinoids: relevance to  cannabinoid-induced effects (full–2017)  http://www.sciencedirect.com/science/article/pii/S0024320517306069?via%3Dihub
Cannabinoid type 2 receptors in dopamine neurons inhibits psychomotor behaviors, alters anxiety, depression and alcohol preference (full–2017)  https://www.nature.com/articles/s41598-017-17796-y
Dual Influence of Endocannabinoids on Long-Term Potentiation of Synaptic
Transmission (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5742107/
The endocannabinoid system in pain and inflammation: Its relevance to rheumatic  disease (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5685274/
Fatty acid amide hydrolase inhibitors produce rapid anti-anxiety responses through  amygdala long-term depression in male rodents (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5487270/
Cannabinoid Receptors Modulate Neuronal Morphology and AnkyrinG Density at the  Axon Initial Segment (full–2017)  http://journal.frontiersin.org/article/10.3389/fncel.2017.00005/full
CB1 Receptors Signaling in the Brain: Extracting Specificity from Ubiquity (link to PDF–2017)  http://www.nature.com/npp/journal/vaop/naam/abs/npp2017206a.html?foxtrotcallback=true
Brain cannabinoid receptor 2: expression, function and modulation (abst-2017) https://www.ncbi.nlm.nih.gov/pubmed/28065934
(S)Pot on Mitochondria: Cannabinoids Disrupt Cellular Respiration to Limit Neuronal Activity (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28076767
N-Oleoylglycine-induced hyperphagia was associated with the activation of AgRP neuron by CB1R (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28102080
Effect of inhibition of fatty acid amide hydrolase on MPTP-induced dopaminergic neuronal damage (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28104279
Endocannabinoid 2-arachidonoylglycerol protects inflammatory insults from sulfur dioxide inhalation via cannabinoid receptors in the brain (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28115138
Antihyperalgesic effect of CB1 receptor activation involves the modulation of P2X3 receptor in the primary afferent neuron (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28131783
Extinction of avoidance behavior by safety learning depends on endocannabinoid  signaling in the hippocampus (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28222356
A selective CB2R agonist (JWH133) restores neuronal circuit after Germinal Matrix  Hemorrhage in the preterm via CX3CR1+ microglia (abst–2017)  http://www.sciencedirect.com/science/article/pii/S002839081730028X
CRIP1a inhibits endocytosis of G-protein coupled receptors activated by  endocannabinoids and glutamate by a common molecular mechanism (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28295323
Cortical adrenoceptor expression, function and adaptation under conditions of  cannabinoid receptor deletion (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0014488617300705
Undercover Power of Endocannabinoids: Postsynaptic Ion-Channel Modulator (abst–2017) http://www.cell.com/neuron/abstract/S0896-6273(17)30197-6
CB1 receptors downregulate a cAMP/Epac2/PLC pathway to silence the nerve terminals  of cerebellar granule cells (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28445587
Endocannabinoid modulation of dopamine neurotransmission (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0028390817301831
Neurosteroid biosynthesis downregulation and changes in GABAA receptor subunit  composition: A biomarker axis in stress-induced cognitive and emotional impairment  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28456011
Peripheral inflammation alters N-arachidonoylphosphatidylethanolamine (20:4-NAPE)  induced modulation of nociceptive spinal cord synaptic transmission (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28476070
Continuous Intrathecal Infusion of Cannabinoid Receptor Agonists Attenuates Nerve  Ligation-Induced Pain in Rats (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28492437
N-stearoyltyrosine protects primary cortical neurons against oxygen-glucose deprivation induced apoptosis through inhibiting anandamide inactivation system (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0168010217300123
Inhibition of SENP3 by URB597 ameliorates neurovascular unit dysfunction in rats with  chronic cerebral hypoperfusion (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28501776
Examining Cholinergic Synaptic Signaling in the Thalamic Reticular Nucleus (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28572192
Endocannabinoid-dependent disinhibition of orexinergic neurons: Electrophysiological  evidence in leptin-knockout obese mice (abst–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5444110/
Activity-based protein profiling reveals off-target proteins of the FAAH inhibitor BIA 10-2474 (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28596366
Synaptic functions of endocannabinoid signaling in health and disease (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0028390817302861
ESSENTIAL DIETARY BIOACTIVE LIPIDS IN NEUROINFLAMMATORY DISEASES (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28637354
Cannabinoid reward and aversion effects in the posterior ventral tegmental area are  mediated through dissociable opiate receptor subtypes and separate amygdalar and  accumbal dopamine receptor substrates (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28669034
The excitatory/inhibitory input to orexin/hypocretin neuron soma undergoes day/night  reorganization (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28669028
The Role of the Endocannabinoid System and Genetic Variation in Adolescent Brain  Development (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28685756
Expression of Type I Cannabinoid Receptors at Different Stages of Neuronal  Differentiation of Human Fibroblasts (abst–2017)  https://link.springer.com/article/10.1007%2Fs10517-017-3782-2
Chronic CB1 cannabinoid receptor antagonism persistently increases dendritic spine  densities in brain regions important to zebra finch vocal learning and production in an  antidepressant-sensitive manner (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28743448
Modeling Neurodegenerative Disorders for Developing Cannabinoid-Based  Neuroprotective Therapies (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28750802
Targeting fatty acid amide hydrolase and transient receptor potential vanilloid-1  simultaneously to modulate colonic motility and visceral sensation in the mouse: A  pharmacological intervention with N-arachidonoyl-serotonin (AA-5-HT) (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28695708
2-arachidonoylglycerol reduces proteoglycans and enhances remyelination in a  progressive model of demyelination (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28751457
Cannabinoids and Pain: Sites and Mechanisms of Action (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28826543
Increase in cortical endocannabinoid signaling in a rat model of basal forebrain  cholinergic dysfunction (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28827178
Could serum S100B be a predictor of neuronal damage and clinical poor outcomes  associated with the use of synthetic cannabinoids? S100B to predict neuronal damage of  SC in the ED (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28867154
Distinct roles of neuronal and microglial CB2 cannabinoid receptors in the mouse  hippocampus (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28888955
Neuronal nitric oxide synthase is involved in CB/TRPV1 signalling: Focus on control of  hippocampal hyperexcitability (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29035821
Activation of cannabinoid receptor 1 is involved in protection against mitochondrial  dysfunction and cerebral ischaemic tolerance induced by isoflurane preconditioning  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29045576
Fatty acid amide hydrolase inhibitor URB597 may protect against kainic acid-induced  damage to hippocampal neurons: Dependence on the degree of injury (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28963903
Cannabinoids Modulate Neuronal Activity and Cancer by CB1 and CB2 Receptor Independent Mechanisms (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29066974
Impact of dietary fats on brain functions (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29046155
Cannabinoid receptor 1/2 double-knockout mice develop epilepsy (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29105060
Endocannabinoid-Mediated Potentiation of Non-Nociceptive Synapses Contributes to  Behavioral Sensitization (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29118192
CB1 Receptors Mediated Inhibition of ATP-Induced [Ca2+]i Increase in Cultured Rat  Spinal Dorsal Horn Neurons (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29127599
Cannabinoid Receptor Type 1 Agonist ACEA Protects Neurons from Death and
Attenuates Endoplasmic Reticulum Stress-Related Apoptotic Pathway Signaling
(abst–2017) https://link.springer.com/article/10.1007%2Fs12640-017-9839-1
Enantiomer-specific positive allosteric modulation of CB1 signaling in autaptic  hippocampal neurons (abst–2017)  http://www.sciencedirect.com/science/article/pii/S104366181730871X?via%3Dihub
LEARNING-INDUCED MODULATION OF THE EFFECT OF ENDOCANNABINOIDS ON INHIBITORY SYNAPTIC TRANSMISSION (abst-2017) https://www.ncbi.nlm.nih.gov/pubmed/29167327
Adolescent ethanol intake alters cannabinoid type-1 receptor localization in astrocytes of the adult mouse hippocampus (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29168269
Endocannabinoid-specific impairment in synaptic plasticity in striatum of Huntington’s  disease mouse model (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29192125
THC Treatment Alters Glutamate Receptor Gene Expression in Human Stem Cell Derived
Neurons (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29230395
Short-term high-fat diet primes excitatory synapses for long-term depression in orexin  neurons (abst–2017) http://onlinelibrary.wiley.com/doi/10.1113/JP275177/abstract
Endocannabinoid Actions on Cortical Terminals Orchestrate Local Modulation of  Dopamine Release in the Nucleus Accumbens (abst–2017)  http://www.cell.com/neuron/fulltext/S0896-6273(17)31065-6
Adolescent synthetic cannabinoid exposure produces enduring changes in dopamine  neuron activity in a rodent model of schizophrenia susceptibility (link to PDF–2018)  https://academic.oup.com/ijnp/advance-article/doi/10.1093/ijnp/pyy003/4796858
Analysis of endocannabinoid receptors and enzymes in the post-mortem motor cortex and spinal cord of amyotrophic lateral sclerosis patients (abst–2018)  https://www.ncbi.nlm.nih.gov/pubmed/29334787
Cannabinoids and glial cells: possible mechanism to understand schizophrenia (abst–2018) https://www.ncbi.nlm.nih.gov/pubmed/29392440


NEUROPATHIC PAIN*+
Cannabinoid-mediated modulation of neuropathic pain and microglial accumulation in a model of murine type I diabetic peripheral neuropathic pain (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2845559/?tool=pmcentrez
R-Flurbiprofen Reduces Neuropathic Pain in Rodents by Restoring Endogenous Cannabinoids (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2869361/
Pharmacological Treatment of Painful HIV-Associated Sensory Neuropathy: A Systematic Review and Meta-Analysis of Randomised Controlled Trials (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3010990/?tool=pmcentrez
Smoked cannabis for chronic neuropathic pain: a randomized controlled trial (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2950205/?tool=pmcentrez
Pharmacological characterization of a novel cannabinoid ligand, MDA19, for treatment of neuropathic pain (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3253719/
top

Misdiagnosed chronic pelvic pain: pudendal neuralgia responding to a novel use of palmitoylethanolamide (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20345619
Information for Health Care Professionals- Marihuana (marijuana, cannabis) dried plant
for administration by ingestion or other means (Health Canada) (full–2010)  http://www.hc-sc.gc.ca/dhp-mps/marihuana/med/infoprof-eng.php
Pain related behaviors and neurochemical alterations in mice expressing sickle  hemoglobin: modulation by cannabinoids (full-2010)  http://bloodjournal.hematologylibrary.org/content/116/3/456.long
Combination Of Cannabinoids For The Treatment Of Peripheral Neuropathic Pain US  2010/ 0035978 A1 Feb. 11, 2010 (full–2010)  http://www.cannabisinternational.org/info/Neuropathic-Pain.pdf
AMELIORATIVE POTENTIAL OF CANNABIS SATIVA EXTRACT ON DIABETES INDUCED NEUROPATHIC PAIN IN RATS (link to PDF–2010)  https://www.researchgate.net/publication/216536386_Ameliorative_potential_of_cannabis_sativa_extract_on_diabetes_induced_neuropathic_pain_in_rats
An Open-Label Comparison of Nabilone and Gabapentin as Adjuvant Therapy or Monotherapy in the Management of Neuropathic Pain in Patients with Peripheral Neuropathy (abst–2010) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=311
Effect of dronabinol on central neuropathic pain after spinal cord injury: a pilot study (abst–2010) http://www.cannabis-med.org/studies/ww_en_db_study_show.php?s_id=313
Cannabinoid subtype-2 receptors modulate the antihyperalgesic effect of WIN 55,212-2 in rats with neuropathic spinal cord injury pain (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20920894
Pharmacological Management of Pain in Patients with Multiple Sclerosis(abst–2010) https://link.springer.com/article/10.2165%2F11537930-000000000-00000
Analgesic effect of Corydalis yanhusuo in a rat model of trigeminal neuropathic pain (abst–2010) https://www.ncbi.nlm.nih.gov/pubmed/20855279
Brief Report: Cannabidiol Prevents the Development of Cold and Mechanical Allodynia in Paclitaxel-Treated Female C57Bl6 Mice (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3249239/
Cannabinoid Agonists Inhibit Neuropathic Pain Induced by Brachial Plexus Avulsion in Mice by Affecting Glial Cells and MAP Kinases (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3172222/?tool=pubmed
Self-medication of a cannabinoid CB(2) agonist in an animal model of neuropathic pain (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3157548/pdf/nihms285774.pdf
Cannabinoids for Treatment of Chronic Non-Cancer Pain; a Systematic Review of Randomized Trials (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3243008/
Mutations in ABHD12 cause the neurodegenerative disease PHARC: An inborn error of endocannabinoid metabolism (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2933347/?tool=pubmed
Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3085542/
Activation of spinal and supraspinal cannabinoid-1 receptors leads to anti-nociception in a rat model of neuropathic spinal cord injury pain (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3159760/
Spinal cannabinoid CB2 receptors as a target for neuropathic pain: an investigation using chronic constriction injury (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/22210507
A drug discovery case history of ‘delta-9-tetrahydrocannabinol, cannabidiol’ (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/22646020
Palmitoylethanolamide restores myelinated-fibre function in patients with chemotherapy induced painful neuropathy (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/22229320
New targets, new drugs for metastatic bone pain: a new philosophy (abst–2011)  http://www.ncbi.nlm.nih.gov/pubmed/21623686
Activation of cannabinoid receptors by the pentacyclic triterpene α,β-amyrin inhibits  inflammatory and neuropathic persistent pain in mice (abst–2011)  http://www.ncbi.nlm.nih.gov/pubmed/21620566
Prescribing Cannabis for Harm Reduction (full–2012) http://www.harmreductionjournal.com/content/pdf/1477-7517-9-1.pdf
top

The maintenance of cisplatin- and paclitaxel-induced mechanical and cold allodynia is suppressed by cannabinoid CB2 receptor activation and independent of CXCR4 signaling in models of chemotherapy-induced peripheral neuropathy (full–2012)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3502129/
Therapeutic utility of palmitoylethanolamide in the treatment of neuropathic pain associated with various pathological conditions: a case series (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3500919/
Endocannabinoids in nervous system health and disease: the big picture in a nutshell (full–2012) http://rstb.royalsocietypublishing.org/content/367/1607/3193.full
The Therapeutic Potential of Cannabis and Cannabinoids (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3442177/
The major brain endocannabinoid 2-AG controls neuropathic pain and mechanical hyperalgesia in patients with neuromyelitis optica (full–2012) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0071500
Dynamic changes to the endocannabinoid system in models of chronic pain (full–2012) http://rstb.royalsocietypublishing.org/content/367/1607/3300.full?sid=1569c370-cd5c-4358-89ff-857201f5e069
Low-Dose Vaporized Cannabis Significantly Improves Neuropathic Pain (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3566631/
Modulation of neuropathic-pain-related behaviour by the spinal endocannabinoid / endovanilloid system (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3481534/
Prevention of Paclitaxel-Induced Neuropathy Through Activation of the Central Cannabinoid Type 2 Receptor System (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3334436/
The Novel Reversible Fatty Acid Amide Hydrolase Inhibitor ST4070 Increases Endo-cannabinoid Brain Levels and Counteracts Neuropathic Pain in Different Animal Models (full–2012) http://jpet.aspetjournals.org/content/342/1/188.full.pdf+html
Peripheral FAAH inhibition causes profound antinociception and protects against indomethacin-induced gastric lesions (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3738192/
Cannabinoids suppress inflammatory and neuropathic pain by targeting α3 glycine receptors (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3371734/
Alterations in endocannabinoid tone following chemotherapy-induced peripheral neuropathy: effects of endocannabinoid deactivation inhibitors targeting fatty-acid amide hydrolase and monoacylglycerol lipase in comparison to reference analgesics following cisplatin treatment (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3525790/
Local Peripheral Effects of β-Caryophyllene through CB2 Receptors in Neuropathic Pain in Mice (full–2012) http://file.scirp.org/Html/23613.html
Multimodal stepped care approach with acupuncture and PPAR-α agonist palmitoylethanolamide in the treatment of a patient with multiple sclerosis and central neuropathic pain (full–2012) http://aim.bmj.com/content/30/1/53.long
Cannabinoid type-1 receptor reduces pain and neurotoxicity produced by chemotherapy  (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3366638/

Palmitoylethanolamide in the Treatment of Chronic Pain Caused by Different  Etiopathogenesis (full–2012)  https://academic.oup.com/painmedicine/article/13/9/1121/1864240
The major brain endocannabinoid 2-AG controls neuropathic pain and mechanical  hyperalgesia in patients with neuromyelitis optica (full–2012)  http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0071500
The atypical cannabinoid O-1602 increases hind paw sensitisation in the chronic constriction injury model of neuropathic pain (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22227298
top

Cannabinoid agonist WIN 55,212-2 prevents the development of paclitaxel-induced peripheral neuropathy in rats. Possible involvement of spinal glial cells (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22374260
Low brain penetrant CB1 receptor agonists for the treatment of neuropathic pain (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/22421020
Characterization of cannabinoid-induced relief of neuropathic pain in rat models of type 1 and type 2 diabetes (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22609797
A Randomized, Double-Blind, Placebo Controlled, Parallel Assignment, Flexible Dose, Efficacy Study of Nabilone as Adjuvant in the Treatment of Diabetic Peripheral Neuropathic Pain Using an Enriched Enrollment Randomized Withdrawal Design (S38.003) (abst–2012) http://www.neurology.org/cgi/content/meeting_abstract/78/1_MeetingAbstracts/S38.003?maxtoshow=&hits=25&RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=180&sortspec=date&resourcetype=HWCIT
An enriched-enrolment, randomized withdrawal, flexible-dose, double-blind, placebo controlled, parallel assignment efficacy study of nabilone as adjuvant in the treatment of diabetic peripheral neuropathic pain (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22921260
Peripheral antinociceptive effect of anandamide and drugs that affect the endocannabinoid system on the formalin test in normal and streptozotocin-diabetic rats (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22959964
A double-blind, randomized, placebo-controlled, parallel-group study of THC/CBD oromucosal spray in combination with the existing treatment regimen, in the relief of central neuropathic pain in patients with multiple sclerosis (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23180178
The Major Brain Endocannabinoid 2-AG Controls Neuropathic Pain and Mechanical Hyperalgesia in Patients with Neuromyelitis Optica (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0071500
Drug Design for Neuropathic Pain Regulation from Traditional Chinese Medicine (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3558695/
Full Inhibition of Spinal FAAH Leads to TRPV1-Mediated Analgesic Effects in Neuropathic Rats and Possible Lipoxygenase-Mediated Remodeling of Anandamide Metabolism (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0060040
The endocannabinoid system, cannabinoids, and pain (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3820295/
Bilateral changes of cannabinoid receptor type 2 protein and mRNA in the dorsal root ganglia of a rat neuropathic pain model (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3707359/
A Double-Blind, Placebo-Controlled, Crossover Pilot Trial With Extension Using an Oral Mucosal Cannabinoid Extract for Treatment of Chemotherapy-Induced Neuropathic Pain (full–2013) http://www.jpsmjournal.com/article/S0885-3924%2813%2900238-8/fulltext
Endocannabinoids in the Brainstem Modulate Dural Trigeminovascular Nociceptive  Traffic via CB1 and “Triptan” Receptors: Implications in Migraine (full–2013)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3771033/
Repeated Low Dose Administration of the Monoacylglycerol Lipase Inhibitor JZL184  Retains CB1 Receptor Mediated Antinociceptive and Gastroprotective Effects (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3657109/
Non-neuronal cell modulation relieves neuropathic pain: efficacy of the endogenous lipid palmitoylethanolamide (link to download–2013)  http://www.eurekaselect.com/107974/article
Reduces Formalin-Induced Neuropathic-Like Behaviour Through Spinal Glial/Microglial  Phenotypical Changes in Mice (link to PDF–2013)  http://www.eurekaselect.com/107975/article
Different Classes of CB2 Ligands Potentially Useful in the Treatment of Pain (link to PDF–2013) http://www.eurekaselect.com/108399/article
Medicinal Cannabis and Painful Sensory Neuropathy (editorial–2013)  http://journalofethics.ama-assn.org/2013/05/oped1-1305.html
Therapeutic potential of cannabinoid medicines (abst–2013)  http://www.ncbi.nlm.nih.gov/pubmed/24006213
Anandamide deficiency and heightened neuropathic pain in aged mice (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23597506
Characterisation of cannabinoid-induced relief of neuropathic pain in a rat model of  cisplatin-induced neuropathy (abst–2013)  http://www.sciencedirect.com/science/article/pii/S0091305713000440
top
Palmitoylethanolamide is a New Possible Pharmacological Treatment for the Inflammation Associated with Trauma (abst–2013) http://www.eurekaselect.com/106175/article
Activation of spinal cannabinoid cb2 receptors inhibits neuropathic pain in streptozotocin-induced diabetic mice (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23892011
Endocannabinoids decrease neuropathic pain-related behavior in mice through the activation of one or both peripheral CB1 and CB2 receptors (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/24148808
Antinociceptive effects of the selective CB2 agonist MT178 in inflammatory and chronic
rodent pain models (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23518609
Spinal gene expression profiling and pathways analysis of a CB2 agonist (MDA7)-
targeted prevention of paclitaxel-induced neuropathy (abst–2013)  http://www.ncbi.nlm.nih.gov/pubmed/24361916
Non-psychotropic analgesic drugs from the endocannabinoid system: “magic bullet” or  “multiple-target” strategies? (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23500197

Prescribing smoked cannabis for chronic noncancer pain: Preliminary recommendations (full–2014) http://www.cfp.ca/content/60/12/1083.long
Cannabidiol inhibits paclitaxel-induced neuropathic pain through 5-HT1A receptors without diminishing nervous system function or chemotherapy efficacy (full–2014)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3969077/
Prophylactic cannabinoid administration blocks the development of paclitaxel-induced neuropathic nociception during analgesic treatment and following cessation of drug delivery (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3998744/
top
Therapeutic benefits of cannabis: a patient survey (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3998228/
Alterations in the anandamide metabolism in the development of neuropathic pain (full–2014) http://www.hindawi.com/journals/bmri/2014/686908/

NMP-7 inhibits chronic inflammatory and neuropathic pain via block of Cav3.2 T-type calcium channels and activation of CB2 receptors (full–2014) http://www.molecularpain.com/content/pdf/1744-8069-10-77.pdf
Celastrol Attenuates Inflammatory and Neuropathic Pain Mediated by Cannabinoid Receptor Type 2 (link to PDF–2014) http://www.mdpi.com/1422-0067/15/8/13637
Glucose concentration in culture medium affects mRNA expression of TRPV1 and CB1 receptors and changes capsaicin toxicity in PC12 cells (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4322151/
Hemopressin, an inverse agonist of cannabinoid receptors, inhibits neuropathic pain in rats (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4112957/
Effects of repeated dosing with mechanistically distinct antinociceptive ligands in a rat model of neuropathic spinal cord injury pain (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4184706/
The cannabinoid CB₂ receptor-selective phytocannabinoid beta-caryophyllene exerts analgesic effects in mouse models of inflammatory and neuropathic pain (full–2014) http://www.europeanneuropsychopharmacology.com/article/S0924-977X%2813%2900302-7/fulltext
JZL184 is anti-hyperalgesic in a murine model of cisplatin-induced peripheral  neuropathy (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4268146/
Combined inhibition of FAAH and COX produces enhanced anti-allodynic effects in mouse neuropathic and inflammatory pain models (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4206939/
Inhibition of anandamide hydrolysis attenuates nociceptor sensitization in a murine model of chemotherapy-induced peripheral neuropathy (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4346731/
Dual inhibition of monoacylglycerol lipase and cyclooxygenases synergistically reduces neuropathic pain in mice (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376450/
Metabolomics uncovers dietary omega-3 fatty acid-derived metabolites implicated in anti-nociceptive responses after experimental spinal cord injury (full–2014) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3844071/
The Pharmacokinetics, Efficacy, Safety, and Ease of Use of a Novel Portable Metered Dose Cannabis Inhaler in Patients With Chronic Neuropathic Pain: A Phase 1a Study (full–2014) http://www.tandfonline.com/doi/full/10.3109/15360288.2014.941130
Pharmacological management of chronic neuropathic pain: Revised consensus statement from the Canadian Pain Society (full–2014)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4273712/
A lipid gate for the peripheral control of pain (full–2014)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4228127/
Endocannabinoid system and pain: an introduction (full–2014)  https://www.cambridge.org/core/journals/proceedings-of-the-nutrition-society/article/endocannabinoid-system-and-pain-anintroduction/4C5678CCAD813D1C978C676155E9E39D/core-reader
CB2 cannabinoid receptors as a therapeutic target – What does the future hold? (link to download–2014)  http://molpharm.aspetjournals.org/content/early/2014/08/08/mol.114.094649.long
A double-blind, randomized, placebo-controlled, parallel group study of THC/CBD spray in peripheral neuropathic pain treatment (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24420962
top
Endocannabinoids and neuropathic pain: focus on neuron-glia and endocannabinoid neurotrophin interactions (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24494680
Involvement of the endocannabinoid system in osteoarthritis pain (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24494687
Cannabinoids in pain management: CB1, CB2 and non-classic receptor ligands (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24836296
Augmented tonic pain-related behavior in knockout mice lacking monoacylglycerol lipase, a major degrading enzyme for the endocannabinoid 2-arachidonoylglycerol (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24906199
Cannabinoids for Neuropathic Pain (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25160710
Neuropathic orofacial pain: Cannabinoids as a therapeutic avenue (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25150831
There is evidence for the use of cannabinoids for symptomatic treatment of multiple sclerosis (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25350886
Attenuation of persistent pain-related behavior by fatty acid amide hydrolase (FAAH) inhibitors in a rat model of HIV sensory neuropathy (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25486617
Discriminating the effects of Cannabis sativa and Cannabis indica: a web survey of medical cannabis users (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25191852
top

Palmitoylethanolamide, a naturally occurring disease-modifying agent in neuropathic pain (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24178954
Inhibition of Voltage-Gated Na+ Channels by the Synthetic Cannabinoid Ajulemic Acid  (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24755846
1-Aryl-2-((6-aryl)pyrimidin-4-yl)amino)ethanols as competitive inhibitors of fatty acid  amide hydrolase (abst–2014)  http://www.sciencedirect.com/science/article/pii/S0960894X14000948
The spinal anti-inflammatory mechanism of motor cortex stimulation: cause of success and refractoriness in neuropathic pain? (full–2015) http://www.jneuroinflammation.com/content/pdf/s12974-014-0216-1.pdf
Nabilone as an Adjunctive to Gabapentin for Multiple Sclerosis-Induced Neuropathic Pain: A Randomized Controlled Trial (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/pme.12569/full
Cannabis in cancer care (full–2015) http://onlinelibrary.wiley.com/doi/10.1002/cpt.108/full
Coadministration of indomethacin and minocycline attenuates established paclitaxel induced neuropathic thermal hyperalgesia: Involvement of cannabinoid CB1 receptors (full–2015) http://www.nature.com/srep/2015/150618/srep10541/pdf/srep10541.pdf
Efficacy and adverse effects of medical marijuana for chronic noncancer pain: Systematic review of randomized controlled trials (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4541447/
Role of the Endocannabinoid System in Diabetes and Diabetic Complications (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/bph.13226/full
CB1 Knockout Mice Unveil Sustained CB2-Mediated Anti-Allodynic Effects of the Mixed CB1/CB2 Agonist CP55,940 in a Mouse Model of Paclitaxel-Induced Neuropathic Pain  (full–2015) http://molpharm.aspetjournals.org/content/88/1/64.long
Selective Monoacylglycerol Lipase Inhibitors: Antinociceptive versus Cannabimimetic Effects in Mice (full–2015) http://jpet.aspetjournals.org/content/353/2/424.full.pdf+html
Medical Marijuana for Treatment of Chronic Pain and Other Medical and Psychiatric Problems: A Clinical Review (full–2015) http://jama.jamanetwork.com/article.aspx? articleid=2338266
Efficacy of Inhaled Cannabis on Painful Diabetic Neuropathy (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5152762/ 
A Cannabinoid CB1 Receptor Positive Allosteric Modulator Reduces Neuropathic Pain in the Mouse with no Psychoactive Effects (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4864630/
Spinal RGS4 inhibition effectively attenuates neuropathic hyperalgesia and restores cannabinoid receptor type 1 signaling (full–2015)  http://onlinelibrary.wiley.com/doi/10.1111/bph.13324/full
Inhaled Cannabis for Chronic Neuropathic Pain: A Meta-analysis of Individual Patient Data (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4666747/
Cannabis in cancer care (full–2015) http://escholarship.org/uc/item/6367m6vj#page-1
Clinical Use of Cannabinoids for Symptom Control in Multiple Sclerosis (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604175/
Tonic Modulation of Nociceptive Behavior and Allodynia by Cannabinoid Receptors in Formalin Test in Rats (full–2015) http://www.cps.org.tw/files/201503160252300.pdf
Medical marijuana: Hints of headway? Despite a conflicted regulatory landscape, support for medical marijuana is growing amid increasing evidence of potential benefits (Part 2 of 2) (article–2015) http://onlinelibrary.wiley.com/doi/10.1002/cncy.21524/full
The entourage effect: Synergistic actions of plant cannabinoids (letter–2015) http://www.researchgate.net/publication/273330402_The_entourage_effect_Synergistic_actions_of_plant_cannabinoids
The Effectiveness of Cannabinoids in the Management of Chronic Nonmalignant Neuropathic Pain: A Systematic Review (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25635955
Influence of nitric oxide synthase or cyclooxygenase inhibitors on cannabinoids activity in streptozotocin-induced neuropathy (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25712641
CB1 receptors modulate affective behaviour induced by neuropathic pain (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25863168
top
N-Palmitoylethanolamine and Neuroinflammation: a Novel Therapeutic Strategy of Resolution (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26055231
Minimizing chemotherapy-induced peripheral neuropathy: preclinical and clinical development of new perspectives (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26058312
Clinical pharmacology of medical cannabinoids in chronic pain (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/26267945
Medical Marijuana and Chronic Pain: a Review of Basic Science and Clinical Evidence (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26325482
The Efficacy of Eslicarbazepine Acetate in Models of Trigeminal, Neuropathic, and Visceral Pain: The Involvement of 5-HT1B/1D Serotonergic and CB1/CB2 Cannabinoid Receptors (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26465930
Analysis of the anti-allodynic effects of combination of a synthetic cannabinoid and a selective noradrenaline re-uptake inhibitor in nerve injury-induced neuropathic mice (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26206340
Prescribing medical cannabis in Canada: Are we being too cautious? (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26451996
Cannabinoids for the Treatment of Chronic Non-Cancer Pain: An Updated Systematic  Review of Randomized Controlled Trials (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/25796592
Emerging concepts of pain therapy based on neuronal mechanisms (abst–2015)  http://link.springer.com/chapter/10.1007%2F978-3-662-46450-2_1
Actions of the dual FAAH/MAGL inhibitor JZL195 in a murine neuropathic pain model (full–2016) http://onlinelibrary.wiley.com/doi/10.1111/bph.13337/full
Integrating cannabis into clinical cancer care (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4791148/
The effect of spinally administered WIN 55,212-2, a cannabinoid agonist, on thermal pain sensitivity in diabetic rats (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4887712/
Neuropathic Pain Treatment: Still a Challenge (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4935814/
Cannabinoid Buccal Spray for Chronic Non-Cancer or Neuropathic Pain: A Review of Clinical Effectiveness, Safety, and Guidelines (full–2016) https://www.ncbi.nlm.nih.gov/books/NBK395789/
A preliminary evaluation of the relationship of cannabinoid blood concentrations with the analgesic response to vaporized cannabis (full–2016) https://www.dovepress.com/a-preliminary-evaluation-of-the-relationship-of-cannabinoid-blood-conc-peer-reviewed-fulltext-articleJPR
Opioid and cannabinoid synergy in a mouse neuropathic pain model (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4959956/
An Exploratory Human Laboratory Experiment Evaluating Vaporized Cannabis in the  Treatment of Neuropathic Pain from Spinal Cord Injury and Disease (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5007175/
The selective monoacylglycerol lipase inhibitor MJN110 produces opioid sparing effects in a mouse neuropathic pain model (link to PDF–2016) http://jpet.aspetjournals.org/content/early/2016/01/20/jpet.115.229971.abstract?sid=97527854 -e2fb-4d74-ad96-6ab0744dc240
Using Medical Cannabis in an Oncology Practice (article–2016) (needs free registration) http://www.cancernetwork.com/oncology-journal/using-medical-cannabis-oncologypractice#sthash.CjT8fR9n.uWvEhfSG.dpuf
Evaluating Sativex® in Neuropathic Pain Management: A Clinical and Neuro-physiological Assessment in Multiple Sclerosis (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26764336
Medical use of cannabis products : Lessons to be learned from Israel and Canada (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26767992
The endocannabinoid system and neuropathic pain (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26785153
Efficacy, tolerability and safety of cannabinoids for chronic neuropathic pain : A systematic review of randomized controlled studies (abst in German & English-2016) http://link.springer.com/article/10.1007%2Fs00482-015-0089-y

Cannabinoids and autoimmune diseases: A systematic review (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26876387
Nabilone for the Management of Pain (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26923810
Polypharmacological Properties and Therapeutic Potential of β-Caryophyllene: a Dietary Phytocannabinoid of Pharmaceutical Promise (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26965491
Endovanilloid control of pain modulation by the rostroventromedial medulla in an animal model of diabetic neuropathy (abst–2016) http://www.sciencedirect.com/science/article/pii/S002839081630079X
The role of carbon monoxide on the anti-nociceptive effects and expression of cannabinoid 2 receptors during painful diabetic neuropathy in mice (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27020787
Mesoporous Silica Particles as a Multifunctional Delivery System for Pain Relief in Experimental Neuropathy (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27028159 Effects of Delta-9-Tetrahydrocannabinol and Cannabidiol on Cisplatin-Induced Neuropathy in Mice (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27214593
The multiplicity of spinal AA-5-HT anti-nociceptive action in a rat model of neuropathic pain (abst–2016) http://www.sciencedirect.com/science/article/pii/S1043661816305667 Cannabinoids for the treatment of neuropathic pain (abst–2016) http://www.ingentaconnect.com/search/article?option1=title&value1=Cannabinoids+for+the+treatment+of+neuropathic+pain.&pageSize=10&index=1
Peripherally selective cannabinoid 1 receptor (CB1R) agonists for the treatment of neuropathic pain (abst–2016) http://pubs.acs.org/doi/abs/10.1021/acs.jmedchem.6b00516
Progress in study on endocannabinoids and cannabinoid receptors in the treatment for neuropathic pain (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27600019
Activation of Cannabinoid Receptor 2 Attenuates Mechanical Allodynia and Neuroinflammatory Responses in a Chronic Post-Ischemic Pain Model of Complex Regional Pain Syndrome Type I in Rats (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27717112
The endocannabinoid hydrolysis inhibitor SA-57: Intrinsic antinociceptive effects, augmented morphine-induced antinociception, and attenuated heroin seeking behavior in mice (abst–2016) http://www.sciencedirect.com/science/article/pii/S0028390816305123
Inflammation of peripheral tissues and injury to peripheral nerves induce diferring effects in the expression of the calcium-sensitive anandamide-synthesising enzyme and related molecules in rat primary sensory neurons (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27997038
Antihyperalgesic Activities of Endocannabinoids in a Mouse Model of Antiretroviral Induced Neuropathic Pain (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5357623/
Rimonabant improves metabolic parameters partially attributed to restoration of high  voltage-activated Ca2+ channels in skeletal muscle in HFD-fed mice (full–2017)  http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2017000600602&lng=en&nrm=iso&tlng=en (full–in varous languages)  http://www.scielo.br/scieloOrg/php/translate.php?pid=S0100-879X2017000600602&caller=www.scielo.br&lang=en&tlang=en&script=sci_arttext
The case for the development of novel analgesic agents targeting both fatty acid amide
hydrolase and either cyclooxygenase or TRPV1 (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2697682/
The Clinical Significance of Endocannabinoids in Endometriosis Pain Management (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5436335/
Activation of dorsal horn cannabinoid CB2 receptor suppresses the expression of P2Y12  and P2Y13 receptors in neuropathic pain rats (full–2017)  https://jneuroinflammation.biomedcentral.com/articles/10.1186/s12974-017-0960-0
Cannabinoids in Pain Management and Palliative Medicine (full–2017)  https://www.aerzteblatt.de/int/archive/article?id=193441
N-Arachidonoyl Dopamine: A Novel Endocannabinoid and Endovanilloid with  Widespread Physiological and Pharmacological Activities (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5627668/
Inflammatory and Neuropathic Nociception is Preserved in GPR55 Knockout Mice (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5430528/
Pharmacologic management of chronic neuropathic pain (full–2017)  http://www.cfp.ca/content/63/11/844.long
Modulating the endocannabinoid pathway as treatment for peripheral neuropathic pain: a selected review of preclinical studies (full–2017)  http://apm.amegroups.com/article/view/16320/16484
Cannabinoid type 2 receptors in dopamine neurons inhibits psychomotor behaviors, alters anxiety, depression and alcohol preference (full–2017)  https://www.nature.com/articles/s41598-017-17796-y
Chapter 4 Neuropathic Pain in Multiple Sclerosis—Current Therapeutic Intervention and  Future Treatment Perspectives (full–2017)  https://www.ncbi.nlm.nih.gov/books/NBK470151/
WWL70 protects against chronic constriction injury-induced neuropathic pain in mice by cannabinoid receptor-independent mechanisms (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5759843/
The slowly signaling G protein-biased CB2 cannabinoid receptor agonist LY2828360  suppresses neuropathic pain with sustained efficacy and attenuates morphine tolerance  and dependence (link to download–2017)  http://molpharm.aspetjournals.org/content/early/2017/11/30/mol.117.109355.long
Efficacy of Cannabis-Based Medicines for Pain Management: A Systematic Review and  Meta-Analysis of Randomized Controlled Trials (link to PDF-2017)  http://www.painphysicianjournal.com/linkout?issn=1533-3159&vol=20&page=E755
Systematic review of safeness and therapeutic efficacy of cannabis in patients with  multiple sclerosis, neuropathic pain, and in oncological patients treated with  chemotherapy (abst in English–2017) https://www.ncbi.nlm.nih.gov/pubmed/29119763  (full in Italian) http://www.epiprev.it/articolo_scientifico/revisione-sistematica-sull%E2%80%99efficacia-terapeutica-e-la-sicurezza-della-cannabis
Endocannabinoid activation of CB1 receptors contributes to long-lasting reversal of  neuropathic pain by repetitive spinal cord stimulation (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28107590
Effects on Spasticity and Neuropathic Pain of an Oral Formulation of Δ9-
Tetrahydrocannabinol in Patients With Progressive Multiple Sclerosis (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28189366
Upregulation of fatty acid amide hydrolase in the dorsal periaqueductal gray is associated with neuropathic pain and reduced heart rate in rats (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28148494
Allodynia Lowering Induced by Cannabinoids and Endocannabinoids (ALICE) (abst–2017) http://www.sciencedirect.com/science/article/pii/S1043661817301536
Role of cannabinoid receptor 1-mediated synaptic plasticity in neuropathic pain and  associated depression (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28364110
Continuous Intrathecal Infusion of Cannabinoid Receptor Agonists Attenuates Nerve
Ligation-Induced Pain in Rats (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28492437
Neuroprotection in oxidative stress-related neurodegenerative diseases: role of  endocannabinoid system modulation (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28497982
Selective Cannabinoids for Chronic Neuropathic Pain: A Systematic Review and Metaanalysis (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28537982
Single and combined effects of delta9 -tetrahydrocannabinol and cannabidiol in a mouse  model of chemotherapy-induced neuropathic pain (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28548225
Antiallodynic effect of β-caryophyllene on paclitaxel-induced peripheral neuropathy in  mice (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0028390817303465?via%3Dihub
Single oral dose of cannabinoid derivate loaded PLGA nanocarriers relieves neuropathic  pain for eleven days (abst–2017)  http://www.nanomedjournal.com/article/S1549-9634(17)30140-5/fulltext
Cannabinoids and Pain: Sites and Mechanisms of Action (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28826543
The Endogenous Cannabinoid System: A Budding Source of Targets for Treating  Inflammatory and Neuropathic Pain (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28857069
Managing neuropathic pain in multiple sclerosis: Pharmacological interventions (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28875858
Cannabis constituent synergy in a mouse neuropathic pain model (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28885457
Liposomal Delivery of Diacylglycerol Lipase-Beta Inhibitors to Macrophages  Dramatically Enhances Selectivity and Efficacy in Vivo (abst–2017)  http://pubs.acs.org/doi/abs/10.1021/acs.molpharmaceut.7b00657
The monoacylglycerol lipase inhibitor KML29 with gabapentin synergistically produces  analgesia in mice (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28963716
Salvinorin A reduces neuropathic nociception in the insular cortex of the rat (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28975684
Neuropathic pain treatment (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28981225
In vitro and in vivo pharmacological characterization of ASP8477: A novel highly  selective fatty acid amide hydrolase inhibitor (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29017758
Modulation of Renal GLUT2 by the Cannabinoid-1 Receptor: Implications for the  Treatment of Diabetic Nephropathy (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29030466
Efficacy, tolerability and safety of cannabis-based medicines for chronic pain  management – An overview of systematic reviews (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29034533
Medical cannabis for the treatment of chronic pain and other disorders: misconceptions  and facts (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29067992
The Inhibitory Effects of Cobalt Protoporphyrin IX and Cannabinoid 2 Receptor Agonists in Type 2 Diabetic Mice (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29143802
Current evidence of cannabinoid-based analgesia obtained in preclinical and human  experimental settings (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29160600
Mechanisms and treatment of painful neuromas (full–2018)  https://www.degruyter.com/view/j/revneuro.ahead-of-print/revneuro-2017-0077/revneuro-2017-0077.xml
The role of cannabinoids in pain control: the good, the bad, and the ugly (abst–2018)  https://www.ncbi.nlm.nih.gov/pubmed/29338150
Medical Cannabis for Neuropathic Pain (abst–2018)  https://link.springer.com/article/10.1007%2Fs11916-018-0658-8


NEUROPROTECTION*+
Neuroprotective potential of CB1 receptor agonists in an in vitro model of Huntington’s disease (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931573/?tool=pubmed
Learning and memory performances in adolescent users of alcohol and marijuana: interactive effects (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2965487/
The effects of Delta-tetrahydrocannabinol and cannabidiol alone and in combination on damage, inflammation and in vitro motility disturbances in rat colitis (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931570/?tool=pubmed
The Neuroprotective Effect of Cannabinoid Receptor Agonist (WIN55,212-2) in Paraoxon Induced Neurotoxicity in PC12 Cells and N-methyl-D-aspartate Receptor Interaction (full–2010) http://celljournal.org/library/upload/article/af_4334422Hashemi.pdf
THC Prevents MDMA Neurotoxicity in Mice (full-2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2824821/
The cannabinoid WIN55212-2 promotes neural repair after neonatal hypoxia-ischemia  (full-2010) http://stroke.ahajournals.org/content/41/12/2956.long
Synergistic neuroprotective therapies with hypothermia (full–2010)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2892736/?tool=pubmed
Regulatory Role of Cannabinoid Receptor 1 in Stress-Induced Excitotoxicity and  Neuroinflammation (full-2010)  http://www.nature.com/npp/journal/vaop/ncurrent/full/npp2010214a.html
Cannabinoid receptor agonist protects cultured dopaminergic neurons from the death by the proteasomal dysfunction (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3145842/?tool=pubmed
CANNABINOID-CONTAINING PLANT EXTRACTS AS NEUROPROTECTIVE AGENTS Patent application number: 20100239693 (full-2010)  http://www.faqs.org/patents/app/20100239693
The neuroprotective effect of cannabidiol in an in vitro model of newborn hypoxicischemic brain damage in mice is mediated by CB(2) and adenosine receptors  (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/19900555
Inhibitory effect of ethanol extract of Magnolia officinalis and 4-O-methylhonokiol on  memory impairment and neuronal toxicity induced by beta-amyloid (abst–2010)  http://www.ncbi.nlm.nih.gov/pubmed/20004682
Circulating endocannabinoids and N-acyl-ethanolamides in patients with sleep apnea-
specific role of oleoylethanolamide (abst–2010)  http://www.ncbi.nlm.nih.gov/pubmed/20429051
The endocannabinoid 2-arachidonoylglycerol reduces lesion expansion and white matter damage after spinal cord injury (abst-2010)  http://www.ncbi.nlm.nih.gov/pubmed/20156559
Activation of cannabinoid 2 receptors protects against cerebral ischemia by inhibiting  neutrophil recruitment (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/19884325
Cannabinoid receptor agonist protects cultured dopaminergic neurons from the death by the proteasomal dysfunction (full–2011)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3145842/?tool=pubmed
Inhibition of COX-2 expression by endocannabinoid 2-arachidonoylglycerol is mediated via PPAR-γ (full–2011) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2011.01444.x/full
Cannabinoids and B cells: emerging targets for treating progressive multiple sclerosis (full–2011) http://msj.sagepub.com/content/17/3/259.long
N-arachidonoyl–serine is neuroprotective after traumatic brain injury by reducing apoptosis (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3170948/
Cannabinoid Receptor Type 1 Protects Nigrostriatal Dopaminergic Neurons against MPTP Neurotoxicity by Inhibiting Microglial Activation (full–2011) http://www.jimmunol.org/content/187/12/6508.full?sid=c3422dd2-7ad0-42e4-a862-845dc670f7cf
Pharmacological activation/inhibition of the cannabinoid system affects alcohol withdrawal-induced neuronal hypersensitivity to excitotoxic insults (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3158793/
HIV-1 infection and alcohol abuse: neurocognitive impairment, mechanisms of neuro-degeneration and therapeutic interventions (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3098312/
Endocannabinoid 2-arachidonoylglycerol protects neurons against β-amyloid insults (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3052737/pdf/nihms266962.pdf
top
The dual neuroprotective-neurotoxic profile of cannabinoid drugs (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165949/
Endocannabinoids and traumatic brain injury (full–2011)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165950
Cannabinoid-containing plant extracts as neuroprotective agents – Patent EP2332533 (A1) ― 2011-06-15 (full–2011) http://worldwide.espacenet.com/publicationDetails/description?CC=EP&NR=2332533A1&KC=A1&FT=D&ND=3&date=20110615&DB=EPODOC&locale=en_EP
Symptom-relieving and neuroprotective effects of the phytocannabinoid D(9) -THCV in
animal models of Parkinson’s disease (link to download–2011)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165958/pdf/bph0163-1495.pdf
Cannabinoids and Innate Immunity: Taking a Toll on Neuroinflammation (link to PDF–2011) http://www.tswj.com/2011/230786/abs/
Role of Cannabinoids in Multiple Sclerosis (link to PDF-2011) http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.659.8269&rank=26
Overexpression of CB2 cannabinoid receptors results in neuroprotection against behavioral and neurochemical alterations induced by intracaudate administration of 6-hydroxydopamine (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/20980074
The endocannabinoid anandamide downregulates IL-23 and IL-12 subunits in a viral model of multiple sclerosis: evidence for a cross-talk between IL-12p70/IL-23 axis and IL-10 in microglial cells (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21310228
Immunomodulatory properties of kappa opioids and synthetic cannabinoids in HIV-1 neuropathogenesis (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21850403
Effects of palmitoylethanolamide on release of mast cell peptidases and neurotrophic factors after spinal cord injury (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21354467
Functional and Structural Protection by N-Acylethanolamines in Diabetic Retinopathy (abst-2011) http://iovs.arvojournals.org/article.aspx?articleid=2356082&resultClick=1
Increased vulnerability to 6-hydroxydopamine lesion and reduced development of
dyskinesias in mice lacking CB1 cannabinoid receptors (abst–2011)  http://europepmc.org/abstract/med/19419794
Neuroprotective effects of phytocannabinoid-based medicines in experimental models of Huntington’s disease (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21674569
Therapeutic potential of the endocannabinoid system in perinatal asphyxia (abst in English–2011) http://www.ncbi.nlm.nih.gov/pubmed/22127663 (abst in Spanish) https://www.neurologia.com/articulo/2011157
Cannabinoid as a neuroprotective strategy in perinatal hypoxic-ischemic injury (abst in English & Japanese-2011) https://link.springer.com/article/10.1007%2Fs12264-011-1008-6
Targetting CB1 Cannabinoid Receptor for Neuroprotetion in Spinal Cord Injury (abst–2011) http://www.fasebj.org/content/25/1_Supplement/lb422.abstract?sid=ebd6611b-9cd5-451c-8d4c-a78d4d17cca1
Cannabinoid receptor type 2 activation yields delayed tolerance to focal cerebral  ischemia (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21443454
Update on the role of cannabinoid receptors after ischemic stroke (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3337695/?tool=pubmed
Palmitoylethanolamide exerts neuroprotective effects in mixed neuroglial cultures and organotypic hippocampal slices via peroxisome proliferator-activated receptor-α (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3315437/?tool=pubmed
Dimerization with Cannabinoid Receptors Allosterically Modulates Delta Opioid Receptor Activity during Neuropathic Pain (full–2012) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0049789
Contribution of Hypothermia and CB(1) Receptor Activation to Protective Effects of TAK-937, a Cannabinoid Receptor Agonist, in Rat Transient MCAO Model (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3397930/?tool=pubmed
Early Endogenous Activation of CB1 and CB2 Receptors after Spinal Cord Injury Is a Protective Response Involved in Spontaneous Recovery (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3496738/
Palmitoylethanolamide exerts neuroprotective effects in mixed neuroglial cultures and organotypic hippocampal slices via peroxisome proliferator-activated receptor-α (full–2012) http://www.jneuroinflammation.com/content/9/1/49
Endocannabinoids in nervous system health and disease: the big picture in a nutshell (full–2012) http://rstb.royalsocietypublishing.org/content/367/1607/3193.full
top
Intrinsic Up-Regulation of 2-AG Favors an Area Specific Neuronal Survival in Different In Vitro Models of Neuronal Damage (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3527460/
Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid? (full–2012)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3579248/

Review article: The endocannabinoid system in normal and pathological brain ageing (full–2012) http://rstb.royalsocietypublishing.org/content/367/1607/3326.full?sid=161e7b36-5055-448b-962e-697c782e901d
Sativex-like Combination of Phytocannabinoids is Neuroprotective in Malonate-Lesioned Rats, an Inflammatory Model of Huntington’s Disease: Role of CB(1) and CB(2) Receptors (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3382456/
Prevention of Paclitaxel-Induced Neuropathy Through Activation of the Central
Cannabinoid Type 2 Receptor System (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3334436/
Cannabinoid type 2 receptor activation downregulates stroke-induced classic and
alternative brain macrophage/microglial activation concomitant to neuroprotection (full–2012) http://stroke.ahajournals.org/content/43/1/211.long
Neuroprotection by inhibiting the c-Jun N-terminal kinase pathway after cerebral ischemia occurs independently of interleukin-6 and keratinocyte-derived chemokine (KC/CXCL1) secretion (full–2012) http://www.jneuroinflammation.com/content/9/1/76
CB1 cannabinoid receptor activation rescues amyloid β-induced alterations in behaviour and intrinsic electrophysiological properties of rat hippocampal CA1 pyramidal neurones (full–2012) http://www.karger.com/Article/Pdf/338494
WIN55,212-2 protects oligodendrocyte precursor cells in stroke penumbra following permanent focal cerebral ischemia in rats (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4086494/
Cannabinoid type-1 receptor reduces pain and neurotoxicity produced by chemotherapy  (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3366638/
Chronic administration of THC prevents the behavioral effects of intermittent adolescent  MDMA administration and attenuates MDMA-induced hyperthermia and neurotoxicity  in rats (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3189263/
Reduced infarct size and accumulation of microglia in rats treated with WIN 55,212-2  after neonatal stroke (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446851/
Cannabinoids: Novel Medicines for the Treatment of Huntington’s Disease (link to download–2012) http://www.eurekaselect.com/89300/article
CB1 Agonist ACEA Protects Neurons and Reduces the Cognitive Impairment of AβPP/PS1 Mice (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22451318
Anandamide and 2-arachidonoylglycerol: Pharmacological Properties, Functional Features and Emerging Specificities of the Two Major Endocannabinoids (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/22801993
Neuroprotective agents: cannabinoids (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/21420365
top
Δ(9)-THC exerts a direct neuroprotective effect in a human cell culture model of Parkinson’s disease (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22236282
Single-dose Pharmacokinetics and Tolerability of Oral Delta-9-Tetrahydrocannabinol in Patients with Amyotrophic Lateral Sclerosis (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22594565
Effects of cannabinoids Δ(9)-tetrahydrocannabinol, Δ(9)-tetrahydrocannabinolic acid and cannabidiol in MPP(+) affected murine mesencephalic cultures (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22571976
A cannabinoid type 2 receptor agonist attenuates blood-brain barrier damage and neuro-degeneration in a murine model of traumatic brain injury (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22903455
A Cannabigerol Quinone Alleviates Neuroinflammation in a Chronic Model of Multiple Sclerosis (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22971837
Cannabinoid Receptor Subtypes 1 and 2 Mediate Long-Lasting Neuroprotection and Improve Motor Behaviour Deficits After Transient Focal Cerebral Ischemia (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23069763
Cannabidiol administration after hypoxia-ischemia to newborn rats reduces long-term brain injury and restores neurobehavioral function (abst–2012)  http://www.sciencedirect.com/science/article/pii/S0028390812002328
Specific inhibition of the JNK pathway promotes locomotor recovery and neuro-protection after mouse spinal cord injury (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22426389
The biology that underpins the therapeutic potential of cannabis-based medicines for the control of spasticity in multiple sclerosis (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/25876933
Long-term behavioral and biochemical effects of an ultra-low dose of Δ(9)-tetra-hydrocannabinol (THC): neuroprotection and ERK signaling (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22821081
WIN55212-2 attenuates amyloid-beta-induced neuroinflammation in rats through activation of cannabinoid receptors and PPAR-γ pathway (abst–2012) http://www.sciencedirect.com/science/article/pii/S0028390812001980
NEUROPROTECTIVE EFFECTS OF CANNABIS SATIVA ALCOHOLIC EXTRACT AGAINST SPINAL ALPHA MOTONEURONS DEGENERATION IN MALE TYPE II DIABETIC RATS (abst–2012) http://en.journals.sid.ir/ViewPaper.aspx?ID=278407
Structural and Functional Protection of the Retina by N-Acylethanolamines in Glaucoma (abst–2012) http://iovs.arvojournals.org/article.aspx?articleid=2350521&resultClick=1
A novel CB2 agonist, COR167, potently protects rat brain cortical slices against OGD and reperfusion injury (abst–2012)  http://www.sciencedirect.com/science/article/pii/S1043661812001636
Potential Control of Multiple Sclerosis by Cannabis and the Endocannabinoid System  (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22583441
WIN55, 212-2 promotes differentiation of oligodendrocyte precursor cells and improve  remyelination through regulation of the phosphorylation level of the ERK 1/2 via  cannabinoid receptor 1 after stroke-induced demyelination (abst–2012)  https://www.sciencedirect.com/science/article/pii/S0006899312018008
Endocannabinoids reduce cerebral damage after hypoxic-ischemic injury in perinatal rats (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22841538
Cerebroprotective effects of TAK-937, a cannabinoid receptor agonist, on ischemic brain
damage in middle cerebral artery occluded rats and non-human primates (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22119394
Orally administered oleoylethanolamide protects mice from focal cerebral ischemic  injury by activating peroxisome proliferator-activated receptor α (abst–2012)  http://www.sciencedirect.com/science/article/pii/S0028390812001062
A CB₁/CB₂ receptor agonist, WIN 55,212-2, exerts its therapeutic effect in a viral  autoimmune model of multiple sclerosis by restoring self-tolerance to myelin (abst–2012) http://www.sciencedirect.com/science/article/pii/S0028390812001487
The endocannabinoid N-arachidonoyldopamine (NADA) exerts neuroprotective effects  after excitotoxic neuronal damage via cannabinoid receptor 1 (CB(1)) (abst–2012)
http://www.sciencedirect.com/science/article/pii/S0028390811005053
Molecular evidence for the involvement of PPAR-δ and PPAR-γ in anti-inflammatory and neuroprotective activities of palmitoylethanolamide after spinal cord trauma (full–2013) http://www.jneuroinflammation.com/content/10/1/20
Using the endocannabinoid system as a neuroprotective strategy in perinatal hypoxic ischemic brain injury (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4146074/
Neuroprotective effects of Cannabis sativa leaves extracts on α-Motoneurons density after sciatic nerve injury in rats (full–2013) http://www.lifesciencesite.com/lsj/life1005s/113_15973life1005s_644_648.pdf
top
HINT1 protein cooperates with cannabinoid 1 receptor to negatively regulate glutamate NMDA receptor activity (full–2013) http://www.molecularbrain.com/content/6/1/42
CB2 Receptor Agonists Protect Human Dopaminergic Neurons against Damage from HIV-1 gp120 (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0077577
Molecular targets underlying SUMO-mediated neuroprotection in brain ischemia (full–2013) http://onlinelibrary.wiley.com/doi/10.1111/jnc.12347/full
A new co-ultramicronized composite including palmitoylethanolamide and luteolin to prevent neuroinflammation in spinal cord injury (full–2013) http://www.jneuroinflammation.com/content/10/1/91
Selective inhibition of alpha/beta-hydrolase domain 6 attenuates neurodegeneration, alleviates blood brain barrier breakdown, and improves functional recovery in a mouse model of traumatic brain injury (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3636589/
The Influence of Cannabinoids on Generic Traits of Neurodegeneration (full–2013) http://onlinelibrary.wiley.com/doi/10.1111/bph.12492/full
Does the neuroprotective role of anandamide display diurnal variations? (full–2013) http://www.mdpi.com/1422-0067/14/12/23341/htm
Transdermal delivery of cannabidiol attenuates binge alcohol-induced neuro-degeneration in a rodent model of an alcohol use disorder (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4096899/
Neuroimmmune interactions of cannabinoids in neurogenesis: focus on interleukin-1β (IL-1β) signalling (full–2013) http://www.biochemsoctrans.org/content/41/6/1577
CB2 cannabinoid agonist enhanced neurogenesis in GFAP/Gp120 transgenic mice displaying deficits in neurogenesis (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3904265/
Cannabinoids: Do they have the potential to treat the symptoms of multiple sclerosis? (full–2013) http://www.wjgnet.com/2218-6212/full/v3/i4/87.htm
CB1 and CB2 Cannabinoid Receptor Antagonists Prevent Minocycline-Induced Neuroprotection Following Traumatic Brain Injury in Mice (full–2013) http://cercor.oxfordjournals.org/content/25/1/35.long
The neuroprotective effects of cocoa flavanol and its influence on cognitive performance (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3575938/
Resuscitation from experimental traumatic brain injury by magnolol therapy (full–2013) http://www.journalofsurgicalresearch.com/article/S0022-4804(13)00432-0/fulltext
Palmitoylethanolamide in Homeostatic and Traumatic Central Nervous System Injuries (link to PDF-2013) http://www.eurekaselect.com/107976/article
Neuroglial Roots of Neurodegenerative Diseases: Therapeutic Potential of Palmitoylethanolamide in Models of Alzheimer’s Disease (link to PDF–2013) http://www.eurekaselect.com/107977/article
Activation of the CB(2) receptor system reverses amyloid-induced memory deficiency (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/22795792
Nicotine-Induced Neuroprotection Against Ischemic Injury Involves Activation of Endocannabinoid System in Rats (abst–2013) http://link.springer.com/article/10.1007/s11064-012-0927-6
The neuroprotective role of endocannabinoids against chemical-induced injury and other adverse effects (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23296873
Neuroprotective effects of topical CB1 agonist WIN 55212-2 on Retinal ganglion cells after acute rise in intraocular pressure induced ischemia in rat (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23454099
Mechanisms Of Cannabidiol Neuroprotection In Hypoxic-Ischemic Newborn Pigs: Role Of 5HT1A And CB2 Receptors (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23587650
top
Glia and Mast Cells as Targets for Palmitoylethanolamide, an Anti-inflammatory and Neuroprotective Lipid Mediator (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23813098
Palmitoylethanolamide is a new possible pharmacological treatment for the inflammation associated with trauma (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/22697514
Neuroprotection and reduction of glial reaction by cannabidiol treatment after sciatic nerve transection in neonatal rats (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23981015
Cannabinoid Effects on β Amyloid Fibril and Aggregate Formation, Neuronal and Microglial-Activated Neurotoxicity In Vitro (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24030360
Activation of STAT3 is involved in neuroprotection by electroacupuncture pre-treatment via cannabinoid CB1 receptors in rats (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23880371
Δ9-Tetrahydrocannabinol is protective through PPARγ dependent mitochondrial bio-genesis in a cell culture model of Parkinson’s Disease (abst–2013) http://jnnp.bmj.com/content/84/11/e2.58.abstract
Cannabidiol Promotes Amyloid Precursor Protein Ubiquitination and Reduction of Beta Amyloid Expression in SHSY5YAPP+ Cells Through PPARγ Involvement (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24288245
The Cannabinoid Agonist HU210 Delays Retinal Degeneration and Vision (abst-2013) http://iovs.arvojournals.org/article.aspx?articleid=2148029&resultClick=1
Molecular mechanisms involved in cochlear implantation trauma and the protection of  hearing and auditory sensory cells by inhibition of c-Jun-N-terminal kinase signaling  (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23382052
Activation of type-2 cannabinoid receptor inhibits neuroprotective and anti-inflammatory actions of glucocorticoid receptor α: when one is better than two (abst–2013) https://link.springer.com/article/10.1007%2Fs00018-012-1253-5
Cerebroprotective effects of TAK-937, a novel cannabinoid receptor agonist, in  permanent and thrombotic focal cerebral ischemia in rats: Therapeutic time window,  combination with t-PA and efficacy in aged rats (abst–2013)  http://www.ncbi.nlm.nih.gov/pubmed/23791950
The G protein-coupled receptor 55 ligand l-α-lysophosphatidylinositol exerts microglia-dependent neuroprotection after excitotoxic lesion (abst–2013)  http://www.ncbi.nlm.nih.gov/pubmed/24038453
Δ9-tetrahydrocannabinol prevents methamphetamine-induced neurotoxicity (full-2014) http://www.plosone.org/article/fetchObject.action?uri=info%3Adoi%2F10.1371%2Fjournal.pone.0098079&representationDF
The endocannabinoid system: a putative role in neurodegenerative diseases (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4070159/
A restricted population of CB1 cannabinoid receptors with neuroprotective activity (full-2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4050577/
Cannabinoids: well-suited candidates for the treatment of perinatal brain injury (full-2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4061885/
Anandamide Protects HT22 Cells Exposed to Hydrogen Peroxide by Inhibiting CB1 Receptor-Mediated Type 2 NADPH Oxidase (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4127243/
Cannabinoid CB2 receptor (CB2R) stimulation delays rubrospinal mitochondrial-dependent degeneration and improves functional recovery after spinal cord hemi-section by ERK1/2 inactivation (full–2014) http://www.nature.com/cddis/journal/v5/n9/full/cddis2014364a.html
Glucose concentration in culture medium affects mRNA expression of TRPV1 and CB1 receptors and changes capsaicin toxicity in PC12 cells (full-2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4322151/
top

Palmitoylethanolamide controls reactive gliosis and exerts neuroprotective functions in a rat model of Alzheimer’s disease (full–2014) http://www.nature.com/cddis/journal/v5/n9/full/cddis2014376a.html
Regulatory role of the Cannabinoid-2 receptor in stress-induced neuroinflammation in mice (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4243857/ 9
Endocannabinoid signalling and the deteriorating brain (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4471876/
Hypoximimetic activity of N-acyl-dopamines. N-arachidonoyl-dopamine stabilizes HIF-1α protein through a SIAH2-dependent pathway (full–2014) http://www.sciencedirect.com/science/article/pii/S0167488914002821
Neuroprotective Properties of Cannabigerol in Huntington’s Disease: Studies in R6/2 Mice and 3-Nitropropionate-lesioned Mice (full-2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4322067/
The fatty acid amide hydrolase inhibitor PF-3845 promotes neuronal survival, attenuates inflammation and improves functional recovery in mice with traumatic brain injury (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4437642/
Impaired Neurogenesis by HIV-1-Gp120 is Rescued by genetic deletion of Fatty Acid Amide Hydrolase Enzyme (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4594266/
Endocannabinoid degradation inhibition improves neurobehavioral function, blood brain barrier integrity, and neuroinflammation following mild traumatic brain injury (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4348366/
Prior stimulation of the endocannabinoid system prevents methamphetamine-induced dopaminergic neurotoxicity in the striatum through activation of CB2 receptors (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4939842/
Endocannabinoids in Synaptic Plasticity and Neuroprotection (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4143501/

Seizing an opportunity for the endocannabinoid system (full–2014)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4189640/
Chemical approaches to therapeutically target the metabolism and signaling of the  endocannabinoid 2-AG and eicosanoids (full–2014)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4159426/
Cannabinoid receptor activation inhibits cell cycle progression by modulating 14-3-3β
(link to PDF–2014) http://www.degruyter.com/view/j/cmble.2014.19.issue-3/s11658-014-0200-x/s11658-014-0200-x.xml
Early increase of cannabinoid receptor density after experimental traumatic brain injury in the newborn piglet (link to PDF–2014) http://www.ncbi.nlm.nih.gov/pubmed/24993629
Changes in Endocannabinoid Receptors and Enzymes in the Spinal Cord of SOD1G93A Transgenic Mice and Evaluation of a Sativex®-like Combination of Phytocannabinoids: Interest for Future Therapies in Amyotrophic Lateral Sclerosis (full–2014) http://onlinelibrary.wiley.com/doi/10.1111/cns.12262/full
Normal aging in rats and pathological aging in human Alzheimer disease decrease FAAH activity: Modulation by cannabinoid agonists (full–2014) http://www.sciencedirect.com/science/article/pii/S0531556514002903
Cannabidiol Normalizes Capase 3, Synatophsin, and Mitochondrial Fission Protein DNM1L Expression Levels in Rats with Brain Iron Overload: Implications for Neuro-protection (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/23893294
Trans-Caryophyllene Suppresses Hypoxia-Induced Neuroinflammatory Responses by Inhibiting NF-κB Activation in Microglia (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24488604
Neuroprotective effects of the cannabinoid agonist HU210 on retinal degeneration (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24495949
Endocannabinoid 2-Arachidonylglycerol Protects Primary Cultured Neurons Against LPS-Induced Impairments in Rat Caudate Nucleus (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24510751
Effect of N-Arachidonoyl Dopamine on Activity of Neuronal Network in Primary Hippocampus Culture upon Hypoxia Modelling (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24771427
top
Functions of the CB1 and CB 2 Receptors in Neuroprotection at the Level of the Blood-Brain Barrier (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24929655
The monoacylglycerol lipase inhibitor JZL184 is neuroprotective and alters glial cell phenotype in the chronic MPTP mouse model (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24973119
Endocannabinoid 2-Arachidonylglycerol Protects Primary Cultured Neurons Against Homocysteine-Induced Impairments in Rat Caudate Nucleus Through CB1 Receptor (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25007951
Cannabinoid Receptor-2 and HIV-Associated Neurocognitive Disorders (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25015040
Ultralow doses of cannabinoid drugs protect the mouse brain from inflammation-induced cognitive damage (abst–2014) http://onlinelibrary.wiley.com/doi/10.1002/jnr.23452/abstract
Protective effects of cannabidiol against hippocampal cell death and cognitive impairment induced by bilateral common carotid artery occlusion in mice (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24532152
Chronic cannabinoid receptor stimulation selectively prevents motor impairments in a mouse model of Huntington’s disease (abst–2014)
http://www.ncbi.nlm.nih.gov/pubmed/25123645
Distinct modulation of the endocannabinoid system upon kainic acid-induced in vivo seizures and in vitro epileptiform bursting (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25064144
Cannabinoid-mediated short-term plasticity in hippocampus (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25123173
Mn-SOD Upregulation by Electroacupuncture Attenuates Ischemic Oxidative Damage via CB1R-Mediated STAT3 Phosphorylation (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25432886
Magnolol protects neurons against ischemia injury via the downregulation of p38/MAPK, CHOP and nitrotyrosine (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25038313
Neuroprotection by association of palmitoylethanolamide with luteolin in experimental Alzheimer’s disease models: the control of neuroinflammation (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25106636
Rising stars: Modulation of brain functions by astroglial type-1 cannabinoid receptors (abst–2014 http://www.ncbi.nlm.nih.gov/pubmed/25452006
Chronic cannabidiol treatment improves social and object recognition in double transgenic APPswe/PS1∆E9 mice (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/24577515
The Association Between Normal Optic Nerve Cupping , Normal Visual Fields and Marijuana Use (abst–2014) http://iovs.arvojournals.org/article.aspx?articleid=2271290&resultClick=1
Cannabinoid receptor agonists reduce the short-term mitochondrial dysfunction and  oxidative stress linked to excitotoxicity in the rat brain (abst–2014)  http://www.ncbi.nlm.nih.gov/pubmed/25446347

Effects of pro-inflammatory cytokines on cannabinoid CB1 and CB2 receptors in immune cells (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/apha.12474/full
The CB1 cannabinoid receptor signals striatal neuroprotection via a PI3K / Akt / mTORC1 / BDNF pathway (full–2015) http://www.nature.com/cdd/journal/vaop/ncurrent/full/cdd201511a.html
Palmitoylethanolamide Inhibits Glutamate Release in Rat Cerebrocortical Nerve Terminals (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4394492/
Perinatal asphyxia results in altered expression of the hippocampal acylethanolamide / endocannabinoid signaling system associated to memory impairments in postweaned rats (full–2015) http://journal.frontiersin.org/article/10.3389/fnana.2015.00141/full
New horizons for newborn brain protection: enhancing endogenous neuroprotection (full–2015) http://fn.bmj.com/content/early/2015/06/10/archdischild-2014-306284.long
Alcohol Versus Cannabinoids: A Review of Their Opposite Neuro-Immunomodulatory Effects and Future Therapeutic Potentials (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4607066/
Increasing levels of the endocannabinoid 2-AG is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson’s disease (full–2015) http://www.sciencedirect.com/science/article/pii/S0014488615300583
A new formulation of cannabidiol in cream shows therapeutic effects in a mouse model of experimental autoimmune encephalomyelitis (full–2015) http://darujps.biomedcentral.com/articles/10.1186/s40199-015-0131-8
HU-446 and HU-465, derivatives of the non-psychoactive cannabinoid cannabidiol, decrease the activation of encephalitogenic T cells (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/cbdd.12637/full
Mitochondrial CB1 receptor is involved in ACEA-induced protective effects on neurons and mitochondrial functions (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4516969/
The therapeutic potential of cannabinoids for movement disorders (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4357541/
Enhancement of endocannabinoid signalling protects against cocaine-induced  neurotoxicity (full–2015)  http://www.sciencedirect.com/science/article/pii/S0041008X15001556
A sativex-like combination of phytocannabinoids as a disease-modifying therapy in a viral model of multiple sclerosis (full–2015)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4507161/
Cannabinoids in Neurodegenerative Disorders and Stroke/Brain Trauma: From Preclinical Models to Clinical Applications (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604192/
Endogenous 2-Arachidonoylglycerol Alleviates Cyclooxygenases-2 Elevation-Mediated Neuronal Injury from SO2 Inhalation via PPARγ Pathway (full–2015) http://toxsci.oxfordjournals.org/content/147/2/535.long
Cannabinoid receptor type 1 agonist ACEA improves motor recovery and protects neurons in ischemic stroke in mice (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/jnc.13288/full
A selective cannabinoid CB2 agonist attenuates damage and improves memory retention
following stroke in mice (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4552583/
Promising cannabinoid-based therapies for Parkinson’s disease: motor symptoms to  neuroprotection (full–2015)  http://www.molecularneurodegeneration.com/content/pdf/s13024-015-0012-0.pdf
Are the endocannabinoid-like compounds N-acyl aminoacids neuroprotective after  traumatic brain injury? (link to PDF–2015)  http://www.degruyter.com/view/j/jbcpp.ahead-of-print/jbcpp-2015-0092/jbcpp-2015-0092.xml
Purified Cannabidiol, the main non-psychotropic component of Cannabis sativa, alone, counteracts neuronal apoptosis in experimental multiple sclerosis (link to PDF–2015) http://www.europeanreview.org/article/10049
Ultra-low doses of tetrahydrocannabinol contribute to the survival of newly-born cells in the dentate gyrus of adult rats (2 pages–2015)  http://link.springer.com/article/10.1134/S1819712415030046
On the Role of Astroglial Syncytia in Self-Repairing Spiking Neural Networks (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25576582
Cannabidiol increases survival and promotes rescue of cognitive function in a murine model of Cerebral Malaria (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25595981
N-stearoyltyrosine protects primary cortical neurons against Aβ(1-40)-induced injury through inhibiting endocannabinoid degradation (abst-2015) http://www.sciencedirect.com/science/article/pii/S0024320515000521
Palmitoyl Serine: An Endogenous Neuroprotective Endocannabinoid-Like Entity After Traumatic Brain Injury (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25721934
Cannabinoid receptor agonist WIN55,212-2 and fatty acid amide hydrolase inhibitor URB597 suppress chronic cerebral hypoperfusion-induced neuronal apoptosis by inhibiting c-Jun N-terminal kinase signaling (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25795598
Elevation of Plasma 2-Arachidonoylglycerol Levels in Alzheimer’s Disease Patients as a Potential Protective Mechanism against Neurodegenerative Decline (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25818503
Monoacylglycerol Lipase Inhibitor Protects Primary Cultured Neurons Against Homocysteine-induced Impairments in Rat Caudate Nucleus through COX-2 signaling (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25818189
Protective effect of paeoniflorin on the hippocampus in rats with cerebral ischemia reperfusion through activating cannabinoid receptor 2 (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25854559
Potential of the cannabinoid CB2 receptor as a pharmacological target against inflammation in Parkinson’s disease (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25863279
Endocannabinoids regulate the activity of astrocytic hemichannels and the microglial response against an injury: In vivo studies (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25917763
The effect of endocannabinoid system in ischemia-reperfusion injury: a friend or a foe?  (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25936364
top
Cannabinoid receptor 2 attenuates microglial accumulation and brain injury following germinal matrix hemorrhage via ERK dephosphorylation in vivo and in vitro (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25963415
Neuroprotective Effect of JZL184 in MPP+-Treated SH-SY5Y Cells Through CB 2 Receptors  (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25976369
Synthetic and endogenous cannabinoids protect retinal neurons from AMPA excitotoxicity in vivo, via activation of CB1 receptors: Involvement of PI3K/Akt and MEK/ERK signaling pathways (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25989217
N-Palmitoylethanolamine and Neuroinflammation: a Novel Therapeutic Strategy of Resolution (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26055231
Combined neuroprotective action of adenosine A1 and cannabinoid CB1 receptors against NMDA-induced excitotoxicity in the hippocampus (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26065937
Effect of Homocysteine on Voltage-Gated Sodium Channel Currents in Primary Cultured Rat Caudate Nucleus Neurons and Its Modulation by 2-Arachidonylglycerol (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26179279
top

Neuroprotective mechanisms of cannabinoids in brain ischemia and neurodegenerative disorders (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26299059
Endocannabinoids in Multiple Sclerosis and Amyotrophic Lateral Sclerosis (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/26408162
Endocannabinoids and Neurodegenerative Disorders: Parkinson’s Disease, Huntington’s Chorea, Alzheimer’s Disease, and Others (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26408163
N-Palmitoyl serotonin alleviates scopolamine-induced memory impairment via regulation of cholinergic and antioxidant systems, and expression of BDNF and p-CREB in mice (abst–2015) http://www.sciencedirect.com/science/article/pii/S0009279715300697
The effect of WIN 55,212-2 suggests a cannabinoid-sensitive component in the early toxicity induced by organic acids accumulating in glutaric acidemia type I and in related disorders of propionate metabolism in rat brain synaptosomes (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26431622
Neuroprotective Effect Is Driven Through the Upregulation of CB1 Receptor in Experimental Autoimmune Encephalomyelitis (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26411568
The neuroprotection of cannabidiol against MPP+-induced toxicity in PC12 cells involves trkA receptors, upregulation of axonal and synaptic proteins, neuritogenesis, and might be relevant to Parkinson’s disease (abst–2015) http://www.sciencedirect.com/science/article/pii/S0887233315300047
THC exerts neuroprotective effect in glutamate affected murine primary mesencephalic cultures and neuroblastoma N18TG2 cells (abst–2015) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0035-1565754
Cannabidiol protects an in vitro model of the blood brain barrier (BBB) from oxygen-glucose deprivation via PPARγ and 5-HT1A (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26497782
Neuroprotective effects of trans-caryophyllene against kainic Acid induced seizure  activity and oxidative stress in mice (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/25417010
Cannabinoid receptor 2 attenuates microglial accumulation and brain injury following  germinal matrix hemorrhage via ERK dephosphorylation in vivo and in vitro (abst–2015) http://www.sciencedirect.com/science/article/pii/S0028390815001574
Cannabinoid CB2 Receptor Mediates Nicotine-Induced Anti-Inflammation in N9 Microglial Cells Exposed to β Amyloid via Protein Kinase C (full–2016) http://www.hindawi.com/journals/mi/2016/4854378/
The Endocannabinoid System as a Therapeutic Target in Glaucoma (full–2016) http://www.hindawi.com/journals/np/2016/9364091/
NO2 inhalation promotes Alzheimer’s disease-like progression: cyclooxygenase-2- derived prostaglandin E2 modulation and monoacylglycerol lipase inhibition-targeted medication (full–2016) http://www.nature.com/articles/srep22429
Natural Phytochemicals in the Treatment and Prevention of Dementia: An Overview (full–2016) http://www.mdpi.com/1420-3049/21/4/518/htm
Cannabinoid 1 receptor knockout mice display cold allodynia, but enhanced recovery from spared-nerve injury-induced mechanical hypersensitivity (full–2016) http://mpx.sagepub.com/content/12/1744806916649191.long B2
CB2 Cannabinoid Receptor As Potential Target against Alzheimer’s Disease (full–2016) http://journal.frontiersin.org/article/10.3389/fnins.2016.00243/full#B36
Amyloid proteotoxicity initiates an inflammatory response blocked by cannabinoids (full–2016) http://www.nature.com/articles/npjamd201612
Delta-9-tetrahydrocannabinol protects against MPP+ toxicity in SH-SY5Y cells by restoring proteins involved in mitochondrial biogenesis (full–2016) http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path %5B%5D=10314&path%5B%5D=32486
The Cannabinoid CB1/CB2 Agonist WIN55212.2 Promotes Oligodendrocyte Differentiation In Vitro and Neuroprotection During the Cuprizone-Induced Central Nervous System Demyelination (full–2016) http://onlinelibrary.wiley.com/doi/10.1111/cns.12506/full
Neuroprotective effect of endogenous cannabinoids on ischemic brain injury induced by the excess microglia-mediated inflammation (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4931157/
VCE-003.2, a novel cannabigerol derivative, enhances neuronal progenitor cell survival and alleviates symptomatology in murine models of Huntington’s disease (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4949444/
Orchestrated activation of mGluR5 and CB1 promotes neuroprotection (full–2016) http://molecularbrain.biomedcentral.com/articles/10.1186/s13041-016-0259-6
Cannabinoid Type 2 (CB2) Receptors Activation Protects against Oxidative Stress and Neuroinflammation Associated Dopaminergic Neurodegeneration in Rotenone Model of Parkinson’s Disease (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969295/
Mild Traumatic Brain Injury Produces Neuron Loss That Can Be Rescued by Modulating Microglial Activation Using a CB2 Receptor Inverse Agonist (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5052277/
CB2 receptor activation prevents glial-derived neurotoxic mediator production, BBB leakage and peripheral immune cell infiltration and rescues dopamine neurons in the MPTP model of Parkinson’s disease (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4892852/
Target regulation of PI3K/Akt/mTOR pathway by cannabidiol in treatment of experimental multiple sclerosis (full–2016) http://www.sciencedirect.com/science/article/pii/S0367326X16304476
Cannabidiol attenuates OGD/R-induced damage by enhancing mitochondrial bioenergetics and modulating glucose metabolism via pentose-phosphate pathway in hippocampal neurons (full–2016) http://www.sciencedirect.com/science/article/pii/S221323171630338X
Inhibitors of diacylglycerol lipases in neurodegenerative and metabolic disorders (full–2016) http://www.sciencedirect.com/science/article/pii/S0960894X16306874
Anticonvulsant activity of β-caryophyllene against pentylenetetrazol-induced seizures  (full–2016) http://www.epilepsybehavior.com/article/S1525-5050(15)00695-2/fulltext
Cannabinoids Occlude the HIV-1 Tat-Induced Decrease in GABAergic Neurotransmission in Prefrontal Cortex Slices (full–2016)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4848126/
CB2 cannabinoid receptor is involved in the anti-inflammatory effects of leptin in a  model of traumatic brain injury (abst–2016)  http://www.sciencedirect.com/science/article/pii/S0014488616300619
Cannabidiol Post-Treatment Alleviates Rat Epileptic-Related Behaviors and Activates Hippocampal Cell Autophagy Pathway Along with Antioxidant Defense in Chronic Phase of Pilocarpine-Induced Seizure (abst–2016) http://link.springer.com/article/10.1007/s12031-015-0703-6 Mn-SOD
Prior Cannabis Use Is Associated with Outcome after Intracerebral Hemorrhage (abst-2016) http://www.ncbi.nlm.nih.gov/pubmed/26820826
Arachidonyl-2-Chloroethylamide Alleviates Cerebral Ischemia Injury Through Glycogen  Synthase Kinase-3β-Mediated Mitochondrial Biogenesis and Functional Improvement  (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26820679
Cannabidiol, neuroprotection and neuropsychiatric disorders (abst–2016)  http://www.sciencedirect.com/science/article/pii/S1043661816000396
Involvement of TRPV1 channels in the activity of the cannabinoid WIN 55,212-2 in an  acute rat model of temporal lobe epilepsy (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/26970948
Endocannabinoid 2-Arachidonoylglycerol Suppresses LPS-Induced Inhibition of A-Type  Potassium Channel Currents in Caudate Nucleus Neurons Through CB1 Receptor (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27129498
Stimulated CB1 Cannabinoid Receptor Inducing Ischemic Tolerance and Protecting  Neuron from Cerebral Ischemia (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/27142423
Inhibition of Endocannabinoid Degradation Improves Outcomes from Mild Traumatic  Brain Injury: A Mechanistic Role for Synaptic Hyperexcitability (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/27189876
Activity of muscarinic, galanin and cannabinoid receptors in the prodromal and  advanced stages in the triple transgenic mice model of Alzheimer’s disease (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/27223629
Upregulation of the cannabinoid CB2 receptor in environmental and viral inflammation driven rat models of Parkinson’s disease (abst–2016)  http://www.sciencedirect.com/science/article/pii/S0014488616301790
Cannabinoid receptor agonism suppresses tremor, cognition disturbances and anxiety-like behaviors in a rat model of essential tremor (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/27317835
Fatty acid amide hydrolase inhibition for the symptomatic relief of Parkinsońs disease  (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27318096

Cannabinoids and Neuro-Inflammation: Regulation of Brain Immune Response (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27334610
The bright side of psychoactive substances: cannabinoid-based drugs in motor diseases (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27373318
A study of cannabinoid-1 receptors during the early phase of excitotoxic damage to rat spinal locomotor networks in vitro (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27450568
Cannabinoid receptor agonist WIN55,212-2 and fatty acid amide hydrolase inhibitor URB597 may protect against cognitive impairment in rats of chronic cerebral hypoperfusion via PI3K/AKT signaling (abst–2016) http://www.sciencedirect.com/science/article/pii/S0166432816304375
The cannabinoid receptor agonist WIN55.212 reduces consequences of status epilepticus in rats (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27520083
Anandamide reverses depressive-like behavior, neurochemical abnormalities and oxidative-stress parameters in streptozotocin-diabetic rats: Role of CB1 receptors (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27544303
Neuroprotective Effects of Cannabidiol In Hypoxic Ischemic Insult: The Therapeutic Window In Newborn Mice (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27686886
Gingival Stromal Cells as an In Vitro Model: Cannabidiol Modulates Genes Linked with Amyotrophic Lateral Sclerosis (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27714895
Activation of Cannabinoid Receptor 2 Attenuates Mechanical Allodynia and Neuroinflammatory Responses in a Chronic Post-Ischemic Pain Model of Complex Regional Pain Syndrome Type I in Rats (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27717112
Cannabinoids prevent the amyloid β-induced activation of astroglial hemichannels: A neuroprotective mechanism (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27757991
The cannabinoid beta-caryophyllene (BCP) induces neuritogenesis in PC12 cells by a cannabinoid-receptor-independent mechanism (abst–2016) http://www.sciencedirect.com/science/article/pii/S0009279716305920
Cannabidiol reduces neuroinflammation and promotes neuroplasticity and functional recovery after brain ischemia (abst–2016) http://www.sciencedirect.com/science/article/pii/S0278584616302524
The arguments for and against cannabinoids application in glaucomatous retinopathy (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/28027538
CB2 cannabinoid receptors modulate HIF-1α and TIM-3 expression in a hypoxiaischemia  mouse model (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/28253997
A Pulsed Electromagnetic Field Protects against Glutamate-Induced Excitotoxicity by  Modulating the Endocannabinoid System in HT22 Cells (full–2017)  http://journal.frontiersin.org/article/10.3389/fnins.2017.00042/full
Cannabinoid Receptor 2 Signaling in Neurodegenerative Disorders: From Pathogenesis
to a Promising Therapeutic Target (full–2017)  http://journal.frontiersin.org/article/10.3389/fnins.2017.00030/full
In vivo Evidence for Therapeutic Properties of Cannabidiol (CBD) for Alzheimer’s Disease (full–2017) http://journal.frontiersin.org/article/10.3389/fphar.2017.00020/full
Endocannabinoids: A Promising Impact for Traumatic Brain Injury (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5314139/
Neuroprotective effect of WIN55,212-2 against 3-nitropropionic acid-induced toxicity in  the rat brain: involvement of CB1 and NMDA receptors (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5340665/
In vivo TSPO and cannabinoid receptor type 2 availability early in post-stroke  neuroinflammation in rats: a positron emission tomography study (full–2017)  https://jneuroinflammation.biomedcentral.com/articles/10.1186/s12974-017-0851-4
Protective Effects of Cannabidiol against Seizures and Neuronal Death in a Rat Model of  Mesial Temporal Lobe Epilepsy (full–2017)  http://journal.frontiersin.org/article/10.3389/fphar.2017.00131/full
Altered striatal endocannabinoid signaling in a transgenic mouse model of  spinocerebellar ataxia type-3 (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5407801/
Plastic and Neuroprotective Mechanisms Involved in the Therapeutic Effects of  Cannabidiol in Psychiatric Disorders (full–2017)  http://journal.frontiersin.org/article/10.3389/fphar.2017.00269/full
Neuroprotective Effects of β-Caryophyllene against Dopaminergic Neuron Injury in a  Murine Model of Parkinson’s Disease Induced by MPTP (full–2017)  http://www.mdpi.com/1424-8247/10/3/60/htm
Endocannabinoids exert CB1 receptor-mediated neuroprotective effects in models of  neuronal damage induced by HIV-1 Tat protein (full–2017)  http://www.sciencedirect.com/science/article/pii/S1044743117300830?via%3Dihub
Modulation of Astrocyte Activity by Cannabidiol, a Nonpsychoactive Cannabinoid (full–2017) http://www.mdpi.com/1422-0067/18/8/1669/htm
Abnormalities in Dynamic Brain Activity Caused by Mild Traumatic Brain Injury Are  Partially Rescued by the Cannabinoid Type-2 Receptor Inverse Agonist SMM-189 (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5562300/
An Update on Safety and Side Effects of Cannabidiol: A Review of Clinical Data and  Relevant Animal Studies (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5569602/
Anti-Inflammatory and Neuroprotective Effects of Co-UltraPEALut in a Mouse Model of  Vascular Dementia (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5460147/
Interplay Between n-3 and n-6 Long-Chain Polyunsaturated Fatty Acids and the  Endocannabinoid System in Brain Protection and Repair (full–2017)  https://link.springer.com/article/10.1007%2Fs11745-017-4292-8
AM1241 alleviates MPTP-induced Parkinson’s disease and promotes the regeneration of  DA neurons in PD mice (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5620217/
(-)-β-Caryophyllene, a CB2 Receptor-Selective Phytocannabinoid, Suppresses Motor  Paralysis and Neuroinflammation in a Murine Model of Multiple Sclerosis (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5412277/
N-Arachidonoyl Dopamine: A Novel Endocannabinoid and Endovanilloid with  Widespread Physiological and Pharmacological Activities (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5627668/
The endocannabinoid system and its therapeutic exploitation in multiple sclerosis: Clues  for other neuroinflammatory diseases (full–2017)  http://www.sciencedirect.com/science/article/pii/S0301008217300709?via%3Dihub
Binge Alcohol Exposure Transiently Changes the Endocannabinoid System: A Potential  Target to Prevent Alcohol-Induced Neurodegeneration (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5742761/
Reversal of age-related cognitive impairments in mice by an extremely low dose of  tetrahydrocannabinol (full–2017) http://www.neurobiologyofaging.org/article/S0197-4580(17)30321-4/fulltext
Elevation of arachidonoylethanolamide levels by activation of the endocannabinoid  system protects against colitis and ameliorates remote organ lesions in mice (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5740744/
Extract of Fructus Cannabis Ameliorates Learning and Memory Impairment Induced by –
D-Galactose in an Aging Rats Model (full–2017)  https://www.hindawi.com/journals/ecam/2017/4757520/
Up-regulation of CB2 receptors in reactive astrocytes in canine degenerative myelopathy, a disease model of amyotrophic lateral sclerosis (link to download–2017)  http://dmm.biologists.org/content/early/2017/01/06/dmm.028373.long
Neuroprotective properties of endocannabinoids N-arachidonoyl dopamine and Ndocosahexaenoyl dopamine examined in neuronal precursors derived from human  pluripotent stem cells (2 pages–2017)  https://link.springer.com/article/10.1134%2FS0006297917110141
Effect of inhibition of fatty acid amide hydrolase on MPTP-induced dopaminergic  neuronal damage (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28104279
Endocannabinoid 2-arachidonoylglycerol protects inflammatory insults from sulfur  dioxide inhalation via cannabinoid receptors in the brain (abst–2017)  http://www.sciencedirect.com/science/article/pii/S1001074216302340
Therapeutic effects of cannabinoids in animal models of seizures, epilepsy,  epileptogenesis, and epilepsy-related neuroprotection (abst–2017)  http://www.epilepsybehavior.com/article/S1525-5050(16)30531-5/fulltext
A selective CB2R agonist (JWH133) restores neuronal circuit after Germinal Matrix  Hemorrhage in the preterm via CX3CR1+ microglia (abst–2017)  http://www.sciencedirect.com/science/article/pii/S002839081730028X
Evaluation of monoacylglycerol lipase as a therapeutic target in a transgenic mouse  model of ALS (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0028390817301296?via%3Dihub
The endocannabinoid system, a novel and key participant in acupuncture’s multiple  beneficial effects (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0149763417301318
Neurosteroid biosynthesis downregulation and changes in GABAA receptor subunit  composition: A biomarker axis in stress-induced cognitive and emotional impairment  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28456011
N-stearoyltyrosine protects primary cortical neurons against oxygen-glucose deprivation induced apoptosis through inhibiting anandamide inactivation system (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0168010217300123
N-stearoyl-l-Tyrosine inhibits the cell senescence and apoptosis induced by H2O2 in  HEK293/Tau cells via the CB2 receptor (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0009279716307293
Activation of CB2 receptor system restores cognitive capacity and hippocampal Sox2  expression in a transgenic mouse model of Alzheimer’s disease (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28551012
Zonisamide ameliorates levodopa-induced dyskinesia and reduces expression of striatal  genes in Parkinson model rats (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0168010217300639
Neuroprotective effects of drug-induced therapeutic hypothermia in central nervous  system diseases (abst–2017)  http://www.eurekaselect.com/152965/article
Perspectives of Cannabinoid type 2 receptor (CB2R) ligands in neurodegenerative  disorders: Structure Affinity Relationship (SAfiR) and Structure Activity Relationship  (SAR) Studies (abst–2017)  http://pubs.acs.org/doi/abs/10.1021/acs.jmedchem.7b00155
Altered responses of dopamine D3 receptor null mice to excitotoxic or anxiogenic  stimuli: Possible involvement of the endocannabinoid and endovanilloid systems (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/19591935
ESSENTIAL DIETARY BIOACTIVE LIPIDS IN NEUROINFLAMMATORY DISEASES (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28637354
The synthetic cannabinoid WIN55212-2 ameliorates traumatic spinal cord injury via  inhibition of GAPDH/Siah1 in a CB2-receptor dependent manner (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28716633
AM1241 alleviates MPTP-induced Parkinson’s disease and promotes the regeneration of  DA neurons in PD mice (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28733540
Alleviation of Neuropathology by Inhibition of Monoacylglycerol Lipase in APP  Transgenic Mice Lacking CB2 Receptors (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28733897
Neuroprotection by (endo)cannabinoids in glaucoma and retinal neurodegenerative  diseases (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28738764
Modeling Neurodegenerative Disorders for Developing Cannabinoid-Based  Neuroprotective Therapies (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28750802
Mouse retinal ganglion cell signalling is dynamically modulated through parallel  anterograde activation of cannabinoid and vanilloid pathways (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28766743
Neuroprotective activity of cannabinoid receptor-2 against oxidative stress and apoptosis in rat pups having experimentally-induced congenital hypothyroidism (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28799288
GPR55: A therapeutic target for Parkinson’s disease? (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0028390817303842
Cannabinoid receptor agonist WIN55,212-2 and fatty acid amide hydrolase inhibitor  URB597 ameliorate neuroinflammatory responses in chronic cerebral hypoperfusion  model by blocking NF-κB pathways (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28825114
The Role of Nuclear Hormone Receptors in Cannabinoid Function (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28826538
Receptor-heteromer mediated regulation of endocannabinoid signaling in activated  microglia. Role of CB1 and CB2 receptors and relevance for Alzheimer’s disease and
levodopa-induced dyskinesia (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28843453
Tetrahydrocannabinolic acid is a potent PPARγ agonist with neuroprotective activity  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28853159
Inhibitor of Endocannabinoid Deactivation Protects Against In Vitro and In Vivo  Neurotoxic Effects of Paraoxon (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28803438
Mechanisms of action of cannabidiol in adoptively transferred experimental autoimmune encephalomyelitis (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0014488617302212
Novel therapeutics in glaucoma management (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28925883
Fatty acid amide hydrolase inhibitor URB597 may protect against kainic acid-induced  damage to hippocampal neurons: Dependence on the degree of injury (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28963903
Impact of dietary fats on brain functions (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29046155
Monoacylglycerol lipase inhibitor JZL184 prevents HIV-1 gp120-induced synapse loss by altering endocannabinoid signaling (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29061509
Neuroprotective effect of cannabinoid receptor 1 antagonist in the MNU-induced retinal  degeneration model (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0014483517305080?via%3Dihub
Cannabinoid Receptor Type 1 Agonist ACEA Protects Neurons from Death and Attenuates Endoplasmic Reticulum Stress-Related Apoptotic Pathway Signaling (abst–2017) https://link.springer.com/article/10.1007%2Fs12640-017-9839-1
Endocannabinoid-specific impairment in synaptic plasticity in striatum of Huntington’s  disease mouse model (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29192125
Preventive Effects of Resveratrol on Endocannabinoid System and Synaptic Protein  Modifications in Rat Cerebral Cortex Challenged by Bilateral Common Carotid Artery  Occlusion and Reperfusion (full–2018) http://www.mdpi.com/1422-0067/19/2/426
Thallium-Induced Toxicity in Rat Brain Crude Synaptosomal/Mitochondrial Fractions is  Sensitive to Anti-excitatory and Antioxidant Agents (abst–2018)  https://www.ncbi.nlm.nih.gov/pubmed/29313218
Analysis of endocannabinoid receptors and enzymes in the post-mortem motor cortex and spinal cord of amyotrophic lateral sclerosis patients (abst–2018)  https://www.ncbi.nlm.nih.gov/pubmed/29334787
Prospects of Cannabidiol for Easing Status Epilepticus-Induced Epileptogenesis and  Related Comorbidities (abst–2018)  https://www.ncbi.nlm.nih.gov/pubmed/29372545
Novel insights into mitochondrial molecular targets of iron-induced neurodegeneration:  reversal by cannabidiol (abst–2018)  https://www.sciencedirect.com/science/article/pii/S0361923017303714
top


NUTRITION-GENERAL*+
Exposure to a high-fat diet decreases sensitivity to Δ9-tetrahydrocannabinol-induced motor effects in female rats (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3014410/
Dietary intakes in a group of marihuana smoking patients (full in Spanish, abst in English–2010) http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0212-16112010000400024&lng=en&nrm=iso&tlng=en
Vegetarian’s Challenge — Optimizing Essential Fatty Acid Status (article-2010)  http://www.todaysdietitian.com/newarchives/020810p22.shtml
The endocannabinoid signaling system: a marriage of PUFA and musculoskeletal health  (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20934863
Dietary hempseed meal intake increases body growth and shortens the larval stage via the upregulation of cell growth and sterol levels in Drosophila melanogaster (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20652493
Cannabis as a Unique Functional Food (full–2011) http://apothecary-genetics.spruz.com/gfile/75r4!-!HLKELE!-!svyr5/cannabis_as_a_unique_functional_food.pdf
N-Docosahhexanoyllethanolamide promotes development of hippocampal neurons (full–2011) http://www.biochemj.org/content/435/2/327
Distinctive effects of plant protein sources on renal disease progression and associated  cardiac hypertrophy in experimental kidney disease (abst–2011)  http://www.ncbi.nlm.nih.gov/pubmed/21294251
Screening of selected Asian spices for anti obesity-related bioactivities (abst–2011) http://www.sciencedirect.com/science/article/pii/S0308814610016870
Cannabinoid Type 1 Receptor Gene Polymorphism and Macronutrient Intake (full–2012) http://www.karger.com/Article/FullText/343563
Dietary linoleic acid elevates endogenous 2-arachidonoylglycerol and anandamide in  Atlantic salmon (Salmo salar L.) and mice, and induces weight gain and inflammation in  mice (full-2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3548985/
Role of G1359A polymorphism of the cannabinoid receptor gene on weight loss and  adipocytokines levels after two different hypocaloric diets (abst–2012)  http://www.ncbi.nlm.nih.gov/pubmed/21543209
Nutritional n-3 polyunsaturated fatty acids deficiency alters cannabinoid receptor  signaling pathway in the brain and associated anxiety-like behavior in mice (abst–2012) http://www.springerlink.com/content/ur5784gm34782505/
Changes on metabolic parameters induced by acute cannabinoid administration (CBD, THC) in a rat experimental model of nutritional vitamin A deficiency (full–2013) http://www.nutricionhospitalaria.com/pdf/6430.pdf
Dietary Linoleic Acid Elevates the Endocannabinoids 2-AG and Anandamide and  Promotes Weight Gain in Mice Fed a Low Fat Diet (full–2013)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3889814/
Association of Expanded Disability Status Scale and Cytokines after Intervention with  Co-supplemented Hemp Seed, Evening Primrose Oils and Hot-natured Diet in Multiple  Sclerosis Patients (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3648912/
Nutritional properties of dietary omega-3-enriched phospholipids (full–2013)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3747496/
Evolution in pharmacologic thinking around the natural analgesic palmitoylethanolamide: from nonspecific resistance to PPAR-α agonist and effective nutraceutical (full–2013) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3744360/
Use of micronutrients attenuates cannabis and nicotine abuse as evidenced from a  reversal design: a case study (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23909004
Effects of dietary nucleotides on acute stress response and cannabinoid receptor 1  mRNAs in sole, Solea solea (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23261992
Nutritional omega-3 modulates neuronal morphology in the prefrontal cortex along with depression-related behaviour through corticosterone secretion (full–2014) http://www.nature.com/tp/journal/v4/n9/full/tp201477a.html
A diet containing a nonfat dry milk matrix significantly alters systemic oxylipins and the  endocannabinoid 2-arachidonoylglycerol (2-AG) in diet-induced obese mice (full–2014)  http://www.nutritionandmetabolism.com/content/11/1/24
Endocannabinoid signaling and its regulation by nutrients (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24753395
Developmentally vitamin D-deficient rats show enhanced prepulse inhibition after acute Δ9-tetrahydrocannabinol (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24776491
Characterization of Byproducts Originating from Hemp Oil Processing (abst–2014) http://pubs.acs.org/doi/abs/10.1021/jf5044426
Oleic acid content of a meal promotes oleoylethanolamide response and reduces  subsequent energy intake in humans (abst–2014)  http://pubs.rsc.org/en/Content/ArticleLanding/2015/FO/C4FO00697F#!divAbstract
The endocannabinoid system: an emerging key player in inflammation (abst–2014)  http://www.ncbi.nlm.nih.gov/pubmed/24419242

Interaction between orexin A and cannabinoid system in the lateral hypothalamus of rats and effects of subchronic intraperitoneal administration of cannabinoid receptor inverse agonist on food intake and the nutritive utilization of protein (full–2015)  http://www.jpp.krakow.pl/journal/archive/04_15/pdf/181_04_15_article.pdf
Dietary Carbohydrates that Modulate the Immune System (abst–2015)  http://www.ingentaconnect.com/content/ben/ciemd/2015/00000002/00000001/art00009?crawler=true
Effects of a High-Protein/Low-Carbohydrate versus a Standard Hypocaloric Diet on  Weight and Cardiovascular Risk Factors during 9 Months: Role of a Genetic Variation in  the Cannabinoid Receptor Gene (CNR1) (G1359A Polymorphism) (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/25766592
Providing a food reward reduces inhibitory avoidance learning in zebrafish (abst–2015) http://www.sciencedirect.com/science/article/pii/S0376635715300309
Maternal Caloric Restriction Implemented during the Preconceptional and Pregnancy Period Alters Hypothalamic and Hippocampal Endocannabinoid Levels at Birth and Induces Overweight and Increased Adiposity at Adulthood in Male Rat Offspring (full–2016) http://journal.frontiersin.org/article/10.3389/fnbeh.2016.00208/full
Exposure to a Highly Caloric Palatable Diet during the Perinatal Period Affects the Expression of the Endogenous Cannabinoid System in the Brain, Liver and Adipose Tissue of Adult Rat Offspring (full–2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0165432
Long-Term Effects of Prenatal Exposure to Undernutrition on Cannabinoid Receptor Related Behaviors: Sex and Tissue-Specific Alterations in the mRNA Expression of Cannabinoid Receptors and Lipid Metabolic Regulators (full–2016) http://journal.frontiersin.org/article/10.3389/fnbeh.2016.00241/full
Lipids in psychiatric disorders and preventive medicine (full–2016)  http://www.sciencedirect.com/science/article/pii/S0149763415303353
Fabp1 gene ablation inhibits high fat diet-induced increase in brain endocannabinoids (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27861894
Cannabimimetic phytochemicals in the diet – an evolutionary link to food selection and metabolic stress adaptation? (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27891602
A review of vulnerability and risks for schizophrenia: Beyond the two hit hypothesis  (abst–2016) http://www.sciencedirect.com/science/article/pii/S0149763415302943
Does the Gut Microbiota Influence Immunity and Inflammation in Multiple Sclerosis  Pathophysiology? (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5337874/
Exercise training and high-fat diet elicit endocannabinoid system modifications in the rat hypothalamus and hippocampus (full–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28283967
Precision Nutrition and Omega-3 Polyunsaturated Fatty Acids: A Case for Personalized  Supplementation Approaches for the Prevention and Management of Human Diseases  (full–2017) http://www.mdpi.com/2072-6643/9/11/1165/htm
Gut microbiota as a potential target of metabolic syndrome: the role of probiotics and  prebiotics (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655955/
Peripheral endocannabinoid signaling controls hyperphagia in western diet-induced  obesity (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0031938416309817
Nutritional status dependent endocannabinoid signalling regulates the integration of rat  visceral information (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28233325
Analysis of cannabinoids by liquid chromatography–mass spectrometry in milk, liver and hemp seed to ensure food safety (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0308814617301346
Sex-dependent effects of neonatal maternal deprivation on endocannabinoid levels in the adipose tissue: influence of diet (abst–2017)  http://link.springer.com/article/10.1007%2Fs13105-017-0558-0
Metabolic effects of intermittent access to caloric or non-caloric sweetened solutions in  mice fed a high-caloric diet (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28347724
ESSENTIAL DIETARY BIOACTIVE LIPIDS IN NEUROINFLAMMATORY DISEASES (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28637354
Impact of dietary fats on brain functions (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29046155
How four U.S. states are regulating recreational marijuana edibles (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28343113
Perinatal maternal high-fat diet induces early obesity and sex-specific alterations of the  endocannabinoid system in white and brown adipose tissue of weanling rat offspring  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29110748
Inhibition of monoacylglycerol lipase terminates diazepam-resistant status epilepticus in mice and its effects are potentiated by a ketogenic diet (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29171003
Analysis of cannabinoids in commercial hemp seed oil and decarboxylation kinetics  studies of cannabidiolic acid (CBDA) (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0731708517322367?via%3Dihub
Therapeutic use of Δ9-THC and cannabidiol: evaluation of a new extraction procedure  for the preparation of cannabis-based olive oil (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29189144
Amplification of mGlu5-endocannabinoid signaling rescues behavioral and synaptic  deficits in a mouse model of adolescent and adult dietary polyunsaturated fatty acids  imbalance (abst–2017)  http://www.jneurosci.org/content/early/2017/06/20/JNEUROSCI.3516-16.2017
The presence and distribution of cannabinoid type 1 and 2 receptors in the mandibular  gland: The influence of different physical forms of diets on their expression in piglets  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29218862
Low-fat yogurt consumption reduces biomarkers of chronic inflammation and inhibits  markers of endotoxin exposure in healthy premenopausal women: a randomised  controlled trial (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29179781
Role of Endocannabinoids on Sweet Taste Perception, Food Preference, and Obesity related Disorders (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29293950
Caloric restriction lowers endocannabinoid tonus and improves cardiac function in type 2 diabetes (full–2018) https://www.nature.com/articles/s41387-017-0016-7


NUTRITION-HEMP SEED*+
The cardiac and haemostatic effects of dietary hempseed (full–2010) http://www.nutritionandmetabolism.com/content/pdf/1743-7075-7-32.pdf
Effects of increasing amounts of hempseed cake in the diet of dairy cows on the production and composition of milk (full–2010) http://journals.cambridge.org/action/displayFulltext?type=6&fid=7909529&jid=ANM&volumeId=4&issueId=11&aid=7909528&bodyId=&membershipNumber=&societyETOCSession=&fulltextType=RA&fileId=S1751731110001254
top
Influence of Feed Supplementation with Cannabis Sativa on Quality of Broilers Carcass (full–2010) http://www.pvj.com.pk/pdf-files/30_1/34-38.pdf
Vegetarian’s Challenge — Optimizing Essential Fatty Acid Status (article-2010)  http://www.todaysdietitian.com/newarchives/020810p22.shtml
Evaluating the Quality of Protein from Hemp Seed (Cannabis sativa L.) Products Through the use of the Protein Digestibility-Corrected Amino Acid Score Method (abst-2010) http://pubs.acs.org/doi/abs/10.1021/jf102636b
Evaluating the effect of aquatic extraction of Cannabis sativa seed on spatial memory  consolidation (abst-2010) http://www.annals-general-psychiatry.com/content/9/S1/S143
Evaluating the effect of Cannabis sativa seed extraction on memory (abst-2010)  https://annals-general-psychiatry.biomedcentral.com/articles/10.1186/1744-859X-9-S1-S208
Dietary hempseed meal intake increases body growth and shortens the larval stage via the upregulation of cell growth and sterol levels in Drosophila melanogaster (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20652493

Dietary intakes in a group of marihuana smoking patients (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20694309
The effects of hempseed meal intake and linoleic acid on Drosophila models of neurodegenerative diseases and hypercholesterolemia (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3933972/
Isolation and Characterization of Edestin from Cheungsam Hempseed (link to PDF–2011) http://koreascience.or.kr/article/ArticleFullRecord.jsp? cn=E1OOBF_2011_v54n2_84
The effect of dietary hempseed on atherogenesis and contractile function in aortae from hypercholesterolemic rabbits (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21893466
Distinctive effects of plant protein sources on renal disease progression and associated cardiac hypertrophy in experimental kidney disease (abst-2011) http://www.ncbi.nlm.nih.gov/pubmed/21294251
Efficacy of a Chinese herbal proprietary medicine (Hemp Seed Pill) for functional  constipation (abst–2011) https://www.ncbi.nlm.nih.gov/pubmed/21045817

Searching for health beneficial n-3 and n-6 fatty acids in plant seeds (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3380567/?toolubmed
Archaeobotanical study of ancient food and cereal remains at the Astana cemeteries, Xinjiang, China (full–2012) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0045137
Nutritive quality of romanian hemp varieties (Cannabis sativa L.) with special focus on oil and metal contents of seeds (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3543203/
Effect of feeding hemp seed and hemp seed oil on laying hen performance and egg yolk fatty acid content: Evidence of their safety and efficacy for laying hen diets (full–2012) http://ps.oxfordjournals.org/content/91/3/701.long
Comparative Study of Sedation, Pre-Anesthetic and Anti-Anxiety Effects of Hemp Seed Extract and Diazepam in Rats (full–2012) http://docsdrive.com/pdfs/medwelljournals/javaa/2012/2148-2151.pdf
The Relationship between Plants Used to Sustain Finches (Fringillidae) and Uses for  Human Medicine in Southeast Spain (full–2012)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3350861/?tool=pubmed

Proteomic profiling of hempseed proteins from Cheungsam (abst-2012)  http://www.sciencedirect.com/science/article/pii/S1570963911002743
Fatty Acid Profile and Sensory Characteristics of Table Eggs from Laying Hens Fed  Hempseed and Hempseed Oil (abst–2012)  http://www.ncbi.nlm.nih.gov/pubmed/22429187
The isolation and identification of two compounds with predominant radical scavenging  activity in hempseed (seed of Cannabis sativa L.) (abst–2012)  http://www.sciencedirect.com/science/article/pii/S0308814612004426
Agents that act luminally to treat diarrhoea and constipation (abst–2012)  http://www.ncbi.nlm.nih.gov/pubmed/22945441
EFFECTS OF GRADED LEVELS OF HEMP SEED (CANNABIS SATIVA L.) ON PERFORMANCE, ORGAN WEIGHT AND SERUM CHOLESTEROL LEVELS ON BROILERS (abst–2012)  http://en.journals.sid.ir/ViewPaper.aspx?ID=276824
Association of Expanded Disability Status Scale and Cytokines after Intervention with Co-supplemented Hemp Seed, Evening Primrose Oils and Hot-natured Diet in Multiple  Sclerosis Patients (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3648912/
Preventive and treatment effects of a hemp seed (Cannabis sativa L.) meal protein  hydrolysate against high blood pressure in spontaneously hypertensive rats (abst–2013) https://link.springer.com/article/10.1007%2Fs00394-013-0625-4
top
A novel hemp seed meal protein hydrolysate reduces oxidative stress factors in spontaneously hypertensive rats (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4276990/
Performance, egg quality, and blood plasma chemistry of laying hens fed hempseed and  hempseed oil (full–2014) http://ps.oxfordjournals.org/content/93/11/2827.long
EFFECT OF BIOFERTILIZER, UNDER SALINITY CONDITION ON THE YIELD AND OIL CONTENT OF THREE ECOTYPE OF HEMP (CANNABIS SATIVA L.) (abst–2014) http://en.journals.sid.ir/ViewPaper.aspx?ID=461808
Molecular characterization of edestin gene family in Cannabis sativa L. (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25280223
Activity of liver enzymes in multiple sclerosis patients with Hot-nature diet and cosupplemented hemp seed, evening primrose oils intervention (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25453518
Structural and functional characterization of hemp seed (Cannabis sativa L.) protein  derived antioxidant and antihypertensive peptides (abst–2014)  http://www.sciencedirect.com/science/article/pii/S1756464613002594
Structural and functional properties of hemp seed protein products (abst–2014) https://www.ncbi.nlm.nih.gov/pubmed/25048774

Characterization of Lignanamides from Hemp (Cannabis sativa L.) Seed and their Antioxidant and Acetylcholinesterase Inhibitory Activities (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/26585089
Alteration of delta-6-desaturase (FADS2), secretory phospholipase-A2 (sPLA2) enzymes by Hot-nature diet with co-supplemented hemp seed, evening primrose oils intervention in multiple sclerosis patients (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26365444
Effect of Hempseed (Cannabis sativa sp.) Inclusion to the Diet on Performance, Carcass and Antioxidative Activity in Japanese Quail (Coturnix coturnix japonica) (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4597843/
Variability in Seed Traits in a Collection of Cannabis sativa L. Genotypes (full-2016) http://journal.frontiersin.org/article/10.3389/fpls.2016.00688/full
Effects of Different Levels of Hemp Seed (Cannabis Sativa L.) and Dextran Oligosaccharide on Growth Performance and Antibody Titer Response of Broiler Chickens (full–2016) http://www.tandfonline.com/doi/full/10.4081/ijas.2015.3473
Proteomic characterization of hempseed (Cannabis sativa L.) (abst–2016) http://www.sciencedirect.com/science/article/pii/S1874391916302354
Seed composition of ten industrial hemp cultivars approved for production in Canada (abst–2016) http://www.sciencedirect.com/science/article/pii/S088915751400194X
Determination of cannabinoids in hemp nuts products in Taiwan by HPLC-MS/MS coupled with chemometric analysis: Quality evaluation and a pilot human study (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27590030
Standardized Cannabis sativa extract attenuates tau and stathmin gene expression in the melanoma cell line (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5673704/
Extract of Fructus Cannabis Ameliorates Learning and Memory Impairment Induced by  D-Galactose in an Aging Rats Model (full–2017)  https://www.hindawi.com/journals/ecam/2017/4757520/
Hemp Industries Association, et al., Petitioners ) v. Drug Enforcement Administration, et  al., Respondents (download–2017) https://thehia.org/resources/Documents/Legal/HIA-v-DEA-9th-Circuit-Motion.pdf
Textual research on Han-Chinese formulae collected in Tubo medical manuscript  unearthed in ‘Bum-pa-Che Tower (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28103984
Analysis of cannabinoids by liquid chromatography–mass spectrometry in milk, liver and hemp seed to ensure food safety (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0308814617301346
Effect of dietary supplementation of hemp seed (Cannabis sativa L.) on meat quality and  egg fatty acid composition of Japanese quail (Coturnix coturnix japonica) (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28444789
Exploration of Potentially Bioactive Peptides Generated from the Enzymatic Hydrolysis  of Hempseed Proteins (abst–2017) http://pubs.acs.org/doi/10.1021/acs.jafc.7b03590
New ACE-Inhibitory Peptides from Hemp Seed (Cannabis sativa L.) Proteins (abst–2017) http://pubs.acs.org/doi/10.1021/acs.jafc.7b04522
(±)-Sativamides A and B, Two Pairs of Racemic Nor-Lignanamide Enantiomers from the  Fruits of Cannabis sativa (abst–2017) https://pubs.acs.org/doi/10.1021/acs.joc.7b02765
top


NUTRITION-HEMP SEED OIL*+
Vegetarian’s Challenge — Optimizing Essential Fatty Acid Status (article-2010)  http://www.todaysdietitian.com/newarchives/020810p22.shtml
Hemp Seed Oil Vs. Flaxseed Oil (article–2010)  http://www.ehow.com/facts_5946119_hemp-oil-vs_-flaxseed-oil.html
QUALITY OF HEMP SEED OIL DEPENDING ON ITS OBTAINING (abst–2010) http://www.potravinarstvo.com/journal1/index.php/potravinarstvo/article/view/32/pdf
Evaluating the quality of protein from hemp seed (Cannabis sativa L.) products through the use of the protein digestibility-corrected amino acid score method (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20977230
Analytical Characterization of Hempseed (Seed of Cannabis sativa L.) Oil from Eight Regions in China (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/22435611
Nutritional omega-3 deficiency abolishes endocannabinoid-mediated neuronal functions (download–2011) [PDF] https://hal.archives-ouvertes.fr/hal-00612705/document
Nutritional omega-3 deficiency abolishes endocannabinoid-mediated neuronal functions. Figure 1: n-3/n-6 PUFA dietary imbalance alters PUFAs level in mouse brain (charts–2011) http://www.nature.com/neuro/journal/v14/n3/fig_tab/nn.2736_F1.html
Searching for health beneficial n-3 and n-6 fatty acids in plant seeds (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3380567/
Antioxidant Activities and Oxidative Stabilities of Some Unconventional Oilseeds (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3311859/?toolubmed
Effect of feeding hemp seed and hemp seed oil on laying hen performance and egg yolk fatty acid content: Evidence of their safety and efficacy for laying hen diets (full–2012) http://ps.oxfordjournals.org/content/91/3/701.long
Antimicrobial Activity of Cannabis sativa L. (full–2012) (this doesn’t quite fit here, but it is about hemp seed oil) http://file.scirp.org/Html/10-8801078_18123.htm
Fatty Acid Profile and Sensory Characteristics of Table Eggs from Laying Hens Fed Hempseed and Hempseed Oil (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/22429187
Chemical Composition and Characterization of Hemp (Cannabis sativa) Seed oil and essential fatty acids by HPLC Method (full–2013) http://scholarsresearchlibrary.com/aasr-vol5-iss1/AASR-2013-5-1-5-8.pdf
Targeted mutation of Δ12 and Δ15 desaturase genes in hemp produce major alterations in seed fatty acid composition including a high oleic hemp oil (full–2014)  http://onlinelibrary.wiley.com/doi/10.1111/pbi.12167/epdf
Hemp (Cannabis sativa L.) seed oil: Analytical and phytochemical characterization of unsaponifiable fraction (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24422510
Effects of Hemp (Cannabis sativa L.) Seed Oil Press-Cake and Decaffeinated Green Tea Leaves (Camellia sinensis) on Functional Characteristics of Gluten-Free Crackers (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24527987
Potential Oil Yield, Fatty Acid Composition, and Oxidation Stability of the Hempseed Oil from Four Cannabis sativa L. Cultivars (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24552275
Hempseed oil induces reactive oxygen species- and C/EBP homologous protein-mediated apoptosis in MH7A human rheumatoid arthritis fibroblast-like synovial cells (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24814038
Cannabinoid-free Cannabis sativa L. grown in the Po valley: evaluation of fatty acid profile, antioxidant capacity and metabolic content (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24934168
Relationship between cannabinoids content and composition of fatty acids in hempseed oils (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25306338
Characterization of Byproducts Originating from Hemp Oil Processing (abst–2014) http://pubs.acs.org/doi/abs/10.1021/jf5044426
Effect of ultrasound pre-treatment of hemp (Cannabis sativa L.) seed on super-critical CO2 extraction of oil (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4348290/ 
Stability of cosmetic emulsion containing different amount of hemp oil (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25704610
Effect-directed analysis of cold-pressed hemp, flax and canola seed oils by planar chromatography linked with (bio)assays and mass spectrometry (abst–2015) http://www.sciencedirect.com/science/article/pii/S0308814615005890
top
Variability in Seed Traits in a Collection of Cannabis sativa L. Genotypes (full-2016) http://journal.frontiersin.org/article/10.3389/fpls.2016.00688/full

Polyphenolic Compounds and Antioxidant Activity of Cold-Pressed Seed Oil from Finola Cultivar of Cannabis sativa L. (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27076277
Cannabinoid Poisoning by Hemp Seed Oil in a Child (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27299295
Formulation, Characterization and Properties of Hemp Seed Oil and Its Emulsions (full–2017) http://www.mdpi.com/1420-3049/22/5/700/htm
Accelerated Burn Wound Closure in Mice with a New Formula Based on Traditional  Medicine (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5292211/
Challenges towards Revitalizing Hemp: A Multifaceted Crop (full–2017)  http://www.cell.com/trends/plant-science/fulltext/S1360-1385(17)30177-2
Hemp Industries Association, et al., Petitioners ) v. Drug Enforcement Administration, et  al., Respondents (download–2017) https://thehia.org/resources/Documents/Legal/HIA-v-DEA-9th-Circuit-Motion.pdf
Short-Term Efficacy of CBD-Enriched Hemp Oil in Girls with Dysautonomic Syndrome  after Human Papillomavirus Vaccination (link to PDF–2017)  https://www.ima.org.il/IMAJ/ViewArticle.aspx?aId=4042
Effect of unconventional oilseeds (safflower, poppy, hemp, camelina) on in vitro ruminal  methane production and fermentation (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28188639
Analysis of cannabinoids in commercial hemp seed oil and decarboxylation kinetics  studies of cannabidiolic acid (CBDA) (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0731708517322367?via%3Dihub


NUTRITION-HEMP SEED PROTEIN ISOLATES/POWDERS
Evaluating the Quality of Protein from Hemp Seed (Cannabis sativa L.) Products Through the use of the Protein Digestibility-Corrected Amino Acid Score Method (abst-2010) http://pubs.acs.org/doi/abs/10.1021/jf102636b
Stable Binding of Alternative Protein-enriched Food Matrices with Concentrated  Cranberry Bioflavonoids for Functional Food Applications (full–2013)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3769697/
Structural and functional properties of hemp seed protein products (abst–2014)  https://www.ncbi.nlm.nih.gov/pubmed/25048774
Denaturation and Oxidative Stability of Hemp Seed (Cannabis sativa L.) Protein Isolate as Affected by Heat Treatment (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26142888
Hemp Industries Association, et al., Petitioners ) v. Drug Enforcement Administration, et  al., Respondents (download–2017) https://thehia.org/resources/Documents/Legal/HIA-v-DEA-9th-Circuit-Motion.pdf
New ACE-Inhibitory Peptides from Hemp Seed (Cannabis sativa L.) Proteins (abst–2017) http://pubs.acs.org/doi/10.1021/acs.jafc.7b04522
top


NUTRITION-HIGH FAT DIET and the ENDOCANNABINOID SYSTEM
Exposure to a high-fat diet decreases sensitivity to Δ9-tetrahydrocannabinol-induced  motor effects in female rats (full-2010)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3014410/
Alterations in the hippocampal endocannabinoid system in diet-induced obese mice  (full–2010) http://www.jneurosci.org/content/30/18/6273.long
Maternal Dietary Fat Determines Metabolic Profile and the Magnitude of  Endocannabinoid Inhibition of the Stress Response in Neonatal Rat Offspring (full–2010) http://endo.endojournals.org/content/151/4/1685.full?sid=f9729cff-d221-42d4-81d8-8545db5df878
Dietary intakes in a group of marihuana smoking patients (full in Spanish, abst in English–2010) http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0212-16112010000400024&lng=en&nrm=iso&tlng=en
Effect of dietary fat on endocannabinoids and related mediators: consequences on energy homeostasis, inflammation and mood (abst-2010)  http://www.ncbi.nlm.nih.gov/pubmed/20013888
Effects of chronic nicotine on food intake and anxiety-like behaviour in CB(1) knockout  mice (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20189358
Expression of the cannabinoid system in muscle: effects of a high fat diet and CB1  receptor blockade (full–2011) http://www.biochemj.org/content/433/1/175
Altered endocannabinoid signalling after a high-fat diet in Apoe(-/-) mice: relevance to  adipose tissue inflammation, hepatic steatosis and insulin resistance (full–2011)  http://link.springer.com/article/10.1007/s00125-011-2274-6/fulltext.html
Resistance to diet-induced adiposity in cannabinoid receptor-1 deficient mice is not due  to impaired adipocyte function (full–2011)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3307495/
Lipid transport function is the main target of oral oleoylethanolamide to reduce  adiposity in high-fat-fed mice (full–2011)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3111743/?tool=pubmed
Roles of G1359A polymorphism of the cannabinoid receptor gene (CNR1) on weight loss  and adipocytokines after a hypocaloric diet (full in English, abst in Spanish–2011)  http://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0212-16112011000200012&lng=en&nrm=iso&tlng=en
Increment of hypothalamic 2-arachidonoylglycerol induces the preference for a high-fat  diet via activation of cannabinoid 1 receptors (abst–2011)  https://www.ncbi.nlm.nih.gov/pubmed/20817042
Hypothalamic 2-arachidonoylglycerol regulates multistage process of high-fat diet  preferences (full–2012)  http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0038609
Metabolic effects of n-3 PUFA as phospholipids are superior to triglycerides in mice fed a high-fat diet: possible role of endocannabinoids (full–2012)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3372498/
The thrifty lipids: endocannabinoids and the neural control of energy conservation (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3744874/
Antihyperglycemic and hypolipidemic effects of α, β-amyrin, a triterpenoid mixture from Protium heptaphyllum in mice (full–2012)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3484111/
CNR1 genotype influences HDL-cholesterol response to change in dietary fat intake (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3342253/
Dietary conditions and highly palatable food access alter rat cannabinoid receptor  expression and binding density (full–2012)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3621143/
Diet-dependent modulation of hippocampal expression of endocannabinoid signaling related proteins in cannabinoid antagonist-treated obese rats (abst–2012)  http://www.ncbi.nlm.nih.gov/pubmed/23033907
Nutritional properties of dietary omega-3-enriched phospholipids (full–2013)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3747496/
High fat diet and body weight have different effects on cannabinoid CB1 receptor  expression in rat nodose ganglia (full–2013)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3866822/
Effect of high fat-diet and obesity on gastrointestinal motility (full–2013)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3890396/
Cardiorespiratory control as a function of wake-sleep behavior and diet in mice lacking  CB1 cannabinoid receptors (abst–2013)  http://www.fasebj.org/content/27/1_Supplement/926.1.short
Changes in cannabinoid CB1 receptor functionality in the female rat prefrontal cortex  following a high fat diet (abst–2013)  http://www.ncbi.nlm.nih.gov/pubmed/23454443
Long-term supplementation of honokiol and magnolol ameliorates body fat  accumulation, insulin resistance, and adipose inflammation in high-fat fed mice (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23901038
Genetic variation in the cannabinoid receptor gene (CNR1) (G1359A polymorphism) and  their influence on anthropometric parameters and metabolic parameters under a high  monounsaturated vs. high polyunsaturated fat hypocaloric diets (abst–2013)  http://www.ncbi.nlm.nih.gov/pubmed/23337343
DHA prevents altered 5-HT1(A), 5-HT2(A), CB1 and GABA(A) receptor binding densities in the brain of male rats fed a high-saturated-fat diet (abst–2013)  http://www.ncbi.nlm.nih.gov/pubmed/23337348
Is the taste of fat regulated? (abst–2013)  http://www.sciencedirect.com/science/article/pii/S0300908413002526
Cannabinoid receptor 2 agonist attenuates pain related behavior in rats with chronic  alcohol / high fat diet induced pancreatitis (full–2014)  http://journals.sagepub.com/doi/full/10.1186/1744-8069-10-66
The effects of leptin in combination with a cannabinoid receptor 1 antagonist, AM 251, or cannabidiol on food intake and body weight in rats fed a high-fat or a free-choice high sugar diet (full–2014)  http://www.jpp.krakow.pl/journal/archive/08_14/pdf/487_08_14_article.pdf
Is fat taste ready for primetime? (full–2014)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4162865/
Vagal afferents are not necessary for the satiety effect of the gut lipid messenger  oleoylethanolamide (full–2014)  http://ajpregu.physiology.org/content/307/2/R167
Haloperidol and rimonabant increase delay discounting in rats fed high-fat and standard chow diets (full–2014)  http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4772744/
Cannabinoid Type 1 (CB1) Receptors on Sim1-Expressing Neurons Regulate Energy  Expenditure in Male Mice (full–2014)  http://press.endocrine.org/doi/10.1210/en.2014-1437
Influence of dietary fat intake on the endocannabinoid system in lean and obese subjects (full–2014) http://onlinelibrary.wiley.com/doi/10.1002/oby.20728/full
Long-term changes in the ghrelin-CB1R axis associated with the maintenance of lower  body weight after sleeve gastrectomy (full–2014)  http://www.nature.com/nutd/journal/v4/n7/full/nutd201424a.html
A diet containing a nonfat dry milk matrix significantly alters systemic oxylipins and the  endocannabinoid 2-arachidonoylglycerol (2-AG) in diet-induced obese mice (full–2014) http://www.nutritionandmetabolism.com/content/11/1/24
Multiple sleep alterations in mice lacking cannabinoid type 1 receptors (full–2014)  http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0089432
The antidiabetic and hepatoprotective effects of magnolol on diabetic rats induced by  high-fat diet and streptozotocin (abst–2014)  http://www.ncbi.nlm.nih.gov/pubmed/24974464
Classical endocannabinoid-like compounds and their regulation by nutrients (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24677570
Role of anorectic N-acylethanolamines in intestinal physiology and satiety control with  respect to dietary fat (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24681513
top

Effects of co-administration of 2-arachidonylglycerol (2-AG) and a selective µ-opioid  receptor agonist into the nucleus accumbens on high-fat feeding behaviors in the rat  (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4522234/
Fatty acid binding protein 5 (FABP5) regulates diet-induced obesity (DIO) via GIP  secretion from enteroendocrine K-cells in response to fat ingestion (full–2015)  http://ajpendo.physiology.org/content/308/7/E583.long
Renal effects of chronic pharmacological manipulation of CB2 receptors in rats with diet induced obesity (full–2015)  http://onlinelibrary.wiley.com/enhanced/doi/10.1111/bph.13056
Fat Diet-Induced Insulin Resistance Does Not Increase Plasma Anandamide Levels or
Potentiate Anandamide Insulinotropic Effect in Isolated Canine Islets (full–2015) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0123558
CB1R antagonist increases hepatic insulin clearance in fat-fed dogs likely via  upregulation of liver adiponectin receptors (full–2015)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4609878/
Orexin-A and Endocannabinoid Activation of the Descending Antinociceptive Pathway  Underlies Altered Pain Perception in Leptin Signalling Deficiency (full–2015)  http://www.nature.com/npp/journal/v41/n2/full/npp2015173a.html
Cannabinoid 2 Receptor Agonist Improves Systemic Sensitivity to Insulin in High-Fat  Diet/Streptozotocin-Induced Diabetic Mice (full–2016)  https://www.karger.com/Article/FullText/453171
Early Low Fat Diet Enriched with Linolenic Acid Reduces Liver Endocannabinoid Tone  and Improves Late Glycemic Control After a High Fat Diet Challenge in Mice (full–2016) http://diabetes.diabetesjournals.org/content/65/7/1824.long
A role for the endocannabinoid 2-arachidonoyl-sn-glycerol for social and high-fat food  reward in male mice (full–2016) http://www.ncbi.nlm.nih.gov/pubmed/26873082
Cannabinoid-glutamate interactions in the regulation of food intake in neonatal layer type chicks: role of glutamate NMDA and AMPA receptors (abst–2016)  https://www.ncbi.nlm.nih.gov/pubmed/27000110
Effects of chronic exercise on the endocannabinoid system in Wistar rats with high-fat  diet-induced obesity (abst–2016)  http://www.ncbi.nlm.nih.gov/pubmed/26880264
Cannabinoid receptor type 1 mediates high-fat diet-induced insulin resistance by  increasing forkhead box O1 activity in a mouse model of obesity (abst–2016)  http://www.spandidos-publications.com/10.3892/ijmm.2016.2475
Fabp1 gene ablation inhibits high fat diet-induced increase in brain endocannabinoids  (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27861894
Exercise training and high-fat diet elicit endocannabinoid system modifications in the rat hypothalamus and hippocampus (full–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28283967
Rimonabant improves metabolic parameters partially attributed to restoration of high  voltage-activated Ca2+ channels in skeletal muscle in HFD-fed mice (full–2017)  http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2017000600602&lng=en&nrm=iso&tlng=en (full–in varous languages)  http://www.scielo.br/scieloOrg/php/translate.php?pid=S0100-879X2017000600602&caller=www.scielo.br&lang=en&tlang=en&script=sci_arttext
Simvastatin and Bezafibrate ameliorate Emotional disorder Induced by High fat diet in  C57BL/6 mice (full-2017)  https://www.nature.com/articles/s41598-017-02576-5
Does the Gut Microbiota Influence Immunity and Inflammation in Multiple Sclerosis  Pathophysiology? (full–2017)  https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5337874/
Review: The Role of Cannabinoids on Esophageal Function—What We Know Thus Far  (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5665514/
Precision Nutrition and Omega-3 Polyunsaturated Fatty Acids: A Case for Personalized  Supplementation Approaches for the Prevention and Management of Human Diseases  (full–2017) http://www.mdpi.com/2072-6643/9/11/1165/htm
Loss of fatty acid binding protein-1 alters the hepatic endocannabinoid system response  to a high fat diet. (click “Full Text” for download–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28972119
The rewarding effects of ethanol are modulated by binge eating of a high-fat diet during  adolescence (abst–2017)  http://www.sciencedirect.com/science/article/pii/S0028390817301909
Oral haloperidol or olanzapine intake produces distinct and region-specific increase in  cannabinoid receptor levels that is prevented by high fat diet (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28619471
Impact of dietary fat on gut microbiota and low-grade systemic inflammation:  mechanisms and clinical implications on obesity (abst–2017)  http://www.tandfonline.com/doi/abs/10.1080/09637486.2017.1343286?journalCode=iijf20
Impact of dietary fats on brain functions (abst–2017)
https://www.ncbi.nlm.nih.gov/pubmed/29046155
Maternal high-fat diet induces sex-specific endocannabinoid system changes in newborn rats and programs adiposity, energy expenditure and food preference in adulthood (abst–2017) http://www.sciencedirect.com/science/article/pii/S0955286317303042?via%3Dihub
Perinatal maternal high-fat diet induces early obesity and sex-specific alterations of the  endocannabinoid system in white and brown adipose tissue of weanling rat offspring  (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/29110748
EFFECT OF MATERNAL HIGH-FAT DIET ON KEY COMPONENTS OF THE PLACENTAL AND HEPATIC ENDOCANNABINOID SYSTEM (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/29138223
Metabolic effects of intermittent access to caloric or non-caloric sweetened solutions in  mice fed a high-caloric diet (abst–2017)  https://www.ncbi.nlm.nih.gov/pubmed/28347724
Effects of acute exposure to chlorpyrifos on cholinergic and non-cholinergic targets in  normal and high-fat fed male C57BL/6J mice (abst–2017)  https://www.sciencedirect.com/science/article/pii/S0041008X17304295?via%3Dihub
Short-term high-fat diet primes excitatory synapses for long-term depression in orexin  neurons (abst–2017) http://onlinelibrary.wiley.com/doi/10.1113/JP275177/abstract
Salivary endocannabinoids and N-acylethanolamines upon mastication of a semisolid  food: implications in fat taste, appetite and food liking (abst–2018)  http://pubs.rsc.org/en/Content/ArticleLanding/2018/FO/C7FO01772C#!divAbstract
Effects of high-fat diet and age on the blood lipidome and circulating endocannabinoids  of female C57BL/6 mice (abst–2018)  https://www.sciencedirect.com/science/article/pii/S1388198117302044?via%
top


Advertisements